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FSP Section 20,000
Checklists and Illustrative Financial
Statements for Life and Health
Insurance Entities
.01 The checklists and illustrative financial statements in this section have been developed by the staff
of the Accounting and Auditing Publications Team of the AICPA as nonauthoritative technical practice aids.
Readers should be aware of the following:
•

The checklists and illustrative financial statements do not include all disclosures and presentation
items promulgated; as a result, pronouncements deemed unlikely to be encountered in financial
statements of life insurance companies are not included.

•

The checklists and illustrative financial statements are "tools" and in no way represent official
positions or pronouncements of the AICPA.

The financial statements and notes checklist have been updated to include relevant disclosure
guidance in accounting pronouncements issued through the following pronouncements:
•

Financial Accounting Standards Board (FASB) Statement of Financial Accounting
Standards (SFAS) No. 153, Exchanges of Nonmonetary Assets, an amendment of APB
Opinion No. 29, and revised FASB Statements issued through December 31, 2004,
including
• FASB Statement No. 123 (revised 2004), Share-Based Payment

•

FASB Interpretation (FASBI) No. 46 (revised December 2003), Consolidation of Variable
Interest Entities, an interpretation of ARB No. 51

•

FASB Technical Bulletin (FTB) No. 01-1, Effective Date for Certain Financial Institutions of
Certain Provisions of Statement 140 Related to the Isolation of Transferred Financial Assets

•

FASB Emerging Issues Task Force (EITF) consensuses adopted through the November
2004 meeting

•

FASB Staff Positions (FSP) issued through December 31,2004

•

AICPA Statement on Auditing Standards (SAS) No. 101, Auditing Fair Value Measurements
and Disclosures

•

Auditing Interpretations No. 17 and No. 18 of SAS No. 58, Reports on Audited Financial
Statements, as amended, titled "Clarification in the Audit Report of the Extent of Testing
of Internal Control Over Financial Reporting in Accordance With Generally Accepted
Auditing Standards," and "References to PCAOB Standards in an Audit Report on a
Nonissuer," respectively

•

AICPA Statement of Position (SOP) 04-2, Accounting for Real Estate Time-Sharing

Transactions
•

AICPA Practice Bulletin (PB) No. 15, Accounting by the Issuer of Surplus Notes
(continued)
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•

AICPA Statement on Standards for Accounting and Review Services (SSARS) No. 11,
Standards for Accounting and Review Services

•

Public Company Accounting Oversight Board (PCAOB) Auditing Standard No. 3, Audit
Documentation (and Amendment to Interim Standards)

The checklists and illustrative financial statements should be modified, as appropriate, for
pronouncements issued subsequent to the above. In determining the applicability of a
pronouncement, its effective date should also be considered.

.02 A description of the insurance industry and a description of common accounting and reporting
features of stock life insurance companies are presented in the AICPA Audit and Accounting Guide Life and
Health Insurance Entities.
.03 The checklists and illustrative financial statements should be used by, or under the supervision of,
persons having adequate technical training and proficiency in the application of generally accepted account
ing principles, generally accepted auditing standards, PCAOB auditing standards, and statements on
standards for accounting and review services.

.04 Users of the checklists and illustrative financial statements are urged to refer directly to applicable
authoritative pronouncements when appropriate. If you have further questions, call the AICPA Technical
Hotline at 1-888-777-7077.

Note: This publication was extracted from sections 20,000 through 20,600 of the AICPA Financial Statement
Preparation Manual (FSP).
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FSP Section 20,100
Introduction
.01 The function of insurance is to pool the risks of many persons who are exposed to similar risks. For
a payment known as a premium, insurance companies undertake to relieve the policyholder of all or part of
a risk and to spread the total cost of similar risks among large groups of policyholders. One of the primary
purposes of life insurance is to provide financial assistance to named beneficiaries at the time of the death of
the insured. The long-term nature of the coverage involving the risk of death—a risk that increases with
age—is the distinguishing characteristic that sets life insurance apart from other forms of insurance.
Traditionally, life insurance entities provided life and health products to protect against the loss of financial
stability resulting from premature death or illness, and provided annuity products to protect against the risk
of outliving one's financial resources. The primary emphasis was on meeting the customer's insurance needs.
The provisions of the AICPA Audit and Accounting Guide Life and Health Insurance Entities, apply to all life
and health insurance entities including stock, mutual, fraternal and assessment entities.

.02 The National Association of Insurance Commissioners (NAIC) codified statutory accounting
practices for certain insurance enterprises, resulting in a revised Accounting Practices and Procedures
Manual (the revised Manual). The insurance laws and regulations of the states require insurance
companies domiciled in the states to comply with the guidance provided in the NAIC Accounting
Practices and Procedures Manual except as prescribed or permitted by state law.
.03 In December 2001, the AICPA issued SOP 01-5, Amendment to Specific AICPA Pronouncements for
Changes Related to the NAIC Codification, which amends SOP 94-5, Disclosures of Certain Matters in the Financial
Statements of Insurance Enterprises, as a result of the completion of the National Association of Insurance
Commissioners (NAIC) Codification of statutory accounting practices for certain insurance enterprises.

.04 The amendments to SOP 94-5 included in SOP 01-5 require insurance enterprises to disclose, at the
date each balance sheet is presented, a description of the prescribed or permitted statutory accounting
practice and the related monetary effect on statutory surplus of using an accounting practice that differs from
either state prescribed statutory accounting practices or NAIC statutory accounting practices.
.05 Those disclosures should be made if (a) state prescribed statutory accounting practices differ from
NAIC statutory accounting practices or (b) permitted state statutory accounting practices differ from either
state prescribed statutory accounting practices or NAIC statutory accounting practices, and the use of
prescribed or permitted statutory accounting practices (individually or in the aggregate) results in reported
statutory surplus or risk-based capital that is significantly different from the statutory surplus or risk-based
capital that would have been reported had NAIC statutory accounting practices been followed.

.06 Those disclosures should be applied by a U.S. insurance enterprise, a U.S. enterprise with a U.S.
insurance subsidiary, or a foreign enterprise with a U.S. insurance subsidiary, if the enterprise prepares U.S.
generally accepted accounting principles (GAAP) financial statements. If a foreign insurance enterprise that
does not have a U.S. insurance subsidiary prepares U.S. GAAP financial statements or is included in its
parent's consolidated U.S. GAAP financial statements, the notes to the financial statements should disclose
permitted regulatory accounting practices that significantly differ from the prescribed regulatory accounting
practices of its respective regulatory authority and their monetary effects.

.07 SOP 01-5 also includes the following auditing guidance that has been updated as a result of the
completion of the NAIC Codification: SOP 95-5, Auditor's Reporting on Statutory Financial Statements of
Insurance Enterprises; SOP 94-1, Inquiries of State Insurance Regulators; and AICPA Auditing Interpretation
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No. 12, "Evaluation of the Appropriateness of Informative Disclosures in Insurance Enterprises' Financial
Statements Prepared on a Statutory Basis," of Statement on Auditing Standards (SAS) No. 62, Special Reports,
as amended (AICPA, Professional Standards, vol. 1, AU sec. 9623.60-.81). The included auditing guidance has
been approved by the Auditing Standards Board.

FSP §20,100.07
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FSP Section 20,200
Checklists—General
.01 AICPA disclosure checklists have been designed as practice aids to assist accountants in the
preparation of financial statements and to assist auditors in their evaluation of the adequacy of disclosures
in the financial statements they audit. Authoritative literature does not require the use of checklists, nor does
it prescribe their format or content.

.02 This checklist consists of a number of questions or statements that are accompanied by references to
the established sources of GAAP in which the disclosure requirements are found. These sources include
Statements of Financial Accounting Standards, FASB Interpretations, FASB Staff Positions, Accounting
Principles Board Opinions, Accounting Research Bulletins, AICPA Audit and Accounting Guides, AICPA
Statements of Position, and EITF consensuses. Checklists are designed to serve as convenient memory aids
but should not be used as a substitute for direct reference to authoritative literature.
.03 These checklists consist of a number of questions or statements that are accompanied by references
to applicable authoritative pronouncements. The checklists provide spaces for checking off or initialing each
question or point to indicate that it has been considered. Users should check or initial:
•

Yes—If the disclosure is required and has been made appropriately.

•

No—If the disclosure is required but is not made.

•

N/A (Not applicable)—If the disclosure is not required to be made.

Users may find it helpful to include references to the place where each disclosure for which a "Yes" is
indicated can be found in the financial statements. It may also be helpful to include either on the checklist or
elsewhere the reasons that items marked "N/A" do not apply in the circumstances of the particular report.
.04 It is important that the effect of any "No" response be considered on the auditor's report. A "No"
response that is material to the financial statements may warrant the issuance of a qualified or adverse report
on the financial statements. (See paragraphs 35-60 of SAS No. 58, Reports on Audited Financial Statements, as
amended [AICPA, Professional Standards, vol. 1, AU sec. 508.35-.60]). If a "No" response is indicated, the
authors recommend that a notation be made in the margin to explain why the disclosure was not made (for
example, because the item was not considered to be material to the financial statements) or to indicate the
effect that the response will have on the auditor's report.
.05 At the beginning of certain sections, a □ appears in the "N/A" column. If the entire section is
deemed to be non-applicable, place a check mark in the □ and proceed to the next section.
.06 As you use this checklist, please remember that:
•

The exercise of sound professional judgment is of paramount importance in applying the checklist
provisions.

•

The checklist may require modification based on the engagement circumstances.

•

The checklist may not be all-inclusive.

•

Users need to modify the checklist for any pronouncements issued subsequent to those mentioned
in the checklist.

FSP §20,200.06
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.07 These checklists and illustrative materials have been prepared by the AICPA staff. They have not
been reviewed, approved, disapproved, or otherwise acted on by any senior technical committee of the
AICPA and do not represent official positions or pronouncements of the AICPA.
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FSP Section 20,300
Financial Statements and Notes Checklist
.01 This checklist has been developed by the Accounting and Auditing Publications Team of the AICPA
as a nonauthoritative practice aid for use by preparers and auditors of financial statements.
This checklist includes disclosures commonly encountered in the financial statements of stock life insurance
companies and reporting issues likely to be encountered by accountants who audit, compile, and review
those types of financial statements. They do not include all disclosures required by GAAP or address all
reporting situations that may arise in performing engagements in accordance with GAAS, PCAOB Stand
ards, and SSARS.

.02 Explanation of References:

.03

SFAS =

FASB Statement of Financial Accounting Standards

FASBI =

FASB Financial Accounting Standards Board Interpretation

AC =

Reference to section number in FASB Accounting Standards—Current Text

APB =

Accounting Principles Board Opinion

ARB =

Accounting Research Bulletin

FTB =

Technical Bulletin issued by the staff of the FASB

AAG =

AICPA Audit and Accounting Guide Life and Health Insurance Entities

SOP =

AICPA Statement of Position

EITF =

Emerging Issues Task Force Consensus

FSP =

FASB Staff Position

PB =

AICPA Practice Bulletin

SAS =

AICPA Statement on Auditing Standards

AU =

Reference to section number in AICPA Professional Standards (vol. 1)

Checklist Questionnaire:

This checklist is organized into the sections listed below. Carefully review the topics listed and consider
whether they represent potential disclosure items for the life insurance company.
Place by
Applicable Sections

•

Balance Sheet
A.
General
B.
Cash
C.
Investment Securities
D.
Investments Accounted for by the Equity Method
E.
Impairment of a Loan
F.
Accounts and Notes Receivable and Agents' Balances
G.
Reinsurance Receivables
H. Lease Finance Receivables
I.
Deferred Acquisition Costs
J.
Property and Equipment
K.
Lessee Leases

FSP §20,300.03
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Place by
Applicable Sections

L.
M.
M1.
N.
O.
P.
Q.
R.
S.
T.
•

Other Assets
Intangible Assets and Goodwill
Transitional Disclosures for Goodwill and Other Intangible Assets
Separate Account Assets
Deposit Accounting
Policy Liabilities
Income Taxes
Current Liabilities, Notes Payable, and Long-Term Debt
Other Liabilities
Shareholders' Equity

Income Statement

A.
B.
C.
D.
E.
F.
G.
H.
I.

Premium Revenue
Investment Income
Other Income
Benefits and Expenses
Income Taxes
Extraordinary Items, Unusual Items, Infrequent Items
Earnings Per Share
Comprehensive Income
Other

•

Statement of Changes in Shareholders' Equity

•

Statement of Cash Flows

•

General

K.
L.
M.
N.
O.
P.

Titles and References
Disclosure of Accounting Policies
Comparative Financial Statements
Accounting Changes
Risks and Uncertainties
Contingencies and Commitments
Environmental Remediation Liabilities
Related-Party Transactions and Economic Dependency
Employee Stock Ownership Plans
Employers' Disclosures About Pensions and Other Postretirement
Benefits
Consolidations
Financial Instruments
Foreign Currency
Impairment of Long-Lived Assets to Be Held and Used
Long-Lived Assets and Disposal Groups to Be Disposed Of
Transfers and Servicing of Financial Assets and Securitizations

Q.

Nonmonetary Transactions

A.
B.
C.
D.
E.
F.
G.
H.
I.
J.

R.
S.
T.
/T1
.
U.
V.
W.
X.

Subsequent Events
Costs Associated With Exit or Disposal Activities
Business Combinations
Segment Information
Postemployment Benefits
Stock Compensation Plans
Asset Retirement Obligations

FSP §20,300.03
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Place by
Applicable Sections

Demutualizations and Formations of Mutual Insurance Holding
Companies
Guarantees

Y.
Z.

_________
_________

•

Auditors' Reports Checklist

_________

•

Supplemental Information for Life Insurance Companies That Are
Securities and Exchange Commission Registrants

_________

Yes

No

N/A

Note: Reminder—A "no" answer is indicative of a potential GAAP de
parture. The reason for the "no" answer and the resolution of the matter
should be documented in the working papers.

Balance Sheet
A. General
1.

For classified balance sheets, are assets and liabilities segregated into
current and noncurrent classifications, with totals presented for cur
rent assets and current liabilities?
[ARB 43, Ch. 3A, pars. 2-8; SFAS 78, pars. 5 and 13 (AC B05.102.109B); SFAS 6, par. 15 (AC B05.118); FASBI8, par. 3 (AC B05.117); TB
79-3, par. 2 (AC B05.501-.503)]

2.

Are assets not expected to be realized during the current operating
cycle classified as noncurrent?
[ARB 43, Ch. 3A, pars. 5 and 6 (AC B05.106 and .107)]

3.

Are valuation allowances for assets shown as deductions from their
related assets with appropriate disclosure?
[APB 12, par. 3 (AC V18.102)]

B. Cash

1.

Is restricted cash appropriately segregated from cash available for
current operations?
[ARB 43, Ch. 3A, par. 6 (AC B05.107)]

2.

Are restrictions on cash appropriately disclosed?
[SFAS 5, pars. 18 and 19 (AC C59.120)]

3.

Is the policy for determining cash equivalents disclosed?
[SFAS 95, par. 10 (AC C25.108)]

4.

If the company has material bank overdrafts or material balance of
undelivered checks as of the balance-sheet date, are:
a. Bank overdrafts presented as a separate caption within current
liabilities?

b. Undelivered checks classified as accounts payable?
[Generally Accepted]

FSP §20,300.03
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Yes

No

N/A

Practice Tip

Be sure that the amount of cash and cash equivalents displayed on the balance sheet equals the amount of
cash and cash equivalents displayed on the statement of cash flows.
C. Investment Securities
1.

Are there separate captions for each of the following investment
categories:
a. Fixed-maturity securities?
b. Mortgage loans on real estate?
c. Investment real estate?

d. Policy loans?
e. Other long-term investments?
[AAG, App. B]

2.

Are the carrying amounts of investment securities on deposit with
regulatory authorities disclosed?
[AAG, App. C, par. 1]

3.

Are debt and equity securities classified as (a) held-to-maturity, (b)
available-for-sale, or (c) trading?
[SFAS 115, par. 6 (AC I80.103)]

4.

If an enterprise presents a classified statement of financial position,
are all individual held-to-maturity securities, individual availablefor-sale securities, and individual trading securities reported as either
current or noncurrent, as appropriate, under the provisions of ARB
43, Chapter 3A, "Working Capital—Current Assets and Current Li
abilities"?
[SFAS 115, par. 17, as amended by SFAS 135 (AC I80.116)]

Practice Tip

Presentation of individual amounts for trading securities, held-to-maturity securities, and available-for-sale
securities on the face of the balance sheet is not required as long as the information is provided in the notes
to the financial statements.

5.

For securities classified as available-for-sale, has the reporting entity
made the following disclosures by major-security type as of each date
for which a statement of financial position is presented:

a. Aggregate fair value?
b. Total gains for securities with net gains in accumulated other
comprehensive income?

c. Total losses for securities with net losses in accumulated other
comprehensive income?
[SFAS 115, par. 19 (AC I80.118)]
6.

For securities classified as held-to-maturity, has the reporting entity
made the following disclosures by major-security type as of each date
for which a statement of financial position is presented:

a. Aggregate fair value?
b. Gross unrecognized holding gains or losses?

FSP §20,300.03
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Yes

No

N/A

c. Net carrying amount?

d. Gross gains and losses in accumulated other comprehensive in
come for any derivatives that hedged the forecasted acquisition of
the held-to-maturity securities?
[SFAS 115, par. 19 (AC I80.118)]
7.

For investments in debt securities classified as available-for-sale or
held-to-maturity:

a. Is disclosure made about their contractual maturities as of the date
of the latest balance sheet presented (maturity information may be
combined in appropriate groupings)?
b. If securities not due at a single date (such as mortgage-backed
securities) are allocated over several maturity groupings, is the
basis for allocation disclosed?
[SFAS 115, par. 20 (AC I80.119)]
8.

For each period for which an income statement is presented, are the
following disclosed:
a. The proceeds from sales of available-for-sale securities and gross
realized gains and losses that have been included in earnings as a
result of those sales?

b. The basis on which the cost of a security sold or the amount
reclassified out of accumulated other comprehensive income into
earnings was determined (i.e., specified identification, average
cost, or other method used)?
c. The gross gains and losses included in earnings from transfers
of securities from the available-for-sale category to the trading
category?

d. The amount of the net unrealized holding gain or loss on availablefor-sale securities for the period that has been included in accumu
lated other comprehensive income and the amount of gains and
losses reclassified out of accumulated other comprehensive in
come into earnings for the period?
e. The portion of trading gains and losses for the period that relates
to trading securities still held at the reporting date?
[SFAS 115, par. 21 (AC I80.120)]

9.

For any sales of or transfers from securities classified as held-tomaturity, are the following disclosed for each period for which an
earnings statement is presented:
a. Net carrying amount of the sold or transferred security?
b. The net gain or loss in accumulated other comprehensive income
for any derivative that hedged the forecasted acquisition of the
held-to-maturity security?

c. Related realized or unrealized gain or loss?

d. The circumstances leading to the decision to sell or transfer the
security?
[SFAS 115, par. 22 (AC I80.121)]

FSP §20,300.03
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Yes

10. Certain quantitative and qualitative disclosures are required for debt
and marketable equity securities classified as available-for-sale or
held-to-maturity under SFAS 115 and SFAS 124 that are impaired at
the balance sheet date but for which an other-than-temporary impair
ment has not been recognized. For those investments with unrealized
losses that have not been recognized as other-than-temporary impair
ments, does the investor disclose:
a. As of each date for which a statement of financial position is
presented, quantitative information, aggregated by each category
of investment that the investor discloses in accordance with SFAS
115 and SFAS 124 (refer to paragraph 5(b) in EITF 03-1), and cost
method investments in tabular form:
(1)

The aggregate amount of unrealized losses (that is, the amount
by which cost or amortized cost exceeds fair value)? and

(2)

The aggregate related fair value of investments with unreal
ized losses?

Notes: The disclosures in (1) and (2) above should be segregated by those
investments that have been in a continuous unrealized loss position for
less than 12 months and those that have been in a continuous loss position
for 12 months or longer.
The reference point for determining how long an investment has been in
a continuous unrealized loss position is the balance sheet date of the
reporting period in which the impairment is identified. For enterprises
that do not prepare interim financial information, the reference point
would be the annual balance sheet date of the period during which the
impairment was identified. The continuous unrealized loss position
ceases upon either (a) the recognition of an other-than-temporary impair
ment or (b) the investor becoming aware of a recovery of fair value up to
(or beyond) the cost of the investment during the period.
b. As of the date of the most recent statement of financial position,
additional information, in a narrative form, that provides suffi
cient information to allow financial statement users to understand
the quantitative disclosures and the information that the investor
considered (both positive and negative) in reaching the conclusion
that the impairments are not other-than-temporary, whose disclo
sure could include:

(1)

The nature of the investment(s)?

(2)

The cause(s) of the impairment(s)?

(3)

The number of investment positions that are in an unrealized
loss position?

(4)

The severity and duration of the impairment(s)?

(5)

Other evidence considered by the investor in reaching its con
clusion that the investment(s) is not other-than-temporarily
impaired, including, for example, industry analyst reports,
sector credit ratings, volatility of the security's market price,
and/or any other information that the investor considered
relevant?
[EITF 03-1, par. 21]

FSP §20,300.03
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Yes

No

N/A

11. For cost method investments, does the investor disclose the following
additional information, if applicable, as of each date for which a
statement of financial position is presented in its annual financial
statements:

a. The aggregate carrying amount of all cost method investments?

____

___

b. The aggregate carrying amount of cost method investments that
the investor did not evaluate for impairment? and

____

___

c. The fact that the fair value of a cost method investment is not
estimated if there are no identified events or changes in circum
stances that may have a significant adverse effect on the fair value
of the investment? and

____

___

____

___

____

___

(1)

(2)

The investor determined, in accordance with paragraphs 14
and 15 of SFAS 107, that it is not practicable to estimate the
fair value of the investment? or
The investor is exempt from estimating fair value under SFAS
126?
[EITF 03-1, par. 22]

Note: EITF 03-1 includes a tabular example of the quantitative disclosures
(see exhibit 03-1C) as referred to in Question 10a above.

12. Are mortgage loans that are purchased at a discount or premium
reported at amortized cost with an allowance for uncollectible
amounts, if any?
[SFAS 60, par. 47 (AC In6.153)]
13. Are changes in the allowance for uncollectible amounts relating to
mortgage loans reported in income as prescribed in SFAS 114, Ac
counting by Creditors for Impairment of a Loan?
[SFAS 60, par. 47, as amended by SFAS 114, par. 23 (AC In6.153)]
14. Are real estate investments (except those held for sale) reported at cost
less accumulated depreciation?
[SFAS 60, par. 48, as amended (AC In6.154); AAG, par. 11.82]
15. Are reductions in the carrying amounts of real estate investments
resulting from the application of SFAS 144, Accounting for the Impair
ment or Disposal of Long-Lived Assets, included in realized gains and
losses?
[SFAS 60, par. 48, as amended (AC In6.154)]
16. For those entities that enter into options with no intrinsic value at
acquisition in order to purchase securities accounted for under SFAS
115, is disclosure made of the accounting policy for the premium paid
(time value) to acquire the option that is classified as held-to-maturity
or available-for-sale disclosed?
[EITF 96-11]
17. Are mortgage loans that are acquired at par value reported at out
standing principal balances?
[SFAS 60, par. 47 (AC In6.153)]

18. Are adjustments to deferred acquisition costs (DAC) and other assets
and liabilities as a result of including unrealized gains or losses as part
of shareholders equity in accordance with SFAS 115 disclosed?
[AAG, App. C, par. 3]

FSP §20,300.03
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Yes

D.

Investments Accounted for by the Equity Method
1.

2.

Are investments in common stock shown in the balance sheet of the
investor as a single amount, and is the investor's share of earnings or
losses of the investee shown in the income statement as a single
amount (except for extraordinary items or prior period adjustments)?
[APB 18, par. 19 (AC I82.109c)]

____

Are the following disclosures made for investments in common stock
accounted for by the equity method:

a. The name of each investee and their percentage of ownership of
common stock?

____

b. The accounting policies of the investor with respect to investments
in common stock?

____

c. The difference between the amount at which an investment is
carried and the amount of underlying equity in net assets?

____

d. The accounting treatment of the difference described in c?

____

e. For investments in common stock for which a quoted market price

f.

is available, the aggregate value of each identified investment
based on the quoted market price? (Note: This is not required for
investments in common stock of subsidiaries.)

____

For investments in common stock, corporate joint ventures, or
other investments which are in the aggregate material in relation
to the financial position or results of operations of an investor,
summarized information as to assets, liabilities, and results of
operation of the investees as appropriate?

____

g. Material effects of conversions of outstanding convertible securi
ties, exercises, or contingent issuances?
[APB 18, par. 20 (AC I82.110)]

3.

____

If the reporting entity holds 20 percent or more of the voting stock of
a significant investee corporation but does not account for the invest
ment using the equity method, are the following disclosed:

a. The name of such investee?

____

b. The reasons why the equity method is not considered appropriate?

____

[APB 18, par. 20, fn. 13 (AC I82.110, fn. 14)]
4.

If the reporting entity holds less than 20 percent of the voting stock of
a significant investee corporation and accounts for the investment
using the equity method, are the following disclosed:

a. The name of such investee?

____

b. The reasons why the equity method is considered appropriate?

____

[APB 18, par. 20, fn. 13 (AC I82.110, fn. 14)]
5.

Does the life insurance entity disclose any contingent obligations or
commitments for additional funding or guarantees of obligations of
the investee?
[AAG, par. 11.88]
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Practice Tip

The significance of an investment to the investor's financial position and results of operations should be
considered in evaluating the extent of disclosures relating to the financial position and results of operations
of an investee.

E. Impairment of a Loan
1.

Is the allowance deducted from the related assets?
[APB 12, par. 3 (AC V18.102)]

2.

Is the following information disclosed, either in the body of the
financial statements or in the accompanying notes for impaired
loans:1

a. As of the date of each balance sheet presented:

(1)

Total recorded investment in the impaired loans at the end of
each period and the amount of the recorded investment for
which there is a related allowance for loan losses?

(2)

The amount of the allowance?

(3)

The amount of the recorded investment for which no allow
ance for loan losses was recorded?

(4)

The company's policy for recognizing interest on impaired
loans, including how cash receipts are recorded?

b. For each period for which a statement of income is presented:

(1)

Average recorded investments?

(2)

Related amount of interest income recognized using the cash
basis method of accounting during the time within the period
the loans were impaired?

(3)

If practicable, the amount of interest income recognized using
cash basis method of accounting during the time within the
period the loans were impaired?

(4)

The activity in the allowance for loan losses related to im
paired loans including the following:
(i)

Opening balance?

(ii) Additions charged to operations?

(iii) Direct write-down charged against the allowance?
(iv) Recovery of amounts previously charged off?
(v) Ending balance?
[SFAS 114, par. 20, as amended by SFAS 118, par. 6 (AC
I08.118 and 118A)]

3.

When a loan is restructured in a troubled debt restructuring (as
defined in SFAS 15) into two (or more) loan agreements, are the
restructured loans considered separately when assessing the applica
bility of the disclosures described in Question 2 above?
[EITF 96-22]

1 In certain circumstances, information about an impaired loan that has been restructured in a troubled debt restructuring involving
a modification of terms need not be included in the disclosures in Questions 2a and 2b (1)—(3).
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F.

Accounts and Notes Receivable and Agents' Balances
1.

Are premiums due reported as assets?
[AAG, Table 3.1]

2.

Are deferred premiums offset against liabilities for future policy
benefits?
[AAG, Table 3.1 and par. 7.19]

3.

Are hypothecation or other pledging of receivables disclosed?
[SFAS 5, pars. 18 and 19 (AC C59.120)]

4.

Are accounts and notes receivable from officers, employees, and
affiliated entities shown separately with appropriate disclosures?
[ARB 43, Ch. 1A, par. 5 (AC R36.105)]

5.

If a note is noninterest bearing or has an inappropriate stated interest
rate:

a. Is the discount or premium presented as a deduction from or
addition to the face amount of the note?

b. Does the disclosure include the effective interest rate and face
amount of the note?

c. Is amortization of discount or premium reported as interest in the
income statement?
[APB 21, par. 16 (AC I69.109)]
6.

Is the unamortized balance of loan origination, commitment, and
other fees and costs and purchase premiums and discounts that is
being recognized as an adjustment of yield reported as part of the loan
balance to which it relates?
[SFAS 91, par. 21 (AC I20.120)]

Note: Regarding SOP 01-6, Accounting by Certain Entities (Including Enti

ties With Trade Receivables) That Lend or Finance the Activities of Others,
Questions 7-15 below apply to organizations that (1) extend credit to
customers (constituents) to encourage them to purchase products and
services, (2) make mortgage loans, or (3) make secured or unsecured loans
to constituents (for example, tenant loans). This checklist includes only the
disclosure requirements for the more common activities within the scope
of SOP 01-6. If the organization purchases or sells loans or servicing rights,
forecloses on a loan, or engages in other more complex lending activities,
the disclosure requirements of SOP 01-6 not included herein also should
be considered.

7.

Does the accounting policy note include the following:

a. The basis of accounting for loans, trade receivables, and lease
financings, including those classified as held for sale?

b. The method used in determining the lower of cost or fair value of
nonmortgage loans held for sale (that is aggregate or individual
asset basis)?

c. The method for recognizing interest income on loan and trade receiv
ables, including the entity's policy for treatment of related fees and
costs and the method of amortizing net deferred fees or costs?
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No

N/A

17

Financial Statements and Notes Checklist
Yes

No

N/A

d. The classification and method of accounting for interest-only
strips, loans, other receivables, or retained interests in securitiza
tions that can be contractually prepaid or otherwise settled in a
way that the holder would not recover substantially all of its
recorded investment?
e. The accounting policies and methodology the entity used to esti
mate its allowance for loan losses, allowance for doubtful ac
counts, any liability for off-balance sheet credit losses, and any
related charges for loan, trade receivable or other credit losses,
including a description of the factors that influenced manage
ment's judgment?

f.

The policy for placing loans (and trade receivables if applicable)
on nonaccrual status (or discontinuing accrual of interest) and
recording payments received on nonaccrual loans (and trade re
ceivables if applicable), and the policy for resuming accrual of
interest?

g. The policy for charging off uncollectible loans and receivables?
h. The policy for determining past due or delinquency status (that is,
whether that status is based on most recent payment or on con
tractual terms)?
[SOP 01-6, par. 13a thru c]

8.

The aggregate amount of gains or losses on sales of loans or trade
receivables (including adjustments to record loans held for sale at the
lower of cost or fair value) presented separately in the financial
statement or disclosed in the notes?
[SOP 01-6, par. 13d]

9.

Loans or trade receivables may be presented on the balance sheet as
aggregated amounts. However,

a. Loans or trade receivables held for sale should be presented on the
balance sheet in a separate balance-sheet category?
b. Major categories of loans or trade receivables should be presented
separately either in the balance sheet or in the notes?

c. The allowance for credit losses, the allowance for doubtful ac
counts, and, as applicable, any unearned income, any unamor
tized premiums and discounts, and any net unamortized deferred
fees and costs, should be disclosed in the financial statements?
[SOP 01-6, par. 13e]
10. Foreclosed and repossessed assets classified as a separate balancesheet amount or included in other assets on the balance sheet with
separate disclosures in the notes?
[SOP 01-6, par. 13f]
11. Are certain returned or repossessed assets, such as inventory, sub
sequently to be utilized by the entity in operations, not classified
separately?
[SOP 01-6, par. 13f]

12. Is the recorded investment in loans (and trade receivables if applica
ble) on nonaccrual status as of each balance sheet date disclosed in the
notes to the financial statements?
[SOP 01-6, par. 13g]
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13. Is the recorded investment in loans (and trade receivables if appli
cable) past due ninety days or more and still accruing interest
disclosed?
[SOP 01-6, par. 13g]
14. Is the carrying amount of securities deposited disclosed if insurance
subsidiaries are required to deposit securities with state regulatory
authorities?
[SOP 01-6, par. 13h]
15. Is the carrying amount of loans, trade receivables, securities and
financial instruments that serve as collateral for borrowings disclosed
pursuant to paragraphs 18and 19 of SFAS5, Accounting for Contingencies?
[SOP 01-6, par. 13i]
Note: SOP 03-3, Accounting for Certain Loans or Debt Securities Acquired in
a Transfer, addresses accounting for differences between contractual cash
flows and cash flows expected to be collected from an investor's initial
investment in loans or debt securities (loans) acquired in a transfer if those
differences are attributable, at least in part, to credit quality. SOP 03-3 is
effective for loans acquired in fiscal years beginning after December 15,
2004. Early adoption is encouraged. For loans acquired in fiscal years
beginning on or before December 15,2004, and within the scope of PB 6,
paragraphs 7 and 8 of SOP 03-3, as they apply to decreases in cash flows
expected to be collected, should be applied prospectively for fiscal years
beginning after December 15,2004.

16. Do the notes to financial statements describe how prepayments are
considered in the determination of contractual cash flows and cash
flows expected to be collected?
[SOP 03-3, par. 14]
17. Is information about loans meeting the scope criteria of paragraph 3
of SOP 03-3 included in the disclosures required by paragraphs 20(a)
and 20(b) of SFAS 114, if the condition in paragraph 16 of SFAS 115
or paragraph 8(a) of SFAS 5 (as discussed in paragraphs 7(a) and 8(a)
of SOP 03-3) is met?
[SOP 03-3, par. 15]

18. In addition to disclosures required by other generally accepted ac
counting principles, for each balance sheet presented, does an investor
disclose the following information about loans within the scope of
SOP 03-3:

a. Separately for both those loans that are accounted for as debt
securities and those loans that are not accounted for as debt
securities:
(1)

The outstanding balance and related carrying amount at the
beginning and end of the period?

(2)

The amount of accretable yield at the beginning and end of
the period, reconciled for additions, accretion, disposals of
loans, and reclassifications to or from nonaccretable differ
ence during the period?

(3)

For loans acquired during the period, the contractually re
quired payments receivable, cash flows expected to be col
lected, and fair value at the acquisition date?
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For those loans within the scope of SOP 03-3 for which the
income recognition model in SOP 03-3 is not applied in
accordance with paragraph 6, the carrying amount at the
acquisition date for loans acquired during the period and the
carrying amount of all loans at the end of the period?

b. Further, for those loans that are not accounted for as debt securi
ties, does an investor disclose:
(1)

The amount of (a) any expense recognized pursuant to para
graph 8(a) of SOP 03-3 and (b) any reductions of the allowance
recognized pursuant to paragraph 8(b)(1) of SOP 03-3 for
each period for which an income statement is presented?

(2)

The amount of the allowance for uncollectible accounts at the
beginning and end of the period?
[SOP 03-3, par. 16]

G. Reinsurance Receivables
1.

Are fronting arrangements treated as reinsurance arrangements for
purposes of disclosures required by SFAS 60 and SFAS 113?
[SFAS 113, par. 6 (AC In6.169)]

2.

Are the following disclosed in relation to ceded insurance transactions:

a. Nature of the transaction(s)?
b. Purpose of the transaction(s)?
c. Effect of the transaction(s)?

d. The fact that the insurer is not relieved of its primary obligation to
the policyholder in a reinsurance transaction?
[SFAS 113, par. 27a (AC In6.191a)]
3.

Are the following disclosed for short-duration reinsurance contracts
on both a written and an earned basis:

a. Premiums from direct business?
b. Reinsurance assumed?
c. Reinsurance ceded?
[SFAS 113, par. 27b (AC In6.191b)]

4.

Are the following disclosed for long-duration reinsurance contracts:
a. Premiums and amounts assessed against policyholders from di
rect business?
b. Reinsurance assumed?

c. Reinsurance ceded?

d. Premiums and amounts earned?
[SFAS 113, par. 27b (AC In6.191b)]

5.

Are the methods used for income recognition on reinsurance contracts
disclosed?
[SFAS 113, par. 27c (AC In6.191c)]
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6.

Are concentrations of credit risk associated with reinsurance receiv
ables and prepaid reinsurance premiums disclosed for a ceding enter
prise under the provisions of paragraph 15A of SFAS 107, Disclosures
about Fair Value of Financial Instruments, as amended by SFAS 133,

Accounting for Derivative Instruments and Hedging Activities?

____

[SFAS 113, par. 28 (AC In6.192); SFAS 133, par. 533]
7.

Are the following items reported separately as assets for those com
panies participating in ceding transactions:

a. Estimated reinsurance receivables arising from ceding transactions?

____

b. Amounts paid to the reinsurer relating to the unexpired portion
of reinsured contracts (prepaid reinsurance premiums)?
[SFAS 113, par. 14 (AC In6.178)]

8.

9.

Are amounts receivable and payable between the ceding company
and an individual reinsurer offset only when a right of offset exists as
defined in FASBI39?
[SFAS 113, par. 15 (AC In6.179)]
Are the amounts of earned premiums ceded and recoveries recog
nized under reinsurance contracts reported in the statements of earn
ings as separate line items or disclosed in the notes?
[SFAS 113, par. 16 (AC In6.180); AAG, par. 12.30]

H. Lease Finance Receivables
1.

Do disclosures include:

a. Appropriate components of the net investment in the leases as of
the date of each balance sheet presented?

b. Future minimum lease payments to be received for each of the five
succeeding fiscal years as of the date of the latest balance sheet
presented?

c. Total contingent rentals included in income for each period for
which a statement of income is presented?
[SFAS 13, par. 23a, as amended by SFAS 91, par. 25d (AC
L10.119a)]

I.

2.

Are leasing arrangements described?
[SFAS 13, pars. 23 and 29 (AC L10.119 and .125); SFAS 91, par. 25 (AC
L10.119a(1)-(3)); SFAS 98, pars. 17-19 (AC L10.130k-m)]

3.

Are leveraged leases appropriately accounted for and reported?
[SFAS 13, pars. 41-47 (AC L10.143-.149)]

Deferred Acquisition Costs
1.

Are unamortized acquisition costs classified in the balance sheet as
assets?
[AAG, par. 10.22]

2.

Are the following disclosed relating to deferred acquisition costs:

a. The nature of costs capitalized?
b. The method of amortizing these costs?
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c. The amount of these costs amortized for the period?
[AAG, App. C, par. 6; SFAS 60, par. 60c (AC In6.166c)]

3.

Is the fact that the company considers anticipated investment income
in determining if a premium deficiency relating to short-duration
contracts exists disclosed?
[SFAS 60, par. 60e (AC In6.166e)]

4.

If a public company acquires a life insurance entity accounted for as
a purchase and the acquirer recognizes an asset for the present value
of future profits (PVP) is the following disclosed:

a. A description of the company's accounting policy?
b. An analysis of the PVP asset account for each year for which an
income statement is presented, including the PVP balance at the
beginning of the year, the amount of PVP additions during the
year arising from acquisitions of insurance entities, the amount of
interest accrued on the unamortized PVP balance during the year,
the interest accrual rate, the amount of amortization during the
year, the amount of any write-offs during the year attributable to
impairment and how those write-offs were determined, and the
PVP balance at the end of the year?
c. The estimated amount or percentage of the end of the year PVP
balance to be amortized during each of the next five years?
[AAG, App. C, par. 7]

J.

Property and Equipment

1.

Is the carrying basis of property and equipment disclosed?
[AAG, App. B; APB 12, par. 5 (AC D40.105)]

2.

For depreciable assets, does disclosure include:

a. Depreciation expense for each period for which an income state
ment is presented?
b. Balances of major classes of depreciable assets, by nature or func
tion, at the balance-sheet date?

c. Accumulated depreciation, either by major classes of depreciable
assets or in total, at the balance-sheet date?

d. A general description of the method or methods used in comput
ing depreciation for major classes of depreciable assets?
[APB 12, par. 5 (AC D40.105)]
3.

Are pledged assets and material commitments for property expendi
tures disclosed?
[SFAS 5, pars. 18 and 19 (AC C59.120)]

4.

For any accounting period in which interest costs are capitalized, is
the total amount of interest cost incurred during the period, and the
amount thereof that is capitalized, disclosed?
[SFAS 34, par. 21b (AC I67.118)]
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5.

Is the amount of interest cost incurred and charged to expense during
the period disclosed for an accounting period in which no interest cost
is capitalized?
[SFAS 34, par. 21a (AC I67.118)]

Note: Subsequent to the adoption of SFAS 143, the following consensus
does not apply to obligations for asbestos removal that are within the
scope of SFAS 143.

6.

For an existing property with an asbestos problem, are the costs
incurred to treat the problem, if charged to expense, not classified as
an extraordinary item?
[EITF 89-13]

K. Lessee Leases

1.

Is the following information disclosed with respect to capital leases:

a. The gross amount of assets recorded under capital leases as of the
date of each balance sheet presented by major classes according to
nature or function (this information may be combined with the
comparable information for owned assets)?
b. Future minimum lease payments as of the date of the latest balance
sheet presented, in the aggregate and for each of the next five fiscal
years, with separate deductions from the total for executory costs,
including any profit thereon that is included in the minimum lease
payments and for the amount of the imputed interest necessary to
reduce the net minimum lease payments to present value?

c. The total of minimum sublease rentals to be received in the future
under noncancelable subleases as of the date of the latest balance
sheet presented?

d. Total contingent rentals actually incurred for each period for
which an income statement is presented?
[SFAS 13, par. 16 (AC L10.112)]
e. Separate identification of:
(1)

Assets recorded under capital leases?

(2)

Accumulated amortization of capital leases?

(3)

Obligations under capital leases?

(4)

Amount of amortization of capital lease assets or the fact that
the amortization of capital lease assets is included in depre
ciation expense?
[SFAS 13, par. 13 (AC L10.112)]

Are the following disclosed for operating leases that have initial or
remaining noncancelable lease terms in excess of one year:

a. Future minimum rental payments required, as of the date of the
latest balance sheet presented, in the aggregate, and for each of the
five succeeding fiscal years?
b. The total of minimum rentals to be received in the future under
noncancelable subleases as of the date of the latest balance sheet
presented?
[SFAS 13, par. 16 (AC L10.112)]
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3.

4.

5.

Yes

No

____

___

a. The basis on which contingent rental payments are determined?

____

___

b. The existence and terms of renewal or purchase options and
escalation clauses?

____

___

c. Restrictions imposed by lease agreements, such as those concern
ing dividends, additional debt, and further leasing?
[SFAS 13, par. 16 (AC L10.112)]

____

___

Is the nature and extent of leasing transactions with related parties
disclosed?
[SFAS 13, par. 29 (AC L10.125)]

____

___

For all operating leases, do disclosures include rental expense for each
period for which an income statement is presented, with separate
amounts for minimum rentals, contingent rentals, and sublease rent
als (rental payments under leases with terms of a month or less that
are not renewed need not be included)?

N/A

Do disclosures include a general description of the lessee's leasing
arrangements including, but not limited to, the following:

L. Other Assets

Note: If SFAS 142, Goodwill and Other Intangible Assets, has not been
adopted, the following questions do apply. See section M for the disclo
sures required after the effective date of SFAS 142. SFAS 142 is required
to be applied at the beginning of an entity's fiscal year and to be applied
to all goodwill and other intangible assets recognized in its financial
statements at that date.
1.

Do disclosures include the method and period of amortization of
intangible assets?
[APB 22, par. 13 (AC A10.106)]

2.

For an unidentified intangible asset arising as a result of the fair value
of liabilities assumed in a purchase method business combination
exceeding fair value of tangible and identified intangible assets ac
quired in a combination initiated after September 30, 1982, is the
method and period of amortization disclosed?
[APB 17, par. 30 (AC App. E, I60.111)]

M. Intangible Assets and Goodwill (Only applicable if the provisions of
SFAS 142 are being applied to the financial statements)

Note: SFAS 142 is not applicable to goodwill and other intangible assets
arising from combinations between mutual enterprises until the Financial
Accounting Standards Board completes its deliberation with respect to
application of the purchase method by those entities. Goodwill and intan
gible assets acquired in a combination between two or more mutual
enterprises for which the acquisition date is after June 30, 2001, shall
continue to be accounted for in accordance with APB 17.
1.

At a minimum, are all intangible assets aggregated and presented as
a separate line item in the statement of financial position? (This
requirement does not preclude presentation of individual intangible
assets or classes of intangible assets as separate line items.)
[SFAS 142, par. 42 (AC G40.141)]
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2.

Are amortization expense and impairment losses for intangible assets
presented in income statement line items within continuing opera
tions as deemed appropriate for each entity?
[SFAS 142, par. 42 (AC G40.141)]

3.

Is the aggregate amount of goodwill presented as a separate line item
in the statement of financial position?
[SFAS 142, par. 43 (AC G40.142)]

4.

Is the aggregate amount of goodwill impairment losses presented as
a separate line item in the income statement before the subtotal income
form continuing operations (or similar caption) unless a goodwill im
pairment loss is associated with a discontinued operation?
[SFAS 142, par. 43 (AC G40.142)]

5.

Is a goodwill impairment loss associated with a discontinued opera
tion included (on a net-of-tax basis) within the results of discontinued
operations?
[SFAS 142, par. 43 (AC G40.142)]

6.

For intangible assets acquired either individually or with a group of
assets, is the following information disclosed in the notes to the
financial statements in the period of acquisition:

a. For intangible assets subject to amortization:
(1)

The total amount assigned and the amount assigned to any
major intangible asset class?

(2)

The amount of any significant residual value, in total and by
major intangible asset class?

(3)

The weighted-average amortization period, in total and by
major intangible asset class?

b. For intangible assets not subject to amortization, the total amount
assigned and the amount assigned to any major intangible asset
class?

c. The amount of research and development assets acquired and
written off in the period and the line item in the income statement
in which the amounts written off are aggregated?
[SFAS 142, par. 44 (AC G40.143)]

7.

Has the following information been disclosed in the financial state
ments or the notes to the financial statements for each period for which
a statement of financial position is presented:

a. For intangible assets subject to amortization:
(1)

The gross carrying amount and accumulated amortization, in
total and by major intangible asset class?

(2)

The aggregate amortization expense for the period?

(3)

The estimated aggregate amortization expense for each of the
five succeeding fiscal years?

b. For intangible assets not subject to amortization, the total carrying
amount and the carrying amount for each major intangible asset
class?
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c. The changes in the carrying amount of goodwill during the period
including:

(1)

The aggregate amount of goodwill acquired?

(2)

The aggregate amount of impairment losses recognized?

(3)

The amount of goodwill included in the gain or loss on
disposal of all or a portion of a reporting unit?

8.

If the entity reports segment information in accordance with SFAS
131, is the above information about goodwill provided in total and for
each reportable segment and are any significant changes in the allo
cation of goodwill by reportable segment disclosed?
[SFAS 142, par. 45 (AC G40.144)]

9.

If any portion of goodwill has not yet been allocated to a reporting
unit at the date the financial statements are issued, is that unallocated
amount and the reasons for not allocating that amount disclosed?
[SFAS 142, par. 45 (AC G40.144)]

10. For each impairment loss recognized related to an intangible asset, is
the following information disclosed in the notes to the financial
statements that include the period in which the impairment loss is
recognized:

a. A description of the impaired intangible asset and the facts and
circumstances leading to the impairment?

b. The amount of the impairment loss and the method for determin
ing fair value?
c. The caption in the income statement in which the impairment loss
is aggregated?

d. If applicable, the segment in which the impaired intangible asset
is reported under SFAS 131?
[SFAS 142, par. 46 (AC G40.145)]

11. For each goodwill impairment loss recognized, is the following infor
mation disclosed in the notes to the financial statement that include
the period in which the impairment loss is recognized:
a. A description of the facts and circumstances leading to the
impairment?

b. The amount of the impairment loss and the method of determining
the fair value of the associated reporting unit (whether based on
quoted market prices, prices of comparable businesses, a present
value or other valuation technique, or a combination thereof)?
c. If a recognized impairment loss is an estimate that has not yet
been finalized (refer to SFAS 142, paragraph 22), that fact and the
reasons therefor and, in subsequent periods, the nature and
amount of any significant adjustments made to the initial estimate
of the impairment loss?
[SFAS 142, par. 47 (AC G40.146-.148)]
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Ml. Transitional Disclosures for Goodwill and Other Intangible Assets

Note: Readers should refer to paragraphs 48-61 of SFAS142 for effective
date and transition guidance related to SFAS 142.
1.

2.

Upon completion of the first step of the transitional goodwill impair
ment test, is the reportable segment or segments in which an impair
ment loss might have to be recognized and the period in which that
potential loss will be measured disclosed in any interim financial
information?
[SFAS 142, par. 60]

____

In the period of initial application and thereafter until goodwill and
all other intangible assets have been accounted for in accordance with
SFAS 142 in all periods presented, is the following information dis
played either on the face of the income statement or in the notes to the
financial statements:

a. Income before extraordinary items and net income for all periods
presented adjusted to exclude amortization expense (including any
related tax effects) recognized in these periods related to goodwill?

b. Intangible assets that are no longer being amortized?

____
____

c. Any deferred credit related to an excess over cost (amortized in
accordance with APB 16)?

____

d. Equity method goodwill?

____

[SFAS 142, par. 61]

3.

4.

5.

Does the adjusted income before extraordinary items and net income
also reflect any adjustments for changes in amortization periods for
intangible assets that will continue to be amortized as a result of
initially applying SFAS 142 (including any related tax effects)?
[SFAS 142, par. 61]

____

Is a reconciliation of reported net income to the adjusted net income
disclosed?
[SFAS 142, par. 61]

____

Are adjusted earnings per share amounts for all periods presented in
either the face of the income statement or in the notes?
[SFAS 142, par. 61]

____

N. Separate Account Assets
1.

2.

Are separate account assets reported as summary totals in the finan
cial statements?
[SFAS 60, par. 54 (AC In6.160)]

____

Has the insurance company disclosed the following information re
garding separate accounts:

a. The general nature of the contracts reporting in separate accounts,
including the extent and terms of minimum guarantees?

____

b. The basis of presentation for separate account assets and liabilities
and related separate account activity?
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c. The aggregate fair value of assets, by major investment asset
category, supporting separate accounts with additional insurance
benefits and minimum investment return guarantees as of each
date for which a statement of financial position is presented?

d. The amount of gains and losses recognized on assets transferred
to separate accounts for the periods presented?
[SOP 03-1, par. 38; AAG, App. C, par. 41
O. Deposit Accounting
1.

Has a description of the contracts accounted for as deposits and the
separate amounts of total deposit assets and total deposit liabilities
reported in the statement of financial position been disclosed?
[SOP 98-7, par. 18; AAG, App. C, par. 24]

2.

Has the following information regarding the changes in the recorded
amount of the deposit arising from an insurance or reinsurance con
tract that transfers only significant underwriting risk been disclosed:
a. The present values of initial expected recoveries that will be reim
bursed under the insurance or reinsurance contracts that have
been recorded as an adjustment to incurred losses?

b. Any adjustment of amounts initially recognized for expected re
coveries? (The individual components of the adjustment (mean
ing, interest accrual, the present value of additional expected
recoveries, and the present value of reductions in expected recov
eries) should be disclosed separately.)
c. The amortization expense attributable to the expiration of cover
age provided under the contract?
[SOP 98-7, par. 19; AAG, App. C, par. 24]

P.

Policy Liabilities

1.

Is the basis for estimating the liabilities for unpaid claims and claim
adjustment expenses disclosed?
[SFAS 60, par. 60a (AC In6.166a); AAG, App. C, par. 9a]

2.

Are the methods and assumptions used in estimating the liability for
future policy benefits and the average rate of assumed investment
yields in effect for the current year disclosed?
[SFAS 60, par. 60b (AC In6.166b); AAG, App. C, par. 12]

3.

Is the carrying amount of liabilities for unpaid claims and claim
adjustment expenses relating to short-duration contracts that are
presented at present value in the financial statements and the range
of interest rates used to discount those liabilities disclosed?
[SFAS 60, par. 60d (AC In6.166d); AAG, App. C, par. 9b]

4.

For each fiscal year for which an income statement is presented is the
following information about the liability for unpaid claims and claim
adjustment expenses disclosed:

a. The balance in the liability for unpaid claims and claim adjustment
expenses at the beginning and end of the period presented with,
if net balances are presented, separate disclosure of the related
amount of reinsurance recoverable?
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b. Incurred claims and claim adjustment expenses with separate
disclosure of the provision of insured events of the current period
and for increases or decreases in the provision for insured events
of prior fiscal years?
c. Payments of claims and claim adjustment expenses with separate
disclosure of payments of claims and claim adjustment expenses
attributable to insured events of the current fiscal year and to
insured events of the prior period?
[SOP 94-5, par. 10; AAG, App. C, par. 10]

5.

If changes in incurred claims and claim adjustment expenses recog
nized in the income statement are attributable to insured events of
prior periods are the following disclosed in the financial statements:

a. The reasons for the change?
b. Whether additional premiums or return premiums have been
accrued as a result of the prior-period effects?
[SOP 94-5, par. 10, as amended by SOP 01-5; AAG, App. C, par.
11]
6.

Is the fact that the company considers anticipated investment income
in determining if a premium deficiency relating to short-duration
contracts exists disclosed?
[SFAS 60, par. 60e (AC In6.166e); AAG, App. C, par. 9c]

7.

For participating insurance, does disclosure include:

a. The relative percentage?

b. The method of accounting for policyholders' dividends?
c. The amount of dividends?

d. The amount of any additional income allocated to participating
policyholders?
[SFAS 60, par. 60g (AC In6.166g); AAG, App. C, par. 18]
Note: SOP 95-1, Accounting for Certain Insurance Activities of Mutual Life
Insurance Enterprises, applies to life insurance contracts that have both of
the following characteristics:2
• They are long-duration participating contracts that are expected to
pay dividends to policyholders based on actual experience of the insur
ance enterprise.
• Annual policyholder dividends are paid in a manner that identifies
divisible surplus and distributes that surplus in approximately the
same proportion as the contracts are considered to have contributed
to divisible surplus (commonly referred to in actuarial literature as
the contribution principle).

8.

Are premiums from participating insurance contracts reported as
revenue in the statement of income when due from policy holders?
[SOP 95-1, par. 12]

2 SFAS 120, Accounting and Reporting by Mutual Life Insurance Enterprises and by Insurance Enterprises for Certain Long-Duration
Participating Contracts, permits stock life insurance enterprises with participating life insurance contracts that meet the conditions listed
above to account for those contracts in accordance with SOP 95-1. [SFAS 120, par. 6]
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9.

Are death and surrender benefits incurred reported as expense in the
statement of income?
[SOP 95-1, par. 13]

No

N/A

____

10. Are annual policyholder dividends:
a. Reported separately as an expense in the statement of income?
[SOP 95-1, par. 14]

____

11. Are the following disclosed in the financial statements with respect to
participating contracts:

a. The methods and assumptions used in estimating the liability for
future policy benefits?

____

b. The average rate of assumed investment yields used in estimating
expected gross margins?

____

c. The nature of acquisition costs capitalized, the method of amortizing
those costs, and the amount of those costs amortized for the period?
[SOP 95-1, par. 24; AAG, App. C, par. 19]
12. Has the entity disclosed a description of the liability valuation meth
ods and assumptions used in estimating the liabilities for additional
insurance benefits and minimum guarantees?
[SOP 03-1, par. 38; AAG, App. C, par. 12]

____

____

13. Have the following been disclosed in relation to minimum guaran
tees:

a. The separate account liability balances subject to various types of
benefits (for example, guaranteed minimum death benefit, guar
anteed minimum income benefit, guaranteed minimum accumu
lation benefit). Disclosures within these categories of benefits for
the types of guarantees provided may also be appropriate (for
example, return of net deposits, return of net deposits accrued at
a stated rate, return of highest anniversary value)?

____

b. The amount of liability reported for additional insurance benefits,
annuitization benefits and other minimum guarantees, by type of
benefit, for the most recent balance sheet date and the incurred and
paid amounts for all periods presented?

____

c. For contracts for which an additional liability is disclosed in
paragraph b above, net amount at risk and weighted average
attained age of contract holders?
[SOP 03-1, par. 38; AAG, App. C, par. 12]

Q.

____

Income Taxes
1.

Are deferred tax assets and liabilities determined for each tax-paying
component (an individual company or group of companies that is
consolidated for tax purposes) in each tax jurisdiction presented
separately?
[SFAS 109, par. 17 (AC I27.116)]

2.

Are the components of the net deferred tax liability or asset recog
nized in the balance sheet disclosed as follows:

a. The total of all deferred tax liabilities?
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b. The total of all deferred tax assets?
c. The total valuation allowance for deferred tax assets?
[SFAS 109, par. 43 (AC I27.142)]
3.

Is the net change during the year in the total valuation allowance
disclosed?
[SFAS 109, par. 43 (AC I27.142)]

4.

Is the following information disclosed whenever a deferred tax liabil
ity is not recognized because of the exceptions to comprehensive
recognition of deferred taxes for any of the areas addressed by APB
23, Accounting for Income Taxes—Special Areas (as amended by SFAS
109, Accounting for Income Taxes):

a. A description of the types of temporary differences for which a
deferred tax liability is not recognized and the types of events that
would cause those temporary differences to become taxable?

b. The cumulative amount of each type of temporary differences?
c. The amount of the unrecognized deferred tax liability for tempo
rary differences related to investments in foreign subsidiaries and
foreign corporate joint ventures that are essentially permanent in
duration if determination of that liability is practicable, or a state
ment that determination is not practicable?

d. The amount of the deferred tax liability for temporary differences
other than those in c. above (i.e., undistributed domestic earnings,
the bad debt reserve for tax purposes of a U.S. savings and loan
association or other qualified thrift lender, the policyholders' sur
plus of a life insurance enterprise, and the statutory reserve funds
of a U.S. steamship enterprise) that is not recognized in accordance
with the provisions of paragraphs 31 and 32 of SFAS 109 (AC
I27.130 and .131)?
[SFAS 109, par. 44 (AC I27.143)]
5.

In a classified balance sheet:

a. Are deferred tax assets and deferred tax liabilities classified as
current or noncurrent based on the classification of the related
asset or liability for financial reporting?
[SFAS 109, par. 41 (AC I27.140)]

b. Are deferred tax assets or liabilities not related to an asset or
liability for financial reporting (including those related to carry
forwards) classified according to the expected reversal date of the
temporary difference?
[SFAS 109, pars. 41 and 288p (AC I27.140)]

c. Is the valuation allowance for a particular tax jurisdiction allocated
between current and noncurrent deferred tax assets for that tax
jurisdiction on a pro rata basis?
[SFAS 109, par. 41 (AC I27.140)]

d. Are the following items offset and presented as a single amount
for a particular taxpaying component and within a particular
taxpaying jurisdiction:
(1)
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(2)

6.

No

N/A

All noncurrent deferred tax liabilities and assets?
[SFAS 109, par. 42 (AC I27.141)]

Do the financial statements include disclosure of the following:

a. Disclosures relating to "Policyholders' Surplus" as defined in the
Internal Revenue Code and as prescribed by APB 23?
b. The portion of retained earnings in excess of statutory unassigned
surplus upon which no income tax provisions have been made and
the reasons therefor?
[AAG, App. C, par. 13]

7.

If the reporting entity is a public enterprise:

a. Is the approximate tax-effect of each type of temporary difference
and carryforward that gives rise to a significant portion of deferred
tax liabilities and deferred tax assets (before valuation allowances)
disclosed?
b. If the reporting entity is not subject to income taxes because its
income is taxed directly to its owners, is that fact and the net
differences between the tax bases and reported amounts of the
enterprises' assets and liabilities disclosed?
[SFAS 109, par. 43 (AC I27.142)]
8.

If the reporting entity is a nonpublic enterprise, are the types of
temporary differences and carryforwards that give rise to a significant
portion of deferred tax liabilities and deferred tax assets (before
valuation allowances) disclosed?
[SFAS 109, par. 43 (AC I27.142)]

R. Current Liabilities, Notes Payable, and Long-Term Debt
1.

For classified balance sheets, do current liabilities include:

a. Obligations for items that entered the operating cycle?
b. Collections received in advance of the performance of services?

c. Debts that arise from operations directly related to the operating
cycle?
d. Other liabilities whose regular and ordinary liquidation is likely
to occur within a relatively short time period?
e. Obligations that, by their terms, are due on demand or will be due
within one year (or operating cycle, if longer) from the balancesheet date, even though liquidation may not be expected within
that period?
[ARB 43, Ch. 3A, pars. 7 and 8 (AC B05.108 and .109); SFAS 78, par.
5 (AC B05.109a)]
2.

Do current liabilities exclude short-term obligations that the provider
intends to refinance on a long-term basis, provided the provider has
demonstrated the ability to consummate the long-term financing?
[SFAS 6, pars. 8-14 (AC B05.113-.116); FASBI8, pars. 2-4 (AC B05.117,
.138 and .139)]
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3.

4.

Is there adequate disclosure of interest rates, maturities, and other
terms and conditions provided in loan agreements and bond inden
tures (such as assets pledged as collateral, and covenants to reduce
debt, and maintain working capital)?
[FASCON 5, par. 11; SFAS 5, par. 18 (AC C59.120)]

____

Are the following disclosed for each of the five years following the
date of the latest balance sheet presented:

a. The aggregate amount of payments for unconditional purchase
obligations that meet the criteria of SFAS 47, Disclosure of LongTerm Obligations, and that are recognized on the purchaser's bal
ance sheet?

____

b. The combined aggregate amount of maturities and sinking fund
requirements for all long-term borrowings?

____

c. The amount of redemption requirements for all issues of capital
stock that are redeemable at fixed or determinable prices on fixed
or determinable dates, separately by issue or combined?
[SFAS 47, par. 10 (AC C32.105)]
5.

Are conversion features appropriately accounted for and disclosed?
[APB 14, par. 12 (AC D10.103); APB 15, par. 19 (AC E09.110)]

6.

If a note is noninterest bearing or has an inappropriate stated interest
rate:

____
____

a. Is the discount or premium presented as a deduction from or
addition to the face amount of the note?

____

b. Does the disclosure include the effective interest rate and face
amount of the note?

____

c. Is amortization of the discount or premium reported as interest
expense?

____

d. Are issue costs reported in the balance sheet as deferred charges?

____

[APB 21, par. 16 (AC I69.109)]
7.

If a short-term obligation is to be excluded from current liabilities in
a classified balance sheet, do disclosures include:

a. A general description of the financing agreement?
b. The terms of any new obligation incurred or expected to be in
curred, or equity securities issued or expected to be issued as a
result of the refinancing?
[SFAS 6, par. 15 (AC B05.118)]
8.

____

____

For a troubled debt restructuring occurring during the current period,
do disclosures include:

a. Description of the principal changes in terms, the major features
of settlement, or both?

____

b. Aggregate gain on restructuring of payables and the related in
come tax effect?

____

c. Aggregate net gain or loss on transfers of assets recognized during
the period?

____

d. Per-share amount of the aggregate gain on restructuring of pay
ables, net of related income tax effect?
[SFAS 15, par. 25 (AC D22.121)]
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9.

No

N/A

For periods after a troubled debt restructuring, do disclosures include:
a. Extent to which amounts contingently payable are included in the
carrying amount of restructured payables?

b. Total amounts that are contingently payable, if applicable, and
conditions under which those amounts would become payable or
forgiven?
[SFAS 15, par. 26 (AC D22.122)]
10. If there is an early extinguishment of debt, is the difference between
reacquisition price and carrying amount identified as income in the
period of extinguishment as gain or loss?
[APB 26, pars. 20 and 21 (AC D14.103 and .104)]
11. Is the following disclosed if debt was considered to be extinguished
by in-substance defeasance under the provisions of SFAS 76, Extin
guishment of Debt, prior to the effective date of SFAS 125:

a. A general description of the transaction?
b. The amount of debt that is considered extinguished at the end of
the period so long as that debt remains outstanding?
[SFAS 140, par. 17(b) (AC L35.109a)]
12. If assets are set aside after January 1,1997 solely for satisfying sched
uled payments of a specific obligation, is disclosure made describing
the nature of restrictions placed on those assets?
[SFAS 140, par. 17(c) (AC L35.109b)]
13. Are long-term obligations that are or will be callable by the creditor,
either because the debtor's violation of the debt agreement at the
balance-sheet date makes the obligation callable, or because the vio
lation (if not cured within a specified grace period) will make the
obligation callable, classified as current unless one of the following
conditions is met:

a. The creditor waives or subsequently loses the right to demand
repayment for more than one year (or operating cycle, if longer)
from the balance-sheet date?
b. The obligation contains a grace period within which the debtor
may cure the violation and it is probable that the violation will be
cured within that period, thus preventing the obligation from
becoming callable?
[SFAS 78, par. 5 (AC B05.109A)]
14. If a covenant on a long-term loan agreement is not met, and thus, the
lender has the right to call the debt, and the lender waives that right
for a period of greater than one year but retains the future covenant
requirements, is the debt classified as noncurrent unless both of the
following are met:

a. The covenant violation occurred at the balance-sheet date or
would have occurred absent a loan modification?
b. It is probable the company will not be able to comply with the
covenant at a measurement date within the next 12 months?
[EITF 86-30]
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15. Are borrowings outstanding under a revolving credit agreement that
includes both a subjective acceleration clause and a requirement to
maintain a lock-box arrangement, whereby remittances from the
borrower's customers reduce the debt outstanding, classified as short
term obligations?
[EITF 95-22]
16. In accordance with PB15, Accounting by the Issuer of Surplus Notes, are
surplus notes classified as debt in the financial statements of the
issuer, and are existing disclosure requirements for debt instruments
complied with?
[AAG, par. 14.15, App. C, par. 14]
17. In accordance with PB 15, is the Insurance Commissioner's role and
ability to approve or disapprove any interest or principal payments
disclosed?
[AAG, par. 14.15, App. C, par. 14]
18. If the reclassification to earnings of the amount in accumulated com
prehensive income resulting from a cash flow hedge of debt is re
quired under SFAS 133 when the debt is extinguished, is the
reclassified amount not classified as extraordinary?
[EITF 00-9]

S.

____

____

____

____

Other Liabilities
1.

2.

Are liabilities appropriately accrued and reported for employees'
compensation for future absences?
[SFAS 43, par. 6 (AC C44.104)]

____

For insurance-related assessments:

a. If amounts relating to insurance-related assessments have been
discounted pursuant to the provisions of SOP 97-3, Accounting by
Insurance and Other Enterprises for Insurance-Related Assessments,
has the entity disclosed in the financial statements the undis
counted amounts of the liability and any related asset for premium
tax offsets or policy surcharges as well as the discount rate used?

____

b. If amounts have not been discounted, has the entity disclosed in
the financial statements the amounts of the liability, any related
asset for premium tax offsets or policy surcharges, the periods
over which the assessments are expected to be paid, and the period
over which the recorded premium tax offsets or policy surcharges
are expected to be realized?
[SOP 97-3, par. 27; AAG, App. C, par. 23]

____

T. Shareholders' Equity
1.

2.

For each class of stock, do disclosures include the number of shares
authorized, issued, and outstanding, and par or stated value per
share?
[Generally Accepted]

Are classes of capital stock presented in order of priority in liquida
tion?
[Generally Accepted]

FSP §20,300.03

____

____

No

N/A

35

Financial Statements and Notes Checklist
Yes

3.

4.

5.

6.

Do the financial statements include a description, in summary form,
sufficient to explain the pertinent rights and privileges of the various
securities outstanding (e.g., dividend and liquidation preferences,
participation rights, call prices and dates, conversion or exercise
prices or rates and pertinent dates, sinking fund requirements, un
usual voting rights, and significant terms of contracts to issue addi
tional shares)?
[SFAS 129, par. 4 (AC C24.102)]

Do disclosures include the number of shares issued upon conversion,
exercise, or satisfaction of required conditions during at least the
most recent annual fiscal period and any subsequent interim period
presented?
[SFAS 129, par. 5 (AC C24.103)]
For preferred stock that has a preference in involuntary liquidation
considerably in excess of par or stated value of the shares, is the
liquidation preference disclosed in the equity section of the balance
sheet in the aggregate, either parenthetically or "in short," rather than
on a per share basis or in the notes to the financial statements?
[SFAS 129, par. 6 (AC C24.104)]

b. The aggregate and per-share amounts of arrearages in cumulative
preferred dividends?
[SFAS 129, par. 7 (AC C24.105)]

8.

N/A

____

____

____

Are the following disclosed on the face of the balance sheet or in the
notes:

a. The aggregate or per-share amounts at which preferred stock may
be called or are subject to redemption through sinking-fund op
erations or otherwise?

7.

No

For redeemable stock, do disclosures include the amount of redemp
tion requirements, separately by issue or combined, for all issues of
capital stock that are redeemable at fixed or determinable prices on
fixed or redeemable dates in each of the five years following the date
of the latest balance sheet?
[SFAS 129, par. 8 (AC C24.106)]

____
____

____

Do disclosures for contingently convertible securities include the
significant quantitative and qualitative terms of the conversion fea
tures to enable users of the financial statements to understand the
circumstances of the contingency and the potential impact of conver
sion, including:

a. Events or changes in circumstances that would cause the contin
gency to be met and any significant features necessary to under
stand the conversion rights and the timing of those rights (for
example, the periods in which (1) the contingency might be met
and (2) the securities may be converted if the contingency is met)?

____

b. The conversion price and the number of shares into which the
security is potentially convertible?

____

c. Events or changes in circumstances, if any, that could adjust or
change the contingency, conversion price, or number of shares,
including significant terms of those changes?

____
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d. The manner of settlement upon conversion and any alternative
settlement methods (for example, cash, shares, or a combination)?
[FSP 129-1, par. 4 (AC C24.804)]

No

____

___

____

___

____

___

____

___

12. After completion of a quasi-reorganization, is a new retained earnings
account established and dated with the date being disclosed in sub
sequent financial statements until it is no longer deemed significant?3
[ARB 43, Ch. 7A, par. 10 (AC Q15.111); ARB 46 (AC Q15.111); SFAS
111, par. 8(a)3]

____

___

13. Are the carrying basis, cost and number of shares of any treasury stock
held by the reporting entity disclosed?
[Generally Accepted]

____

___

a. Shown separately as a deduction from the total of capital stock,
additional paid-in capital, and retained earnings? or

____

___

b. Accorded the accounting treatment appropriate for retired stock?

____

___

____

___

____

___

____

___

____

___

9.

Do disclosures indicate whether the shares that would be issued if the
contingently convertible securities were converted are included in the
calculation of diluted EPS, and the reasons why or why not?
[FSP 129-1, par. 5 (AC C24.805)]

10. Are appropriations of retained earnings for loss contingencies clearly
identified and included in shareholders' equity?
[SFAS 5, par. 15 (AC R70.103)]
11. Are restrictions on payment of dividends disclosed?
[SFAS 5, pars. 18 and 19 (AC C59.120)]

14. If treasury stock is purchased for purposes other than retirement or if
ultimate disposition has not yet been decided is its cost:

15. If state laws relating to acquisition of stock restrict the availability of
retained earnings for payment of dividends or other significant ef
fects, is appropriate disclosure made?
[APB 6, par. 13 (AC C23.104)]

16. If an additional liability required to be recognized pursuant to SFAS
87, paragraph 36 (AC P16.130), exceeds unrecognized prior-service
cost, is the excess (which would represent a net loss not yet recognized
as net periodic pension cost) reported in other comprehensive income,
net of any tax benefits that result from considering such losses as
temporary differences, for purposes of applying the provisions of
SFAS 87, paragraph 37 (AC I27) and SFAS 109, paragraph 287?
[SFAS 87, par. 37 (AC P16.131)]
17. For treasury shares purchased at a stated price significantly in excess
of current market price, is the allocation of amounts paid and the
accounting treatment for such amounts disclosed?
[FTB 85-6, pars. 1-3 (AC C23.501-.503)]

18. Is the following information relating to stockholders' equity, statutory
capital and surplus, and the effects of statutory accounting practices
on the ability to pay dividends to stockholders disclosed:

a. The amount of statutory capital and surplus?

3 As stated in paragraph 8(a)3 of SFAS 111, the dating would rarely, if ever, be of significance after a period of ten years.
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b. The amount of statutory capital and surplus necessary to satisfy
regulatory requirements (based on current operations) if signifi
cant in relation to the statutory capital and surplus?
c. The nature of statutory restrictions on the payment of dividends
and the amount of retained earnings that is not available for the
payment of dividends to stockholders?
[SFAS 60, par. 60h (AC In6.166h); AAG, App. C, par. 16]

19. If the company receives a note rather than cash as a contribution to its
equity, is the note classified as a reduction of stockholders' equity
unless (in the very limited circumstance) there is substantial evidence
of ability and intent to pay within a reasonably short period of time?
[EITF 85-1]

Yes

No

____

___

____

___

____

___

____

___

____

___

____

___

____

___

____

___

____

___

____

___

N/A

Income Statement
A. Premium Revenue

1.

Are premiums from universal life contracts no longer included in
revenue but recorded in the balance sheet policyholder accounts?
[SFAS 97, par. 59 (AC In6.116A)]

B. Investment Income

1.

Are amounts of interest income, loan origination, commitment, am
ortization amounts, and other fees and costs recognized as an adjust
ment of yield reported as part of interest income?
[SFAS 91, par. 22 (AC L20.121); AAG, par. 11.55]

2.

Is investment income presented net of investment expenses?
[SFAS 97, par. 23 (AC In6.137B)]

3.

Are realized gains and losses on all investments (except invest
ments that are classified as trading securities and those that are
accounted for as either hedges of net investments in foreign opera
tions or cash flow hedges as described in SFAS 133) reported in the
statement of income as a component of other income, on a pretax
basis?
[SFAS 97, par. 28 (AC In6.156)]

4.

For all three categories of investments under SFAS 115, is interest and
dividend income, including amortization of premium and discount,
included in earnings?
[AAG, par. 11.12]

C. Other Income
1.

Is amortization of other fees, such as commitment fees that are being
amortized on a straight-line basis over the commitment period or
included in income when the commitment expires, reported as service
fee income?
[SFAS 91, par. 22 (AC L20.121)]

D. Benefits and Expenses
1.

Do disclosures for advertising costs include:
a. The accounting policy selected from the two alternatives in para
graph 26 of SOP 93-7, Reporting on Advertising Costs, for reporting
advertising, indicating whether such costs are expensed as in
curred or the first time the advertising takes place?
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b. A description of the direct-response advertising reported as assets
(if any), the accounting policy, and the amortization period?

c. The total amount charged to advertising expense for each income
statement presented, with separate disclosure of amounts, if any,
representing a write-down to net realizable value and the reasons
for such a write-down?

d. The total amount of advertising reported as assets in each balance
sheet?
[SOP 93-7, par. 49]

E.

2.

Are payments to policyholders that represent a return of policyholder
balances not reported as expenses in the statement of earnings?
[AAG, par. 9.19; SFAS 97, par. 21]

3.

Do amounts reported as expenses include benefit claims in excess of
the related policyholder balances, expenses of contract administra
tion, interest accrued to policyholders, and amortization of capital
ized acquisition costs?
[AAG, par. 9.19]

4.

Are depreciation and other related charges or credits related to real
estate investments recorded as investment expense or operating ex
pense depending on the balance-sheet classification of the underlying
assets?
[AAG, par. 11.77; SFAS 60, par. 48 (AC In6.154)]

Income Taxes

1. Are the types of significant temporary differences and carryforwards
disclosed?
[SFAS 109, par. 43 (AC I27.142)]

2.

Are the following significant components of income tax expense
attributable to continuing operations for each year presented dis
closed in the financial statements or notes thereto:

a. Current tax expense or benefit?

b. Deferred tax expense or benefit (exclusive of the effects of other
components listed below)?

c. Investment tax credits?
d. The benefits of operating loss carryforwards?

e. Tax expense that results from allocating certain benefits, either
directly to contributed capital or to reduce goodwill or other
noncurrent intangible assets, of an acquired company?

f. Adjustments of a deferred tax liability or asset for enacted changes
in tax laws or rates or a change in the tax status of the enterprise?

g. Adjustments of the beginning-of-the-year balance of a valuation
allowance because of a change in circumstances that causes a
change in judgment about the realizability of the related deferred
tax asset in future years?
[SFAS 109, par. 45a-h (AC I27.144A-H)]
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h. The amounts and expiration dates of operating loss and tax credit
carryforwards for tax purposes?

i.

Any portion of the valuation allowance for deferred tax assets for
which subsequently recognized tax benefits will be allocated to
reduce goodwill or other noncurrent intangible assets of an ac
quired entity or directly to contributed capital?
[SFAS 109, pars. 45 and 48 (AC I27.144 and .147)]

3.

Is the amount of income tax expense or benefit allocated to continuing
operations and the amounts separately allocated to other items (in
accordance with the provisions of paragraphs 35-39 of SFAS 109 (AC
I27.134-.138)) disclosed for each year for which those items are pre
sented?
[SFAS 109, par. 46 (AC I27.145)]

4.

If the company is a public enterprise, do the financial statements
disclose a reconciliation using percentages or dollar amounts of (i) the
reported amount of income tax expense attributable to continuing
operations for the year to (ii) the amount of income tax expense that
would result from applying domestic federal statutory tax rates to
pretax income from continuing operations?
[SFAS 109, par. 47 (AC I27.146)]

5.

If the company is a public enterprise, is the estimated amount and the
nature of each significant reconciling item disclosed?
[SFAS 109, par. 47 (AC I27.146)]

6.

If the company is a non-public enterprise, is the nature of signifi
cant reconciling items disclosed (a numerical reconciliation may be
omitted)?
[SFAS 109, par. 47 (AC I27.146)]

7.

If the company is a member of a group that files a consolidated tax
return, are the following items disclosed in its separately issued
financial statements:

a. The aggregate amount of current and deferred tax expense for
each statement of income presented and the amount of any
tax-related balances due to or from affiliates as of the date of each
statement of financial position presented?
b. The principal provisions of the method by which the consolidated
amount of current and deferred tax expense is allocated to mem
bers of the group and the nature and effect of any changes in that
method (and in determining related balances to or from affiliates)
during the years for which the disclosures in Question a above are
presented?
[SFAS 109, par. 49a and b (AC I27.148A and B)]
8.

Does an enterprise that previously recognized the qualified produc
tion activities deduction, associated with the American Jobs Creation
Act of 2004, as a tax rate reduction restate its financial statements in
accordance with paragraph 27 of APB 20, Accounting Changes, to
reflect the deduction as a special deduction as prescribed in para
graphs 231 and 232 of SFAS 109, and provide the disclosures required
by paragraph 28 of APB 20 and paragraph 14 of SFAS 3, Reporting
Accounting Changes in Interim Financial Statements, if applicable?
[FSP 109-1]
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9.

Is the following information disclosed for an enterprise that has not
yet completed its evaluation of the repatriation provision, associated
with the American Jobs Creation Act of 2004 ("Act"), for purposes of
applying SFAS 109 for each period for which financial statements
covering periods affected by the Act are presented:

a. A summary of the repatriation provision as it applies to the
enterprise, including the status of the enterprise's evaluation of the
effects of the repatriation provision as well as the evaluation's
expected completion date?

____

b. If the entity makes decisions in stages, the effect on income tax
expense (or benefit) for any amounts that have been recognized
under the repatriation provision? For annual financial statements,
any effect should be shown separately in the same place (either on
the face of the income statement or in the footnotes) that the
amounts of current and deferred taxes are disclosed for the period.

____

c. The range of reasonably possible amounts of unremitted earnings
that is still being considered for repatriation as a result of the
repatriation provision and the related potential range of income
tax effects of such repatriation? If the related range of income tax
effects of such repatriation cannot be reasonably estimated at the
time of issuance of its financial statements, an enterprise shall
provide a statement to that effect.

____

d. Pro forma financial data for any effect of the repatriation provision
(at a minimum, the effect on income tax expense (or benefit)) if the
enterprise decides on a plan for reinvestment or repatriation of
foreign earnings (as a result of the repatriation provision) sub
sequent to the date of its financial statements but prior to the
issuance of those financial statements?
[FSP109-2]

____

10. Is the following information provided in an enterprise's financial
statements for the period in which it completes its evaluation of the
repatriation provision, associated with the American Jobs Creation
Act of 2004:

a. The total effect on income tax expense (or benefit) for amounts that
have been recognized under the repatriation provision? For an
nual financial statements, any effect should be shown separately
in the same place (either on the face of the income statement or in
the footnotes) that the amounts of current and deferred taxes are
disclosed for the period.
[FSP 109-2]
F.

____

Extraordinary Items, Unusual Items, Infrequent Items

1.

2.

Do extraordinary items meet both criteria of (1) unusual nature and
(2) infrequency of occurrence?
[APB 30, par. 20 (AC I17.107)]

Are extraordinary items segregated and shown (including applicable
income taxes) following income before extraordinary items and be
fore net income?
[APB 30, par. 11 (AC I17.102)]
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3.

4.

5.

6.

7.

Are descriptive captions and amounts (including applicable income
taxes) presented for individual extraordinary events or transactions,
preferably on the face of the income statement?
[APB 30, par. 11 (AC I17.102)]
Do disclosures include descriptions of an extraordinary event or
transaction and the principal items entering into determination of
extraordinary gain or loss?
[APB 30, par. 11 (AC I17.102)]
Are the income taxes applicable to extraordinary events disclosed on
the face of the statement of operations or in related notes?
[APB 30, par. 11 (AC I17.102)]
Is each adjustment in the current period of an element of an extraor
dinary item that was reported in a prior period separately disclosed
as to year of origin, nature, and amount and classified separately in
the current period as an extraordinary item?
[SFAS 16, par. 16c (AC I17.119)]

b. Accompanied by disclosure of the nature and financial effects of
each event?
[APB 30, par. 26 (AC I22.101)]

9.

If the losses and costs incurred as a result of the September 11, 2001
attacks meet the criteria for disclosure of unusual or infrequently
occurring items, are they reported as a separate component of income
from continuing operations, either on the face of the statement of
operations or in the notes to the financial statements?
[EITF 01-10]

____

____

____

____

____
____

____

Is the following information disclosed in the notes to the financial
statements in the period(s) in which business interruption (BI) insur
ance recoveries are recognized:

a. The nature of the event resulting in business interruption losses?

b. The aggregate amount of BI insurance recoveries recognized dur
ing the period and the line item(s) in the statement of operations
in which those recoveries are classified (including amounts re
ported as an extraordinary item pursuant to APB 30)?
[EITF 01-13]
G.

N/A

Are material events or transactions that are either unusual in nature
or of infrequent occurrence, but not both (and therefore not meeting
criteria for extraordinary items):
a. Reported as a separate component of income from continuing
operations?

8.

No

____

____

Earnings Per Share
Note: SFAS 128, Earnings per Share, applies only to entities with publicly
held common stock or potential common stock.
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1.

2.

3.

4.

5.

If the reporting entity has a simple capital structure (only common
stock outstanding), are basic per-share amounts for income from
continuing operations and for net income presented on the face of the
income statement for all periods for which an income statement or
summary of earnings is presented?
[SFAS 128, pars. 36 and 38 (AC E11.131 and .133)]
If the reporting entity has other than a simple capital structure, are
basic and diluted per-share amounts for income from continuing
operations and for net income presented on the face of the income
statement with equal prominence for all periods for which an income
statement or summary of earnings is presented? (Note: If diluted EPS
data are reported for at least one period, they should be reported for
all periods presented, even if they are the same amounts as basic EPS.)
[SFAS 128, pars. 36 and 38 (AC E11.131 and .133)]
If discontinued operations, extraordinary items, or the cumulative
effect of accounting changes are reported in the period, are the basic
and diluted per share amounts for those line items presented on the
face of the income statement or in the notes?
[SFAS 128, par. 37 (AC E11.132)]

If per share amounts not required to be presented by SFAS 128 are
disclosed, are they disclosed only in the notes and do the disclosures
indicate whether the per share amounts are pretax or net of tax?
[SFAS 128, par. 37 (AC E11.132)]

____

____

____

____

Are the following disclosed for each period for which an income
statement is presented:
a. A reconciliation of the numerators and denominators of the basic
and diluted per share computations for income from continuing
operations?

____

b. The effect that has been given to preferred dividends in arriving
at income available to common shareholders' in computing basic
EPS?

____

c. Securities (including those issuable pursuant to contingent stock
agreements) that could potentially dilute basic EPS in the future
that were not included in the computation of diluted EPS because
to do so would have been antidilutive for the period(s) presented?
[SFAS 128, par. 40 (AC E11.135)]
6.

For the latest period for which an income statement is presented, do
disclosures include a description of any transaction that occurs after
the end of the most recent period but before issuance of the financial
statements that would have changed materially the number of com
mon shares or potential common shares outstanding at the end of the
period if the transaction had occurred before the end of the period?
[SFAS 128, par. 41 (AC E11.136)]

Note: EITF 03-6 is effective for reporting periods beginning after March
31,2004.
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7.

Are prior period earnings per share amounts presented for compara
tive purposes restated to conform to the consensus guidance in EITF
03-6, Participating Securities and the Two-Class Method under FASB
Statement No. 128, Earnings per Share?
[EITF 03-6]

____

No

N/A

___

Note: At the November 17-18, 2004 meeting, the EITF discussed the
effective date of the consensus in EITF 04-8. The consensus would have
been applied to reporting periods ending after the effective date of the
proposed Statement that amends SFAS 128, which was expected to be
December 15, 2004. The FASB staff indicated that it now expects that the
proposed Statement will be issued in the first quarter of 2005, and its
effective date will need to be deliberated at a future Board meeting. The
EITF agreed to change the transition provisions of the consensus to require
that the guidance in EITF 04-8 be applied to reporting periods ending after
December 15,2004.

8.

9.

For contingently convertible instruments outstanding at the date of
adoption of EITF 04-8 and whose terms have not been modified since
the date of issuance, are prior-period diluted earnings per share
restated to conform to the guidance in the consensus for comparative
purposes?
[EITF 04-8]
For contingently convertible instruments outstanding at the date of
adoption of EITF 04-8 and whose terms have been modified, are
prior-period diluted earnings per share restated to conform to the
guidance in the consensus for comparative purposes based on the
modified terms of the instrument at the date of adoption of EITF 04-8?
[EITF 04-8]

10. For contingently convertible instruments that have been stock settled
(stock settled would include conversion) prior to the date of adoption
of EITF 04-8, are all prior-period diluted earnings per share restated
to conform to the guidance in the consensus for comparative pur
poses?
[EITF 04-8]

____

____

____

H. Comprehensive Income
1.

2.

3.

4.

Are all components of comprehensive income reported in the finan
cial statements in the period in which they are recognized?
[SFAS 130, par. 14 (AC C49.108)]

Is a total amount for comprehensive income displayed in the financial
statement where the components of other comprehensive income are
reported?
[SFAS 130, par. 14 (AC C49.108)]
Is an amount for net income displayed and included as a component
of comprehensive income?
[SFAS 130, pars. 15 and 22 (AC C49.109 and .116)]
Are items included in other comprehensive income classified sepa
rately into foreign currency items, minimum pension liability adjust
ments, and unrealized gains and losses on certain investments in debt
and equity securities?
[SFAS 130, par. 17 (AC C49.111)]

____

____

____

____
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5.

6.

7.

8.

9.

Are reclassification adjustments made to avoid double counting in
comprehensive income of items that are displayed as part of net
income for a period that also had been displayed as part of other
comprehensive income in that period or other periods presented on
the face of the financial statement in which comprehensive income is
reported or disclosed in the notes?
[SFAS 130, par. 20 (AC C49.114)]
Are comprehensive income and its components displayed in a finan
cial statement that is displayed with the same prominence as the other
financial statements? (Note: SFAS 130 encourages but does not re
quire that the components of other comprehensive income and total
comprehensive income be displayed below the total for net income in
a statement that reports results of operations or in a separate state
ment of comprehensive income that begins with net income.)
[SFAS 130, pars. 22 and 23 (AC C49.116 and .117)]
Are the components of other comprehensive income displayed either
net of related tax effects, or before related tax effects with one amount
shown for the aggregate tax effect related to the total of other compre
hensive income items?
[SFAS 130, par. 24 (AC C49.118)]

Is the amount of income tax expense or benefit allocated to each
component of other comprehensive income (including reclassifica
tion adjustments) displayed on the face of the statement in which
those components are displayed or disclosed in the notes to the
financial statements?
[SFAS 130, par. 25 (AC C49.119)]
Is the total of other comprehensive income for a period transferred to
a component of equity that is displayed separately from retained
earnings and additional paid-in-capital in the balance sheet with a
descriptive title such as accumulated other comprehensive income?
[SFAS 130, par. 26 (AC C49.120)]

10. Are accumulated balances for each classification within accumulated
other comprehensive income disclosed on the face of the balance sheet,
in the statement of changes in shareholders' equity, or in the notes?
[SFAS 130, par. 26 (AC C49.120)]
11. Has the enterprise reported a total for comprehensive income in
condensed financial statements of interim periods?
[SFAS 130, par. 27 (AC C49.121)]

12. Has the entity displayed as a separate classification within other
comprehensive income the net gain or loss on derivative instruments
designated and qualifying as cash flow hedging instruments that are
reported in comprehensive income pursuant to paragraphs 30 and 41
of SFAS 133?
[SFAS 133, par. 46 (AC D50)]
13. As part of the disclosures of accumulated other comprehensive in
come, pursuant to paragraph 26 of SFAS 130, Reporting Comprehensive
Income, has the entity separately disclosed the beginning and ending
accumulated derivative gain or loss, the related net change associated
with current period hedging transactions, and the net amount of any
reclassification into earnings?
[SFAS 133, par. 47 (AC D50)]
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I.

No

N/A

Other
1.

Are the following excluded from determination of net income or
results of operations under all circumstances:
a. Adjustments or charges or credits resulting from transactions in
the company's own capital stock?
b. Transfers to and from accounts properly designated as appropri
ated retained earnings?

c. Adjustments made pursuant to a quasi reorganization?
[APB 9, par. 28 (AC C08.101)]
2.

Is the amount of revenue and expense recognized from advertising
barter transactions disclosed for each income statement period pre
sented?
[EITF 99-17]

3.

If the entity engages in advertising barter transactions for which the
fair value is not determinable within the limits of EITF 99-17, is
information regarding the volume and type of advertising surren
dered and received (such as the number of equivalent pages, the
number of minutes, or the overall percentage of advertising volume)
disclosed for each income statement period presented?
[EITF 99-17]

4.

At a minimum, is a description of the nature and amounts of losses
and costs recognized as a result of the September 11 events and the
amount of related insurance recoveries (if any) recognized disclosed
in the notes to the financial statements in all periods affected by the
September 11,2001 attacks?
[EITF 01-10]

5.

Are losses and costs incurred as a result of the September 11, 2001
attacks classified as part of income from continuing operations?
[EITF 01-10]

6.

Does a vendor disclose the following in regard to revenue arrange
ments with multiple deliverables:
a. Its accounting policy for recognition of revenue from multipledeliverable arrangements (for example, whether deliverables are
separable into units of accounting)?
b. The description and natures of such arrangements, including per
formance, cancellation, termination, or refund-type provisions?
[EITF 00-21]

7.

Is the income statement classification of the expense associated with
a "free" product or service delivered at the time of sale of another
product or service classified as cost of sales?
[EITF 01-9]

Statement of Changes in Shareholders' Equity
1.

Are changes in the separate accounts of shareholders' equity disclosed?
[APB 12, par. 10 (AC C08.102)]

2.

Are changes in the number of shares of equity securities disclosed?
[APB 12, par. 10 (AC C08.102)]

____
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3.

No

N/A

If prior-period adjustments have been recorded during the current
year, are their resulting effects (both gross and net of applicable
income taxes and including the amounts of income tax applicable to
the prior period adjustments) appropriately disclosed:

a. For single-period statements, does the disclosure indicate the
effects of such restatement on the balance of retained earnings at
the beginning of the period and on the net income of the immedi
ately preceding period?
b. If financial statements of more than one period are presented, does
disclosure include the effects for each of the periods presented in
the statements?
[APB 9, par. 26 (AC A35.107)]
Practice Tip

Disclosure of restatements in annual reports issued subsequent to the first such post-revision disclosure
would ordinarily not be required.

4.

If the reporting entity is a publicly traded company and if interim
financial data and disclosures are not separately reported for the
fourth quarter, are accounting changes made during the fourth quar
ter, disposals of segments of a business (components of an entity, if
SFAS 144 is effective), extraordinary, unusual, or infrequently occur
ring items recognized in the fourth quarter, and the aggregate effect
of year end adjustments that are material to the results of that quarter
disclosed in a note to the financial statements?
[APB 28, par. 31 (AC I73.147); SFAS 3, par. 14]

5.

If the reporting entity is a publicly traded company, is disclosure
about the effect of accounting changes on interim periods that are
required by paragraphs 23-26 of APB 28 or by paragraphs 9-13 of
SFAS 3 included in a note to the financial statements for the fiscal year
in which the change is made?
[SFAS 3, par. 14 (AC I73.147)]

6.

For a correction of an error, is the nature of the error disclosed in the
period in which the error was discovered and corrected:

a. Nature of the error in previously issued financial statements?
b. Effect of its correction on income before extraordinary items, net
income, and related per-share amounts, if applicable?
[APB 20, par. 37 (AC A35.105)]

Statement of Cash Flows
1.

Is a statement of cash flows presented as a basic financial statement
(for each period for which a statement of income is presented) if
financial statements present both financial position and results of
operations?
[SFAS 95, par. 3 (AC C25.101)]

2.

Are cash receipts and cash payments from operating activities shown
separately on the statement of cash flows?
[SFAS 95, pars. 27 and 28 (AC C25.125 and .126)]
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a. Are cash receipts and cash payments resulting from purchases and
sales of securities classified as trading securities as discussed in
SFAS 115, Accounting for Certain Investments in Debt and Equity
Securities, classified as operating cash flows?
[SFAS 102, par. 8, as amended by SFAS 115, as amended by SFAS
145 (AC C25.122A)]

____

___

____

___

____

___

a. Cash receipts from sales of goods or services?

____

___

b. Cash receipts from interest and dividends?

____

___

c. All other cash receipts that do not stem from transactions defined
as investing or financing activities?

____

___

d. Cash payments to suppliers and employees, such as benefits paid
to policyholders, surrender benefits, and dividends paid to poli
cyholders?

____

___

e. Cash payments to governments for taxes, duties, fines, and other
fees or penalties and the cash that would have been paid for
income taxes if increases in the value of equity instruments issued
under share-based payment arrangements that are not included
in the costs of goods or services recognizable for financial report
ing purposes also had not been deductible in determining taxable
income? (This is the same amount reported as a financing cash
inflow pursuant to paragraph 19(e) of SFAS 95.)

____

___

____

___

b. Are cash receipts and cash payments from purchases and sales of
securities and other assets acquired for resale and carried at mar
ket value in a trading account classified as operating cash flows?
[SFAS 102, par. 8, as amended by SFAS 115 (AC C25.122A)]
c. Are cash receipts and cash payments resulting from purchases,
acquisitions and sales of loans, if those loans are acquired specifi
cally for resale and are carried at market value or the lower of cost
or market, classified as operating cash flows?
[SFAS 102, par. 9 (AC C25.122B)]
3.

____

___

h. Contributions to charities?

____

___

____

___

____

___

Is cash payment made to settle an asset retirement obligation classi
fied in the statement of cash flows as an operating activity?
[EITF 02-6]

____

___

Are cash receipts and cash payments from investing activities shown
separately on statement of cash flows?
[SFAS 95, par. 31 (AC C25.129)]

____

___

____

___

j.

6.

Cash payments to lenders and other creditors for interest?

g. Payments to settle lawsuits?

i.

5.

N/A

Are cash receipts and cash payments for the following transactions
classified as cash flows from operating activities:

f.

4.

No

Cash flows from purchases, sales, and maturities of trading
securities?
All other cash payments that do not stem from transactions de
fined as investing or financing activities?
[SFAS 95, pars. 22 and 23, as amended by SFAS 123(R) (AC C25.120
and .121)]

Are cash receipts and cash payments for the following transactions
classified as cash flows from investing activities:
a. Receipts from collections or sales of loans?
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b. Receipts from sales of property, plant, and equipment?

c. Loans to others?
d. Payments to acquire property, plant, and equipment?

e. Receipts from sales of equity instruments of other enterprises
exclusive of those carried in the trading account?
f.

Payments to acquire equity instruments of other enterprises, ex
clusive of those carried in a trading account?
[SFAS 95, pars. 16 and 17, as amended by SFAS 102, as amended
by SFAS 115 (AC C25.114 and .115)]

7.

Are cash receipts and cash payments from financing activities shown
separately on the statement of cash flows?
[SFAS 95, par. 31 (AC C25.129)]

8.

Are cash receipts and cash payments for the following transactions
classified as cash flows from financing activities:

a. Proceeds from issuing equity instruments?
b. Proceeds from issuing bonds, mortgages, and notes, and from
other short- or long-term borrowing?

c. Repayment of amounts borrowed?
d. Dividend payments to stockholders?

e. Acquisition of treasury stock?
f.

Other principal payments to creditors who have extended long
term credit?

g. Debt issue costs?
h. Proceeds received from derivative instruments and distributions
to counterparties of derivative instruments that include financing
elements at inception?
[SFAS 95, pars. 19 and 20, as amended by SFAS 149 (AC C25.117
and .118); EITF 95-13]

i. Cash retained as a result of the tax deductibility of increases in the
value of equity instruments issued under share-based payment
arrangements that are not included in the cost of goods or services
that is recognizable for financial reporting purposes? For this
purpose, excess tax benefits shall be determined on an individual
award (or a portion thereof) basis. (Note: This item is only effec
tive if the provisions of SFAS 123(R) are effective.)
[SFAS 123(R), par. 68a]

9.

If applicable, is the effect of exchange rate changes on cash balances
held in foreign currencies shown separately on statement of cash
flows?
[SFAS 95, par. 25 (AC C25.123)]

10. Is the change in cash and cash equivalents shown?
[SFAS 95, pars. 7 and 26 (AC C25.105 and .124)]
11. Is the policy for defining cash equivalent disclosed?
[SFAS 95, par. 10 (AC C25.108)]
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Practice Tip
Any change in policy for determining which items are treated as cash equivalents is a change in accounting
principle.

12. Are noncash investing and financing activities, such as converting
debt to equity, summarized in a separate schedule?
[SFAS 95, par. 32 (AC C25.134)]
13. If the direct method is used, is a separate schedule provided to
reconcile net income to net cash flow from operating activities?
[SFAS 95, par. 30 (AC C25.128)]
14. If the indirect method is used:

a. Is the same amount for net cash flow from operating activities
reported indirectly, by adjusting net income to reconcile it to net
cash flow from operating activities?
b. Is the reconciliation of net income to net cash flows from operating
activities reported, either within the statement of cash flows or
provided in a separate schedule (the reconciliation should sepa
rately report all major reconciling items pertaining to operating
activities)?
[SFAS 95, pars. 29 and 30 (AC C25.128)]
15. If the indirect method is used, are the amounts of interest paid (net of
amounts capitalized) and income taxes paid during the period(s)
disclosed?
[SFAS 95, par. 29 (AC C25.127)]
16. Are the following classes of operating cash receipts and payments for
life insurance companies using the direct method, at a minimum,
separately disclosed:

a. Cash collected from customers, including lessees, licensees, and
the like?

b. Interest and dividends received?
c. Other operating cash receipts, if any?

d. Cash paid to employees and other suppliers of goods or services,
including suppliers of insurance, advertising, and the like?
e. Interest paid?
f.

Income taxes paid and, separately, the cash that would have been
paid for income taxes if increases in the value of equity instru
ments issued under share-based payment arrangements that are
not recognizable as a cost of goods or services for accounting
purposes also had not been deductible in determining taxable
income (paragraph 19(e) of SFAS 95)?

g. Other operating cash payments, if any?
[SFAS 95, par. 27, as amended by SFAS 123(R) (AC C25.125)]
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Notes: The provisions of SFAS 123(R) are effective (a) for public entities
that do not file as small business issuers—as of the beginning of the first
interim or annual reporting period that begins after June 15,2005; (b) for
public entities that file as small business issuers—as of the beginning of
the first interim or annual reporting period that begins after December 15,
2005; and (c) for nonpublic entities—as of the beginning of the first annual
reporting period that begins after December 15,2005.

Questions 17 and 18 apply only if the provisions of SFAS 123(R) are not
effective.

17. If the indirect method is used, is the reduction of income taxes paid
as a result of a deduction triggered by employee exercise of stock
options classified as an operating cash flow?
[EITF 00-151
18. If a material income tax benefit realized as a result of the deduction
triggered by employee exercise of stock options is not presented as a
separate line item in the statement of cash flows or in the statement
of changes in stockholders' equity, is disclosure made of the material
income tax benefit realized?
[EITF 00-15]
19. If an other-than-insignificant financing element is present at incep
tion, other than a financing element inherently included in an at-themarket derivative instrument with no prepayments (that is, the
forward points in an at-the-money forward contract), does the bor
rower report all cash inflows and outflows associated with that de
rivative instrument in a manner consistent with financing activities as
described in paragraphs 18-20 of SFAS 95?
[SFAS 133, par. 45A, as amended by SFAS 149, par. 18 (AC D50.142A)]

General
A. Titles and References
1.

For a full presentation in conformity with generally accepted accounting
principles (GAAP), are the following financial statements presented:
a. Balance sheet?

____

b. Statement of income (operations)?

____

c. Statement of retained earnings or changes in shareholders' equity?

____

d. Statement of cash flows?

____

e. Description of accounting policies?

____

f.

Notes to the financial statements?
[Generally Accepted]

2.

Are the financial statements suitably titled?
[Generally Accepted]

3.

Does each statement include a general reference indicating that the
notes are an integral part of the financial statement presentation?
[Generally Accepted]

FSP §20,300.03

____
____

____

No

N/A

51

Financial Statements and Notes Checklist
Yes

No

N/A

B. Disclosure of Accounting Policies

1.

Is a description of all significant accounting policies of the reporting
company presented as an integral part of the financial statements?
[APB 22, par. 8 (AC A10.102)]

2.

Do the summary or notes identify and describe all significant account
ing principles followed by the reporting entity and the methods of
applying those principles that materially affect the determination of
financial position, cash flows, and results of operations?
[APB 22, par. 12 (AC A10.105)]

3.

Do those principles and methods identified in Question 2 include all
instances in which there:

a. Is a selection from existing acceptable alternatives?
b. Are principles and methods peculiar to the industry in which the
reporting entity operates, even if such principles and methods are
predominantly followed in that industry?
c. Are unusual or innovative applications of GAAP?
[APB 22, par. 12 (AC A10.105)]

4.

Does disclosure of significant accounting policies include appropriate
reference to details presented elsewhere (in the statements and notes
thereto) so duplication of details is avoided?
[APB 22, par. 14 (AC A10.107)]

5.

Is the company's accounting policy with respect to vendor's sales
incentive arrangements disclosed?
[EITF 03-10]

6.

Do mutual life insurance companies disclose the principles and meth
ods used to account for marketable securities and insurance activities?
[FASBI40, par. 5 (AC A10.102A)]

7.

If (a) state prescribed statutory accounting practices differ from NAIC
statutory accounting practices or (b) permitted state statutory accounting
practices differ from either state prescribed statutory accounting prac
tices or NAIC statutory accounting practices, is the following informa
tion about the use of prescribed or permitted statutory accounting
practices (individually or in the aggregate) results in reported statutory
surplus or risk-based capital that is significantly different from the
statutory surplus or risk-based capital that would have been reported
had NAIC statutory accounting practices been followed, disclosed:

a. If an insurance enterprise's risk-based capital would have trig
gered a regulatory event had it not used a permitted practice, is
that fact disclosed in the financial statements?
b. A description of the prescribed or permitted statutory accounting
practice by insurance enterprises at the date each financial state
ment is presented?
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c. The related monetary effect on statutory surplus of using an accounting
practice that differs from either state prescribed statutory accounting
practices or NAIC statutory accounting practices by insurance enter
prises at the date each financial statement is presented?4
[SOP 94-5, par. 8, as amended by SOP 01-5]
8.

Are managements' policies and methodologies for estimating a liabil
ity for unpaid claims and claim adjustment expenses for difficult-toestimate liabilities such as for claims for toxic waste cleanup,
asbestos-related illnesses, or other environmental remediation expo
sures disclosed?
[SOP 94-5, par. 11, as amended by SOP 01-5]

9.

Do the notes to the accompanying insurance enterprise's statutory
financial statements contain a summary of significant accounting
policies that discuss the following:

a. Statutory accounting practices?
b. Describe how this basis differs from GAAP?
[SOP 95-5, par. 17, as amended by SOP 01-5]

10. For general-use statutory financial statements, are the effects of the
differences between statutory accounting practices and GAAP, if
quantified, disclosed?
[SOP 95-5, par. 17, as amended by SOP 01-5]
11. Has the insurance company disclosed its accounting policy for sales
inducements, including:

a. The nature of the costs deferred?

b. The method of amortizing those costs?
[SOP 03-1, par. 39; AAG, App. C, par. 8]

12. For sales inducements, are the amount of costs deferred and amor
tized for each of the periods presented and the unamortized balance
as of each balance sheet date disclosed?
[SOP 03-1, par. 39; AAG, App. C, par. 8]
13. Has the insurance company disclosed its accounting policy for sepa
rate accounts, including:
a. The general nature of the contracts reporting in separate accounts,
including the extent and terms of minimum guarantees?

b. The basis of presentation for separate account assets and liabilities
and related separate account activity?
[SOP 03-1, par. 38; AAG, App. C, par. 4]
14. Has the insurance company included a description of the liability
valuation methods and assumptions used in estimating the liabilities
for additional insurance benefits and minimum guarantees?
[SOP 03-1, par. 38; AAG, App. C, par. 12]
4 Disclosures in this question should be applied by a U.S. insurance enterprise, a U.S. enterprise with a U.S. insurance subsidiary, or
a foreign enterprise with a U.S. insurance subsidiary, if the enterprise prepares U.S. generally accepted accounting principles (GAAP)
financial statements. If a foreign insurance enterprise that does not have a U.S. insurance subsidiary prepares U.S. GAAP financial
statements or is included in its parent's consolidated U.S. GAAP financial statements, the notes to the financial statements should
disclose permitted regulatory accounting practices that significantly differ from the prescribed regulatory accounting practices of its
respective regulatory authority and their monetary effects.
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15. If consolidated statements are presented; is the consolidation policy
disclosed?
[ARB 51, par. 5 (AC C51.108); APB 22, par. 13 (AC A10.106)]

Yes

No

N/A

____

____

____

____

____

____

____

____

____

____

____

____

C. Comparative Financial Statements
1.

Are comparative statements considered?
[ARB 43, Ch. 2A, pars. 1 and 2 (AC F43.101 and .102)]

2.

Are the notes and other disclosures included in the financial state
ments of the preceding year(s) presented, repeated, or at least referred
to, to the extent that they continue to be of significance?
[ARB 43, Ch. 2A, par. 2 (AC F43.102)]

3.

If changes occurred in the manner of or basis for presenting corre
sponding items for two or more periods, are appropriate explanations
of the changes disclosed?
[ARB 43, Ch. 2A, par. 3, as amended by APB 20 (AC F43.103)]

D. Accounting Changes
1.

2.

For all changes in accounting principles, are the following disclosures
made in the year of change:

a. Nature of the change?

____

____

____

b. Justification for the change?

____

____

____

c. Effect on income before extraordinary items and on net income?

____

____

____

d. Effect on related per-share amounts?
[APB 20, pars. 17 and 19 (AC A06.113 and .115)]

____

____

____

a. Are financial statements for prior periods, included for compara
tive purposes, presented as previously reported?

____

____

____

b. Is the effect of adopting the new accounting principle on income
before extraordinary items and on net income and the related
per-share amounts disclosed in the period of the change?

____

____

____

____

____

____

____

____

____

____

____

____

For all changes in accounting principles, except those concerning a
change in entity and those recognized in paragraphs 27-30 of APB 20:

c. Are income before extraordinary items and net income computed
on a pro forma basis shown on the face of the income statements
for all periods presented as if the newly adopted accounting
principle had been applied during all periods affected?
[APB 20, pars. 19-21 and 25 (AC A06.115-.117 and .121)]

3.

4.

□

If appropriate, is the cumulative effect of a change in accounting
principle shown separately between the captions "extraordinary
items" and "net income"?
[APB 20, pars. 19b, 20, and 21 (AC A06.114-.122 and E09.104)]

Is the reason for not reporting the cumulative effect of the change and
not disclosing the pro forma amounts for prior years disclosed if it is
impossible to determine such effects?
[APB 20, pars. 25 and 26 (AC A06.121 and .122)]

FSP §20,300.03

54

Life and Health Insurance Entities
Yes

5.

For changes in accounting principle that are required to be accounted
for by applying retroactively the new method in restatements of prior
periods, is the effect of the change on income before extraordinary
items, net income, and related per share amounts disclosed?
[APB 20, par. 28 (AC A10.124)]

6.

For a change in accounting estimate affecting several future periods,
are the following disclosures made in the year of change:

a. Effect on income before extraordinary items and on net income?
b. Effect on related per-share amounts?
[APB 20, par. 33 (AC A06.132)]
7.

For correction of an error, is the nature of the error disclosed in the
period in which the error was discovered and corrected:

a. Nature of the error in previously issued financial statements?
b. Effect of its correction on income before extraordinary items, net
income, and related per-share amounts, if applicable?
[APB 20, par. 37 (AC A35.105)]
8.

If any accounting change has no material effect in the period of change
but is reasonably certain to materially affect later periods, is the
change disclosed in the financial statements of the period of the
change?
[APB 20, par. 38 (AC A06.133)]

9.

For an accounting change that is in effect a change in reporting entity,
are the financial statements of all prior periods restated in order to
show financial information for the new reporting entity for all periods
and are the following disclosures made for all periods presented:

a. The nature of the change?

b. The reason for the change?
c. The effect of the change on income before extraordinary items, net
income, and related per share amounts?
[APB 20, pars. 34 and 35 (AC A35.112-.113)]

10. If interim financial reports contain an adjustment related to prior
interim periods of the current fiscal year, do disclosures include:

a. The effect on income from continuing operations, net income, and
related per share amounts for each prior interim period of the
current fiscal year?

b. Income from continuing operations, net income, and related per
share amounts for each prior interim period restated?
[SFAS 16, par. 15 (AC A35.111)]
11. If the accounting practice for internal replacements, other than re
placements by a universal life-type contract, is changed and the effect
is material, does the life insurance entity reflect the accounting change
as well as disclose the change in their financial statements as a change
in accounting principle, as described in paragraphs 18 through 26 of
APB 20?
[AAG, par. 10.52]
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Note: EITF 03-16 is effective for reporting periods beginning after June
15,2004.

12. Is the effect of adopting the consensus in EITF 03-16, Accounting for
Investments in Limited Liability Companies, reported as the cumulative
effect of a change in accounting principle pursuant to the guidance in
SFAS 3 and APB 20? If the determination of the cumulative effect of
retroactive application is impracticable, is the cumulative effect deter
mined as the difference between the investor's carrying amount of the
investment and the investor's share of the net assets of the LLC as of
the date of initial application of the consensus?
[EITF 03-16]

____

E. Risks and Uncertainties
1.

2.

3.

4.

Is a description of the major products and services the entity sells or
provides and the principal markets, including the location of those
markets, disclosed?
[SOP 94-6, par. 10]

If the company operates in more than one business, are the relative
importance of its operations in each business and the basis for the
determination (for example, assets, revenues, or earnings) disclosed?
[SOP 94-6, par. 10]
Is an explanation that the preparation of financial statements in
conformity with GAAP requires the use of management's estimates
included in the financial statements?
[SOP 94-6, par. 11]

b. The effect of the change will be material?
[SOP 94-6, par. 13]

6.

____

____

Is the disclosure regarding an estimate made when known informa
tion available prior to the issuance of the financial statements indi
cates that both of the following criteria have been met:

a. It is at least reasonably possible that the estimate of the effect on
the financial statements of a condition, situation, or set of circum
stances that existed at the date of the financial statements will
change in the near term due to one or more future confirming
events?

5.

____

Does the disclosure in Question 4 above, indicate the nature of the
uncertainty and include an indication that it is reasonably possible
that a change in estimate will occur in the near term?5
[SOP 94-6, par. 14]

If the estimate in Question 4 above involves a loss contingency cov
ered by SFAS 5, do disclosures include an estimate of the possible loss
or range of loss, or state that such an estimate cannot be made?6
[SOP 94-6, pars. 13 and 14]

____
____

____

____

5 If risk reduction techniques are used to mitigate losses or the uncertainty that may result from certain events, these disclosures are
encouraged but not required.
6 See footnote 5.
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7.

Is disclosure of the concentrations described in paragraph 22 of SOP
94-6 made if, based on information known to management before the
financial statements are issued, the criteria in paragraph 21 of SOP
94-6 are met?
[SOP 94-6, pars. 21 and 22]

8.

For those concentrations of labor subject to collective bargaining
agreements and concentrations of operations located outside of the
company's home country that meet the criteria of paragraph 21 of SOP
94-6, are the following disclosed:

a. The percentage of labor force covered by a collective agreement
and the percentage of the labor force covered by a collective
bargaining agreement that will expire in one year?
b. The carrying amounts of net assets and the geographic areas in
which they are located for operations located outside the com
pany's home country?
[SOP 94-6, par. 24]
9.

Have the optional disclosures in paragraphs 14 and 15 of SOP 94-6
been considered?
[SOP 94-6, pars. 14 and 15]

10. Are applicable disclosures related to the attacks of September 11 made
in the notes to the financial statements in all periods affected by the
September 11,2001 attacks, pursuant to SOP 94-6?
[EITF 01-1]

F.

Contingencies and Commitments (See also section "Z. Guarantees")
1.

Is the nature and amount of significant accrued loss contingencies not
related to life insurance disclosed as necessary to keep the financial
statements from being misleading?
[SFAS 5, par. 9 (AC C59.108)]

2.

For loss contingencies not accrued, do disclosures indicate:

a. Nature of the contingency?
b. Estimate of possible loss or range of loss, or a statement that such
estimate cannot be made?
[SFAS 5, par. 10 (AC C59.109)]
3.

Is the nature and amount of guarantees disclosed (e.g., obligations
under standby letters of credit, guarantees to repurchase loans that
are sold)?
[SFAS 5, par. 12 (AC C59.113); FASBI45, par. 13 (AC G80.112)]

4.

Are gain contingencies adequately disclosed with care to avoid any
misleading implications about likelihood of realization?
[SFAS 5, par. 17 (AC C59.118)]

5.

Is there adequate disclosure of commitments, such as those for capital
expenditures, for purchase or sale of securities under financial futures
contracts, and for funding of loans and unused letters of credit?
[SFAS 5, pars. 18 and 19 (AC C59.120); SFAS 80 (AC F80)]

FSP §20,300.03

No

N/A

57

Financial Statements and Notes Checklist
Yes

6.

7.

8.

9.

If the company as guarantor "lends" its creditworthiness to another
party (borrower) for a fee, is the guarantee disclosed in a note, if
material?
[EITF 85-20]
If exposure to loss exists in excess of the amount accrued for a loss
contingency, do disclosures include the excess amount or state that
no estimate is possible?
[SFAS 5, par. 10 (AC C59.109)]

When, after considering management's plans, the auditor concludes
there is substantial doubt about the entity's ability to continue as a
going concern for a reasonable period of time, is adequate disclosure
of the situation made in the financial statements?
[SAS 59, par. 10 (AU 341.10); AAG, par. 5.113c]
Is a description of contingencies resulting from the September 11
events that have not yet been recognized in the financial statements
but that are reasonably expected to impact the entity's financial
statements in the near term disclosed in the notes to the financial
statements in all periods affected by the September 11,2001 attacks?
[EITF 01-10]

No

N/A

____

____

____

____

Note: SFAS 5 states that it does not discourage disclosure of uninsured
risks in appropriate circumstances. AcSEC believes that, though opera
tional criteria have not been developed for such disclosures as stated in
SFAS 5, they should be encouraged rather than simply not discouraged.

10. For publicly held entities and entities with public accountability, such
as governments, are circumstances disclosed in which:

a. They are exposed to risks of future material loss related to:
(1)

Torts?

____

(2)

Theft of, damage to, expropriation of, or destruction of assets?

____

(3)

Business interruption?

____

(4)

Errors or omissions?

____

(5)

Injuries to employees? or

____

(6)

Acts of God? and

____

b. Those risks have not been transferred to unrelated third parties
through insurance? (Encouraged, but not required.)
[EITF 03-8]

____

11. Does each reporting entity decide the matters to be disclosed, depend
ing on its circumstances? The following are some of the matters
reporting entities may consider for disclosure:

a. The actual and potential effects of losses from such risks on the
entity's historical or planned operations, including exposure to
losses from claims, curtailment of research and development or
manufacturing, or contraction or cessation of other activities, such
as discontinuance of a product line?

____
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b. Comparison of current insurance coverage by major categories of
risk to coverage in prior periods, without necessarily quantifying
such coverage or change in coverage?
c. Recent claims experience?

d. A description of the reporting entity's risk management pro
grams? (Encouraged, but not required.)
[EITF 03-8]
Note: Disclosure of this kind is experimental. Its location in a financial
report, therefore, depends on the judgment of those preparing the finan
cial report.

G. Environmental Remediation Liabilities

Note: SOP 96-1, Environmental Remediation Liabilities, does not provide
guidance on recognizing liabilities of insurance companies for unpaid
claims.
1.

Is there disclosure of the following accounting policies:

a. Whether accruals for environmental remediation liabilities are
measured on a discounted basis?
b. The policy concerning the timing of recognition of recoveries?
(Encouraged, but not required.)
[SOP 96-1 (Ch. 7, pars. 11 and 12)]
2.

Do the financial statements disclose the event, situation, or set of
circumstances that triggered recognition of loss contingencies that
arose out of the reporting entity's environmental remediation-related
obligations? (Encouraged, but not required.)
[SOP 96-1 (Ch. 7, par. 12)]

____
____

____

Recognized Losses and Recoveries of Losses, and Reasonably Possible
Loss Exposures

3.

With respect to recorded accruals for environmental remediation loss
contingencies and assets for third-party recoveries related to environ
mental remediation obligations, are the following disclosed:

a. The nature of the accruals, if such disclosure is necessary for the
financial statements not to be misleading, and, in situations where
disclosure of the nature of the accruals is necessary, the total
amount accrued for the remediation obligation, if such disclosure
is also necessary for the financial statements not to be misleading?

____

b. If any portion of the accrued obligation is discounted, the undis
counted amount of the obligation and the discount rate used in the
present-value determinations?

____

c. If the criteria of SOP 94-6 (it is at least reasonably possible that an
estimate of the effect on the financial statements of a matter that
existed at the balance-sheet date will change in the near term and
the effect of the change would be material to financial statements)
are met with respect to the accrued obligation or to any recognized
asset for third-party recoveries, an indication that it is at least
reasonably possible that a change in the estimate of the obligation
or of the asset will occur in the near term?
[SOP 96-1 (Ch. 7, par. 20)]
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4.

No
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With respect to reasonably possible loss contingencies, including
reasonably possible loss exposures in excess of the amount accrued,
are the following disclosed:
a. The nature of the reasonably possible loss contingency, that is, a
description of the reasonably possible remediation obligation, and
an estimate of the possible loss exposure or the fact that such an
estimate cannot be made?

____

b. If the criteria of SOP 94-6 are met with respect to estimated loss (or
gain) contingencies, an indication that it is at least reasonably
possible that a change in the estimate will occur in the near term?

____

c. The estimated time frame of disbursements for recorded amounts
if expenditures are expected to continue over the long term?
(Encouraged, but not required.)

____

d. The estimated time frame for realization of recognized probable
recoveries, if realization is not expected in the near term? (Encour
aged, but not required.)

____

e. If the criteria of SOP 94-6 are met with respect to the accrued
obligation, to any recognized asset for third-party recoveries, or to
reasonably possible loss exposures or disclosed gain contingen
cies, the factors that cause the estimate to be sensitive to change?
(Encouraged, but not required.)

____

If an estimate of the probable or reasonably possible loss or range
of loss cannot be made, the reasons why it cannot be made?
(Encouraged, but not required.)

____

f.

g. If information about the reasonably possible loss or the recognized
and additional reasonably possible loss for an environmental
remediation obligation related to an individual site is relevant to
an understanding of the financial position, cash flows, or results
of operations of the entity, the following with respect to the site:
(Encouraged, but not required.)
(1)

The total amount accrued for the site?

____

(2)

The nature of any reasonably possible loss contingency or
additional loss, and an estimate of the possible loss or the fact
that an estimate cannot be made and the reasons why it
cannot be made?

____

Whether other potentially responsible parties are involved
and the entity's estimated share of the obligation?

____

(4)

The status of regulatory proceedings?

____

(5)

The estimated time frame for resolution of the contingency?
[SOP 96-1 (Ch. 7, pars. 21 and 22)]

____

(3)

Probable But Not Reasonably Estimable Losses

5.

If the reporting entity's probable but not reasonably estimable envi
ronmental remediation obligations may be material, are the nature of
the probable contingency (that is, a description of the remediation
obligation) and the fact that a reasonable estimate cannot currently be
made disclosed?
[SOP 96-1 (Ch. 7, par. 25)]

____

FSP §20,300.03

60

Life and Health Insurance Entities
Yes

6.

Is the estimated time frame for resolution of the uncertainty as to the
amount of the loss disclosed? (Encouraged, but not required.)
[SOP 96-1 (Ch. 7, par. 25)]

____

Environmental Remediation Costs Recognized Currently
7.

Is the amount of environmental remediation costs recognized in the
income statement disclosed in the following detail: (Encouraged, but
not required.)

a. The amount recognized for environmental remediation loss con
tingencies in each period?

____

b. The amount of any recovery from third parties that is credited to
environmental remediation costs in each period?

____

c. The income statement caption in which environmental remedia
tion costs and credits are included?
[SOP 96-1 (Ch. 7, par. 29)]

____

Other Matters
8.

9.

Do the financial statements include a contingency conclusion that ad
dresses the estimated total unrecognized exposure to environmental
remediation and other loss contingencies? (Optional.)
[SOP 96-1 (Ch. 7, par. 30)]
Is there a description of the general applicability and impact of
environmental laws and regulations upon their business and how the
existence of such laws and regulations may give rise to loss contin
gencies for future environmental remediation? (Optional.)
[SOP 96-1 (Ch. 7, par. 31)]

10. Are applicable disclosures about environmental obligations (and re
coveries) related to the attacks of September 11 disclosed in the notes
to the financial statements in all periods affected by the September 11,
2001 attacks, pursuant to SOP 96-1?
[EITF 01-10]
H.

____

____

____

Related-Party Transactions and Economic Dependency
1.

For related-party transactions, do disclosures include:

a. The nature of the relationship(s) involved (e.g., parent, subsidiary,
and affiliate companies, officers, stockholders, etc.)?

____

b. A description of the transactions, including transactions to which
no amounts or nominal amounts were ascribed, for each of the
periods for which an income statement is presented, and such
other information deemed necessary to an understanding of the
effects of the transactions on the financial statements?

____

c. The dollar amounts of transactions for each of the periods for
which an income statement is presented and the effects of any
change in the method of establishing the terms from that used in
the preceding period?

____

d. Amounts due from or to related parties as of the date of each
balance sheet presented and, if not otherwise apparent, the terms
and manner of settlement?
[SFAS 57, par. 2 (AC R36.102)]
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2.

I.

Is the nature of a controlled relationship disclosed, even though there
are no transactions between the enterprises, if the reporting company
and one or more other enterprises are under common ownership or
management control, and the existence of the control could result in
operating results or financial position of the reporting company being
significantly different from those that would have resulted if the
company were autonomous?
[SFAS 57, par. 4 (AC R36.104)]

Yes

No

N/A

____

____

____

Employee Stock Ownership Plans
1.

If an employer sponsors an employee stock ownership plan (ESOP),
do the employer's disclosures include:

a. A description of the plan, the basis for determining contributions,
including the employee groups covered, and the nature and effect
of significant matters affecting comparability of information for all
periods presented?

____

____

____

For leveraged ESOPs and pension reversion ESOPs, does the
description include the basis for releasing shares and how
dividends on allocated and unallocated shares are used?

____

____

____

b. A description of the accounting policies followed for ESOP trans
actions, including the method of measuring compensation, the
classification of dividends on ESOP shares, and the treatment of
ESOP shares for EPS computations?

____

____

____

If the entity has both old ESOP shares for which it does not
adopt the guidance in SOP 93-6 and new ESOP shares for
which the guidance in SOP 93-6 is required, are the account
ing policies for both blocks of shares disclosed?

____

____

____

c. The amount of compensation cost recognized during the period?

____

____

____

d. The number of allocated shares, committed-to-be-released
shares, and suspense shares held by the ESOP at the balancesheet date?

____

____

____

If the entity has both old ESOP shares for which it does not
adopt the guidance in SOP 93-6 and new ESOP shares for
which the guidance in SOP 93-6 is required, is the above
disclosure made separately for both blocks of shares?

____

____

____

e. The fair value of unearned ESOP shares at the balance-sheet date
for shares accounted for under SOP 93-6?7

____

____

____

____

____

____

____

____

____

(1)

(1)

(1)

f.

2.

□

The existence and nature of any repurchase obligation, including
disclosure of the fair value of the shares allocated as of the balancesheet date, which are subject to a repurchase obligation?8
[SOP 93-6, par. 53]

Are all the items listed in Question 1 above disclosed even if the
employer with an ESOP does not adopt SOP 93-6 for shares held by
the ESOP on December 31,1992?
[SOP 93-6, par. 55]

7 This disclosure need not be made for old ESOP shares for which the entity does not apply the guidance in SOP 93-6.

8 Employers may wish to disclose additional information about the obligation, particularly information about the timing of
payments. [SOP 93-6, par. 95]
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J.

3.

For leveraged ESOPs and for nonleveraged ESOPs where the assets
from the pension plan are used by the ESOP to purchase shares, when
the employer reports the issuance of shares or the sale of treasury
shares to the ESOP, is the charge to unearned ESOP shares presented
as a separate item in the balance sheet as a contra-asset account?
[SOP 93-6, pars. 13 and 46]

4.

If the employer sponsors an ESOP with an indirect loan, is the outside
loan reported as a liability and the receivable from the ESOP not
reported on the employer's balance sheet?
[SOP 93-6, par. 26]

5.

If the employer sponsors an ESOP with an employer loan, is the
ESOP's note payable and the employer's note receivable from the
ESOP not reported in the employer's balance sheet?
[SOP 93-6, par. 27]

6.

If SOP 76-3 is still being followed for ESOP shares purchased before
December 31,1992 and if the reporting entity has guaranteed the debt
of an ESOP or made a commitment to make future contributions to
the ESOP sufficient to meet debt service requirements, are the com
pensation element and the interest element of annual contributions
reported separately and are the interest rate and debt terms disclosed
in the notes to the financial statements?
[SOP 76-3, par. 10]

No

N/A

Employers' Disclosures About Pensions and Other Postretirement
Benefits*
Note: In December 2003, the FASB issued a revised SFAS 132, Employers'
Disclosures about Pensions and Other Postretirement Benefits. This revised
Statement retains the disclosure requirements contained in the original
SFAS 132, which it replaces. It requires additional disclosures to those in
the original SFAS 132. The following disclosures reflect the revised SFAS
132. Disclosures added by the revision are indicated at the end of the
question. The provisions of SFAS 132 remain in effect until the provisions
of the revised Statement are adopted. The revised SFAS 132 is effective for
financial statements with fiscal years ending after December 15,2003. The
interim-period disclosures required by the revised SFAS 132 are effective
for interim periods beginning after December 15, 2003. Disclosure of
estimated future benefit payments required by paragraph 5(f) of revised
SFAS 132 is effective for fiscal years ending after June 15,2004. Disclosure
of information for nonpublic entities required by paragraphs 8(c)-(f) and
8(j) of revised SFAS 132 (Questions 9c-f and 9j below) is effective for fiscal
years ending after June 15,2004. See the revised SFAS 132 for information
about the effective date of disclosure information about foreign plans.
Reduced Disclosure Requirements for Nonpublic Entities

Note: A nonpublic entity is not required to disclose the information
required by paragraphs 5(a)-(c), 5(m), and 5(o)-(r) of SFAS 132(R). See the
related disclosure questions above.

EITF 03-4, Determining the Classification and Benefit Attribution Method for a “Cash Balance" Pension Plan, states that cash balance plans
should be considered a defined benefit plan.

FSP §20,300.03

63

Financial Statements and Notes Checklist
Yes

1.

No

N/A

For a nonpublic entity9 that sponsors one or more defined benefit
pension plans or one or more other defined benefit postretirement
plans, has the following information been disclosed, separately for
pension plans and other postretirement benefit plans:
a. The benefit obligation, fair value of plan assets, and funded status
of the plan?
[SFAS 132(R), par. 8a (AC P16.150Aa and P40.169Aa)]
b. Employer contributions, participant contributions, and benefits
paid?
[SFAS 132(R), par. 8b (AC P16.150Ab and P40.169Ab)]

c. Information about plan assets:
(1)

For each major category of plan assets which shall include,
but is not limited to, equity securities, real estate, and all other
assets, the percentage of the fair value of total plan assets held
as of the measurement date used for each statement of finan
cial position presented? (Added by revised SFAS 132.)
[SFAS 132(R), par. 8c(1) (AC P16.I50Ac(1) and P40.169Ac)]

(2)

A narrative description of investment policies and strategies,
including target allocation percentages or range of percent
ages for each major category of plan assets presented on a
weighted-average basis as of the measurement date(s) of the
latest statement of financial position presented, if applicable,
and other factors that are pertinent to an understanding of the
policies or strategies such as investment goals, risk manage
ment practices, permitted and prohibited investments in
cluding the use of derivatives, diversification, and the
relationship between plan assets and benefit obligations?
(Added by revised SFAS 132.)
[SFAS 132(R), par. 8c(2) (AC P16.150Ac(2) and P40.169Ac)]

(3)

A narrative description of the basis used to determine the
overall expected long-term rate-of-return-on-assets assump
tion, such as the general approach used, the extent to which
the overall rate-of-return-on-assets assumption was based on
historical returns, the extent to which adjustments were made
to those historical returns in order to reflect expectations of
future returns, and how those adjustments were determined?
(Added by revised SFAS 132.)
[SFAS 132(R), par. 8c(3) (AC P16.150Ac(3) and P40.169Ac)]

Note: Disclosure of additional asset categories and additional informa
tion about specific assets within a category is encouraged if that informa
tion is expected to be useful in understanding the risks associated with
each asset category and the overall expected long-term rate of return on
assets. (Added by revised SFAS 132.)
[SFAS 132(R), par. 8c(4) (AC P16.150Ac(4) and P40.169Ac(4))]

9 A nonpublic entity is any entity other than one (a) whose debt or equity securities trade in a public market either on a stock
exchange (domestic or foreign) or in the over-the-counter market including securities quoted only locally or regionally, (b) that makes
a filing with a regulatory agency in preparation for the sale of any class of debt or equity securities in a public market or (c) that is
controlled by an entity covered by (a) or (b).
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d. For defined benefit pension plans, the accumulated benefit obli
gation? (Added by revised SFAS132.)
[SFAS 132(R), par. 8d (AC P16.150Ad)]
e. The benefits (as of the date of the latest statement of financial
position presented) expected to be paid in each of the next five
fiscal years, and in the aggregate for the five fiscal years thereafter?
(The expected benefits should be estimated based on the same
assumptions used to measure the company's benefit obligation at
the end of the year and should include benefits attributable to
estimated future employee service.) (Added by revised SFAS 132.)
[SFAS 132(R), par. 8e (AC P16.150Ae and P40.169Ad)]

f.

The employer's best estimate, as soon as it can be reasonably
determined, of contributions expected to be paid to the plan
during the next fiscal year beginning after the date of the latest
statement of financial position presented? (Estimated contribu
tions may be presented in the aggregate combining (a) contribu
tions required by funding regulations or laws, (b) discretionary
contributions, and (c) noncash contributions.) (Added by revised
SFAS 132.)
[SFAS 132(R), par. 8f (AC P16.150Af and P40.169Ae)]

g. The amounts recognized in the statements of financial position,
including net pension and other postretirement benefit prepaid
assets or accrued liabilities and any intangible asset and the
amount of accumulated other comprehensive income recognized
pursuant to paragraph 37 of SFAS 87, as amended?
[SFAS 132(R), par. 8g (AC P16.150Ag and P40.169Af)]

h. The amount of net periodic benefit cost recognized and the
amount included within other comprehensive income arising
from a change in the minimum pension liability recognized pur
suant to paragraph 37 of SFAS 87, as amended?
[SFAS 132(R), par. 8h (AC P16.150Ag)]
i.

j.

On a weighted-average basis, the following assumptions used in
the accounting for the plans: assumed discount rates, rates of
compensation increase (for pay-related plans), and expected long
term rates of return on plan assets specifying, in a tabular format,
the assumptions used to determine the benefit obligation and the
assumptions used to determine net benefit cost? (Partly added by
revised SFAS 132.)
[SFAS 132(R), par. 8i (AC P16.150Ai and P40.169Ah)]

The measurement date(s) used to determine pension and other
postretirement benefit measurements for the pension plans and
other postretirement benefit plans that make up at least the major
ity of plan assets and benefit obligations? (Added by revised SFAS
132.)
[SFAS 132(R), par. 8j (AC P16.150Aj and P40.169Ai)]

k. The assumed health care cost trend rate(s) for the next year used
to measure the expected cost of benefits covered by the plan (gross
eligible charges) and a general description of the direction and
pattern of change in the assumed trend rates thereafter, together
with the ultimate trend rate(s) and when that rate is expected to
be achieved?
[SFAS 132(R), par. 8k (AC P40.169Aj)]
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If applicable, the amounts and types of securities of the employer
and related parties included in plan assets, the approximate
amount of future annual benefits of plan participants covered by
insurance contracts issued by the employer or related parties, and
any significant transactions between the employer or related par
ties and the plan during the period?
[SFAS 132(R), par. 81 (AC P16.150Ak and P40.169Ak)]

m. The nature and effect of significant nonroutine events, such as
amendments, combinations, divestitures, curtailments, and settle
ments?
[SFAS 132(R), par. 8m (AC P16.150Al and P40.169Al)]

2.

Are amounts related to the employer's results of operations disclosed
for each period for which a statement of income is presented?
[SFAS 132(R), par. 8 (AC P16.150A and P40.169A)]

3.

Are amounts related to the employer's statement of financial position
disclosed as of the measurement date used for each statement of
financial position presented?
[SFAS 132(R), par. 8 (AC P16.150A and P40.169A)]

Disclosures in Interim Financial Reports

4.

If the entity is publicly traded, does it disclose the following informa
tion in its interim financial statements that include a statement of
income:

a. The amount of net periodic benefit cost recognized, for each period
for which a statement of income is presented, showing separately
the service cost component, the interest cost component, the ex
pected return on plan assets for the period, the amortization of the
unrecognized transition obligation or transition asset, the amount
of recognized gains or losses, the amount of prior service cost
recognized, and the amount of gain or loss recognized due to a
settlement or curtailment? (Added by revised SFAS 132.)
b. The total amount of the employer's contributions paid, and ex
pected to be paid, during the current fiscal year, if significantly
different from amounts previously disclosed pursuant to para
graph 5(g) of SFAS 132? (Estimated contributions may be pre
sented in the aggregate combining (a) contributions required by
funding regulations or laws, (b) discretionary contributions, and
(c) noncash contributions.) (Added by revised SFAS 132.)
[SFAS 132(R), par. 9]

5.

If the entity is nonpublic, does it disclose in interim periods, for which
a complete set of financial statements is presented, the total amount of
the employer's contributions paid, and expected to be paid, during the
current fiscal year, if significantly different from amounts previously
disclosed pursuant to paragraph 8(f) of SFAS 132? (Estimated contribu
tions may be presented in the aggregate combining (a) contributions
required by funding regulations or laws, (b) discretionary contributions,
and (c) noncash contributions.) (Added by revised SFAS 132.)
[SFAS 132(R), par. 10 (AC P16.150B and P40.169B)]

FSP §20,300.03

66

Life and Health Insurance Entities
Yes

No

N/A

____

____

____

____

____

____

Pensions and Other Postretirement Benefits

1. If an employer sponsors one or more defined benefit pension plans or
one or more defined benefit postretirement plans has the following
information been provided, separately for pension plans and other
postretirement benefit plans:

a. A reconciliation of beginning and ending balances of the benefit
obligation10 showing separately, if applicable, the effects during
the period attributable to each of the following: service cost, inter
est cost, contributions by plan participants, actuarial gains and
losses, foreign currency exchange rate changes11 benefits paid,
plan amendments, business combinations, divestitures, curtail
ments, settlements, and special termination benefits?
[SFAS 132(R), par. 5a (AC P16.150 and P40.169)]
b. A reconciliation of beginning and ending balances of the fair value
of plan assets showing separately, if applicable, the effects during
the period attributable to each of the following: actual return on
plan assets, foreign currency exchange rate changes12 contribu
tions by the employer, contributions by plan participants, benefits
paid, business combinations, divestitures, and settlements?
[SFAS 132(R), par. 5b (AC P16.150 and P40.169)]
c. The funded status of the plans, the amounts not recognized in the
statement of financial position, and the amounts recognized in the
statement of financial position, including:

(1)

The amount of any unamortized prior service cost?

____

____

____

(2)

The amount of any unrecognized net gain or loss (including
asset gains and losses not yet reflected in market-related
value)?

____

____

____

(3) The amount of any remaining unamortized, unrecognized
net obligation or net asset existing at the initial date of appli
cation of SFAS 87 or SFAS 106?

____

____

____

(4) The net pension or other postretirement benefit, prepaid
assets, or accrued liabilities?

____

____

____

____

____

____

____

____

____

(5)

Any intangible asset and the amount of accumulated other
comprehensive income recognized pursuant to paragraph 37
of SFAS 87, as amended?
[SFAS 132(R), par. 5c (AC P16.150 and P40.169)]

d. Information about plan assets:
(1)

For each major category of plan assets, which shall include,
but is not limited to, equity securities, debt securities, real
estate, and all other assets, the percentage of the fair value of
total plan assets held as of the measurement date used for
each statement of financial position presented? (Added by
revised SFAS 132.)

10 For defined benefit pension plans, the benefit obligation is the projected benefit obligation—the actuarial present value as of a date
of all benefits attributed by the pension benefit formula to employee service rendered prior to that date. For defined benefit
postretirement plans, the benefit obligation is the accumulated postretirement benefit obligation—the actuarial present value of
benefits attributed to employee service rendered to a particular date.
11 The effects of foreign currency exchange rate changes that are to be disclosed are those applicable to plans of a foreign operation
whose functional currency is not the reporting currency pursuant to SFAS 52, Foreign Currency Translation.

12 Refer to footnote 10.
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(2)

(3)

(4)

A narrative description of the basis used to determine the
overall expected long-term rate-of-return-on-assets assump
tion, such as the general approach used, the extent to which
the overall rate-of-return-on-assets assumption was based on
historical returns, the extent to which adjustments were made
to those historical returns in order to reflect expectations of
future returns, and how those adjustments were determined?
(Added by revised SFAS 132.)

____

A narrative description of the basis used to determine the
overall expected long-term rate-of-return-on-assets assump
tion, such as the general approach used, the extent to which
the overall rate-of-return-on-assets assumption was based on
historical returns, the extent to which adjustments were made
to those historical returns in order to reflect expectations of
future returns, and how those adjustments were determined?
(Added by revised SFAS 132.)

____

Disclosure of additional asset categories and additional infor
mation about specific assets within a category is encouraged
if that information is expected to be useful in understanding
the risks associated with each asset category and the overall
expected long-term rate of return on assets? (Added by re
vised SFAS 132.)
[SFAS 132(R), par. 5d (AC P16.150d and P40.169d)]

e. For defined benefit pension plans, the accumulated benefit obli
gation? (Added by revised SFAS 132.)
[SFAS 132(R), par. 5e (AC P16.150e)]

f.

The benefits (as of the date of the latest statement of financial
position presented) expected to be paid in each of the next five
fiscal years, and in the aggregate for the five fiscal years thereafter?
The expected benefits should be estimated based on the same
assumptions used to measure the company's benefit obligation at
the end of the year and should include benefits attributable to
estimated future employee service. (Added by revised SFAS 132.)
[SFAS 132(R), par. 5f (AC P16.150f and P40.169e)]

g. The employer's best estimate, as soon as it can reasonably be
determined, of contributions expected to be paid to the plan
during the next fiscal year beginning after the date of the latest
statement of financial position presented? Estimated contribu
tions may be presented in the aggregate combining (a) contribu
tions required by funding regulations or laws, (b) discretionary
contributions, and (c) noncash contributions. (Added by revised
SFAS 132.)
[SFAS 132(R), par. 5g (AC P16.150g and P40.169f)]
h. The amount of net periodic benefit cost recognized, showing
separately the service cost component, the interest cost compo
nent, the expected return on plan assets for the period, the amor
tization of the unrecognized transition obligation or transition
asset, the amount of recognized gains and losses, the amount of
prior service cost recognized, and the amount of gain or loss
recognized due to a settlement or curtailment?
[SFAS 132(R), par. 5h (AC P16.150h and P40.169g)]

No

N/A

____

____

____

____

____
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i.

The amount included within other comprehensive income for the
period arising from a change in the additional minimum pension
liability recognized pursuant to paragraph 37 of SFAS 87, as
amended?
[SFAS 132(R), par. 5i (AC P16.150i)]

j.

On a weighted-average basis, the following assumptions used in
the accounting for the plans: assumed discount rates, rates of
compensation increase (for pay-related plans), and expected long
term rates of return on plan assets specifying, in a tabular format,
the assumptions used to determine the benefit obligation and the
assumptions used to determine net benefit cost? (Added by revised
SFAS 132.)
[SFAS 132(R), par. 5j (AC P16.150j and P40.169h)]

k. The measurement date(s) used to determine pension and other
postretirement benefit measurements for the pension plans and
other postretirement benefit plans that make up at least the major
ity of plan assets and benefit obligations? (Added by revised SFAS
132.)
[SFAS 132(R), par. 5k (AC P16.150k and P40.169i)]
l.

The assumed health care cost trend rate(s) for the next year used
to measure the expected cost of benefits covered by the plan (gross
eligible charges) and a general description of the direction and
pattern of change in the assumed trend rates thereafter, together
with the ultimate trend rate(s) and when that rate is expected to
be achieved?
[SFAS 132(R), par. 51 (AC P40.169j)]

m. The effect of a one-percentage-point increase and the effect of a
one-percentage-point decrease in the assumed health care cost
trend rates on (1) the aggregate of the service and interest cost
components of net periodic postretirement health care benefit
cost and (2) the accumulated postretirement benefit obligation
for health care benefits? (For purposes of this disclosure, all
other assumptions shall be held constant, and the effects shall
be measured based on the substantive plan that is the basis for
the accounting.)
[SFAS 132(R), par. 5m (AC P40.169k)]
n. If applicable, the amounts and types of securities of the employer
and related parties included in plan assets, the approximate
amount of future annual benefits of plan participants covered by
insurance contracts issued by the employer or related parties, and
any significant transactions between the employer or related par
ties and the plan during the period?
[SFAS 132(R), par. 5n (AC P16.1501 and P40.169l)]

o. If applicable, any alternative amortization method used to amor
tize prior service amounts or unrecognized net gains and losses
pursuant to paragraphs 26 and 33 of SFAS 87 or paragraphs 53 and
60 of SFAS 106?
[SFAS 132(R), par. 5o (AC P16.150m and P40.169m)]

p. If applicable, any substantive commitment such as past practice
or a history of regular benefit increases, used as the basis for
accounting for the benefit obligation?
[SFAS 132(R), par. 5p (AC P16.150n and P40.169n)]
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q. If applicable, the cost of providing special or contractual termina
tion benefits recognized during the period and a description of the
nature of the event?
[SFAS 132(R), par. 5q (AC P16.150o and P40.169o)]

r. An explanation of any significant change in the benefit obligation
or plan assets not otherwise apparent in the other disclosures
required by SFAS 132?
[SFAS 132(R). par. 5r (AC P16.150p and P40.169p)]
2.

3.

No

N/A

____

____

Are amounts related to the employer's results of operations disclosed
for each period for which an income statement is presented?
[SFAS 132(R), par. 5 (AC P16.150 and P40.169)]

____

Are amounts related to the employer's statement of financial position
disclosed for each balance sheet presented?
[SFAS 132(R), par. 5 (AC P16.150 and P40.169)]

____

Employers With Two or More Plans

1.

2.

3.

Are the disclosures required by SFAS 132 aggregated for all of an
employer's defined benefit pension plans and for all of an employer's
other defined benefit postretirement plans unless disaggregating in
groups is considered to provide useful information or is otherwise
required by paragraph 6 of SFAS 132 and paragraph 7 of SFAS 132?
[SFAS 132(R), par. 6 (AC P16.153 and P40.172)]
Unless otherwise stated, are disclosures as of the measurement date
for each statement of financial position presented?
[SFAS 132(R), par. 6 (AC P16.153 and P40.172)]
Does the disclosure of amounts recognized in the statement of finan
cial position present prepaid benefit costs and accrued benefit liabili
ties separately?
[SFAS 132(R), par. 6 (AC P16.153 and P40.172)]

____

____

____

Note: Disclosures about pension plans with assets in excess of the accu
mulated benefit obligation generally may be aggregated with disclosures
about pension plans with accumulated benefit obligations in excess of
assets. The same aggregation is permitted for other postretirement benefit
plans.
[SFAS 132(R), par. 6 (AC P16.153 and P40.172)]
4.

If aggregate disclosures are presented, does the employer disclose:
a. The aggregate benefit obligation and aggregate fair value of plan
assets for plans with benefit obligations in excess of plan assets as
of the measurement date of each statement of financial position
presented?
b. The aggregate pension accumulated benefit obligation and aggre
gate fair value of plan assets for pension plans with accumulated
benefit obligations in excess of plan assets?
[SFAS 132(R), par. 6 (AC P16.153 and P40.172)]
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5.

If a U.S. reporting entity combines disclosures about pension plans or
other postretirement benefit plans outside the United States with
those for U.S. plans, are the benefit obligations of the plans outside
the United States not significant relative to the total benefit obligation
and do those plans not use significantly different assumptions?
[SFAS 132(R), par. 7 (AC P16.153A and P40.173)]

Note: A foreign reporting entity that prepares financial statements in
Conformity with U.S. generally accepted accounting principles (GAAP)
shall apply the preceeding guidance to its domestic and foreign plans.
Defined Contribution Plans
1.

Does the employer disclose the amount of cost recognized for defined
contribution pension plans and for other defined contribution postre
tirement benefit plans for all periods presented separately from the
amount of cost recognized for defined benefit plans?
[SFAS 132(R), par. 11 (AC P16.162 and P40.198)]

2.

Do the disclosures include a description of the nature and effect of any
significant changes during the period affecting comparability, such as
a change in the rate of employer contributions, a business combina
tion, or a divestiture?
[SFAS 132(R), par. 11 (AC P16.162 and P40.198)]

Multiemployer Plans
1.

Has the employer disclosed the amount of contributions to multiem
ployer plans for each annual period for which a statement of income
is presented?
[SFAS 132(R), par. 12 (AC P16.166 and P40.178)]
If the employer chooses to disclose total contributions to multiem
ployer plans without disaggregating the amounts attributable to pen
sion plans and other postretirement benefit plans, do the disclosures
include a description of the nature and effect of any changes affecting
comparability, such as a change in the rate of employer contributions,
a business combination, or a divestiture?
[SFAS 132(R), par. 12 (AC P16.166 and P40.178)]

3.

In some situations, withdrawal from a multiemployer plan may result
in an employer having an obligation to the plan for a portion of the
unfunded benefit obligation of the pension plans and other postretire
ment benefit plans. If withdrawal under circumstances that would
give rise to an obligation is either probable or reasonably possible,
have the provisions of SFAS 5, Accounting for Contingencies, been
applied (SFAS 87, paragraph 70)?
[SFAS 132(R), par. 13 (AC P16.167 and P40.179)]

4.

If it is either probable or reasonably possible that (a) an employer
would withdraw from the plan under circumstances that would give
rise to an obligation or (b) an employer's contribution to the fund
would be increased during the remainder of the contract period to
make up a shortfall in the funds necessary to maintain the negotiated
level of benefit coverage (a "maintenance of benefits" clause), has the
employer applied the provisions of SFAS 5 (SFAS 106, paragraph 83)?
[SFAS 132(R), par. 13 (AC P16.167 and P40.179)]
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Other Matters

5.

If the matters addressed in EITF 03-2, Accounting for the Transfer to the
Japanese Government of the Substitutional Portion of Employee Pension
Fund Liabilities, apply, are the disclosure requirements of that EITF
Issue complied with?
[EITF 03-2]

Notes: In January 2004, the FASB issued FSP 106-1, Accounting and Dis
closure Requirements Related to the Medicare Prescription Drug, Improvement
and Modernization Act of2003, which permits a sponsor of a postretirement
health care plan that provides a prescription drug benefit to make a
one-time election to defer accounting for the effects of the Act. Regardless
of whether a sponsor elects that deferral, the FSP requires certain disclo
sures pending further consideration of the underlying accounting issues.
The disclosures required by FSP 160-1, Accounting and Disclosure Require
ments Related to the Medicare Prescription Drug, Improvement and Modern
ization Act of2003, (Questions 6 and 7) are effective for financial statements
of fiscal years ending after December 7, 2003. When FSP 106-2 becomes
effective, or upon earlier adoption if elected, it supersedes FSP 106-1, and
Questions 8,9, and 10 would apply (see below).

In May 2004, the FASB issued FSP 106-2, Accounting and Disclosure Require
ments Related to the Medicare Prescription Drug, Improvement and Modern
ization Act of 2003, which provides guidance on the accounting for the
effects of the Act for employers that sponsor postretirement health care
plans that provide prescription drug benefits. This FSP also requires those
employers to provide certain disclosures regarding the effect of the federal
subsidy provided by the Act. When this FSP becomes effective, or upon
earlier adoption if elected, it supersedes FSP 106-1. Except for certain
nonpublic entities, FSP 106-2 is effective for the first interim or annual
period beginning after June 15,2004. For a nonpublic entity, as defined in
SFAS 87, Employers' Accounting for Pensions, that sponsors one or more
defined benefit postretirement health care plans that provide prescription
drug coverage but of which no plan has more than 100 participants, FSP
106-2 is effective for fiscal years beginning after December 15,2004. Earlier
application of FSP 106-2 is encouraged. Readers should refer to the de
tailed effective date requirements in FSP 106-2.

6.

If the entity sponsors a postretirement health care plan that provides
prescription drug benefits and has elected to defer recognizing the
effects of the Medicare Prescription Drug, Improvement and Modern
ization Act of 2003 (the Act), did the entity disclose:

a. The existence of the Act and the fact that in accordance with FSP
106-1, any measures of the accumulated postretirement benefit
obligation or net periodic postretirement benefit cost in the finan
cial statements or accompanying notes do not reflect the effects on
the plan of the Act?
b. The fact that specific authoritative guidance on the accounting for
the federal subsidy is pending and that guidance, when issued,
could require the entity to change previously reported informa
tion?
c. Any additional information is appropriate to help the reader
understand the Act's possible economic consequences, including
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whether the entity would need to amend the plan (regardless of
whether it intends to do so) in order to benefit from the new
legislation? (This disclosure is encouraged, but not required.)

____

d. An estimate of the cash flows that the entity believes it will be
entitled to receive under the federal subsidy with an acknow
ledgment that the issues of how and when the federal subsidy
should be accounted for are not yet resolved by the FASB? (This
disclosure is encouraged, but not required.)
[FSP 106-1]
7.

____

If the entity sponsors a postretirement health care plan that provides
prescription drug benefits and has recognized the effects of the Medi
care Prescription Drug, Improvement and Modernization Act of 2003
(the Act), did the entity disclose:

a. The effects, if any, of the Act on the reported measure of the
accumulated postretirement benefit obligation?

____

b. How that effect has been, or will be reflected, in the net postretire
ment benefit costs of current or subsequent periods?

____

c. The effects of any changes in estimates of participation rates or per
capita claims costs as a result of the Act?

____

d. The fact that specific authoritative guidance on the accounting for
the federal subsidy is pending and that guidance, when issued,
could require the entity to change previously reported informa
tion?

____

e. The basis for concluding that its plan is at least "actuarially equiva
lent" (as defined in the Act) to Medicare Part D?

____

f. If some or all of the federal subsidy (other than current period
amortization) related to prescription drug is recognized immedi
ately as a component of income from continuing operations, is the
amount recognized reported as a separate line item on the face of
the statement of activities?
[FSP 106-1]

Note: FSP 106-2, Accounting and Disclosure Requirements Related to the
Medicare Prescription Drug, Improvement and Modernization Act of 2003,
disclosure requirements described in Questions 8 through 10 below are
effective for fiscal years beginning after December 15,2004. Earlier appli
cation of FSP 106-2 is encouraged.
8.

Until an employer is able to determine whether benefits provided by
its plan are actuarially equivalent, does it disclose the following in
financial statements for interim or annual periods:

a. The existence of the Act?
b. The fact that measures of the accumulated postretirement benefit
obligation (APBO) or net periodic postretirement benefit cost do
not reflect any amount associated with the subsidy because the
employer is unable to conclude whether the benefits provided by
the plan are actuarially equivalent to Medicare Part D under the
Act?
[FSP 106-2]

9.

In interim and annual financial statements for the first period in which
an employer includes the effects of the subsidy in measuring the
APBO and the first period in which an employer includes the effects
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of the subsidy in measuring net periodic postretirement benefit cost,
does it disclose the following:
a. The reduction in the APBO for the subsidy related to benefits
attributed to past service?

____

____

____

b. The effect of the subsidy on the measurement of net periodic
postretirement benefit cost for the current period? That effect
includes (1) any amortization of the actuarial experience gain in a
as a component of the net amortization called for by paragraph 59
of SFAS106, (2) the reduction in current period service cost due to
the subsidy, and (3) the resulting reduction in interest cost on the
APBO as a result of the subsidy.

____

____

____

____

____

____

____

____

____

____

____

____

____

____

____

____

____

____

c. Any other disclosures required by paragraph 5(r) of SFAS 132(R),
Employers' Disclosures about Pensions and Other Postretirement Bene
fits? Paragraph 5(r) of SFAS 132(R) requires disclosure of "an
explanation of any significant change in the benefit obligation or
plan assets not otherwise apparent in the other disclosures re
quired by this Statement."
[FSP 106-2]

10. For purposes of the disclosures required by paragraphs 5(a) and 5(f)
of SFAS 132(R), does an employer disclose gross benefit payments
(paid and expected, respectively), including prescription drug bene
fits, and separately, the gross amount of the subsidy receipts (received
and expected, respectively)?
[FSP 106-2]

K. Consolidations
1.

2.

3.

If consolidated statements are presented, is the consolidation policy
disclosed?
[ARB 51, par. 5 (AC C51.108); APB 22, par. 13 (AC A10.106)]
Are the accounts of all majority-owned subsidiaries (except those for
which control is likely to be temporary or does not rest with the
majority owner) consolidated?
[SFAS 94, par. 13 (AC C51.103)]
If the financial reporting periods of any subsidiaries are different from
that of the parent, are intervening events that materially affect finan
cial position or results of operations disclosed?
[ARB 51, par. 4 (AC C51.107)]

Consolidation of Variable Interest Entities
Important: FASBI 46(R), Consolidation of Variable Interest Entities, an
interpretation of ARB 51, contains different effective dates based on the
nature of the entity applying its provisions. Also, FASBI 46(R) contains
scope exceptions that should be considered in determining whether its
provisions apply to a particular entity. Financial statement preparers and
auditors should familiarize themselves with the effective date guidance
and scope exceptions contained in FASBI 46(R), which can be obtained
on the FASB Web site at www.fasb.org. Note that FASBI 46(R) replaces
the original FASBI 46 that was issued in January 2003.

Separate accounts of life insurance entities as described in the AICPA
Audit and Accounting Guide Life and Health Insurance Entities, are not
subject to consolidation according to the requirements of FASBI 46.
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4.

Does the primary beneficiary of a variable interest entity disclose the
following (unless the primary beneficiary also holds a majority voting
interest):

a. The nature, purpose, size, and activities of the variable interest
entity?

____

b. The carrying amount and classification of consolidated assets that
are collateral for the variable interest entity's obligations?

____

c. Lack of recourse if creditors (or beneficial interest holders) of a
consolidated variable interest entity have no recourse to the gen
eral credit of the primary beneficiary?
[FASBI 46(R), par. 23]

5.

____

Does an enterprise that holds a significant variable interest in a
variable interest entity but is not the primary beneficiary disclose:

a. The nature of its involvement with the variable interest entity and
when that involvement began?

____

b. The nature, purpose, size, and activities of the variable interest
entity?

____

c. The enterprise's maximum exposure to loss as a result of its
involvement with the variable interest entity?
[FASBI 46(R), par. 24 (AC C54.124)]
6.

7.

Are disclosures required by SFAS 140 about a variable interest entity
included in the same note to the financial statements as the informa
tion required by FASBI 46(R)?
[FASBI 46(R), par. 25 (AC C54.125)]

____

____

If an entity does not apply FASBI 46(R) to one or more variable interest
entities or potential variable interest entities because of the condition
described in paragraph 4(g) of FASBI 46(R), is the following informa
tion disclosed:

a. The number of entities to which this Interpretation is not being
applied and the reason why the information required to apply this
Interpretation is not available?

____

b. The nature, purpose, size (if available), and activities of the en
tity(ies) and the nature of the enterprise's involvement with the
entity(ies)?

____

c. The reporting enterprise's maximum exposure to loss because of
its involvement with the entity(ies)?

____

d. The amount of income, expense, purchases, sales, or other meas
ure of activity between the reporting enterprise and the entity(ies)
for all periods presented? (However, if it is not practicable to
present that information for prior periods that are presented in the
first set of financial statements for which this requirement applies,
the information for those prior periods is not required.)
[FASBI 46(R), par. 26 (AC C54.126)]

L.

Financial Instruments

Derivative Instruments and Hedging Activities
1.

If an entity holds or issues derivative instruments (or nonderivative
instruments that are designated and qualify as hedging instruments
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2.

3.

4.
5.

6.

pursuant to paragraphs 37 and 42 of SFAS 133, as amended by SFAS
138) has disclosure been made of its objectives for holding or issuing
those instruments, the context needed to understand those objectives,
and its strategies for achieving those objectives?

____

Does the description distinguish between derivative instruments (and
nonderivative instruments) designated as fair value hedging instru
ments, derivative instruments designated as cash flow hedging in
struments, derivative instruments (and nonderivative instruments)
designated as hedging instruments for hedges of the foreign currency
exposure of a net investment in a foreign operation, and all other
derivatives?

____

Does the description also indicate the entity's risk management policy
for each of those types of hedges, including a description of the items
or transactions for which risks are hedged?

____

For derivative instruments not designated as hedging instruments,
does the description indicate the purpose of the derivative activity?

____

Qualitative disclosures about an entity's objectives and strategies for
using derivative instruments may be more meaningful if such objec
tives and strategies are described in the context of an entity's overall
risk management profile. If appropriate, an entity is encouraged, but
not required, to provide such additional qualitative disclosures. Have
such disclosures been made?
[SFAS 133, par. 44 (AC D50)]

No

N/A

____

Do the entity's disclosures for every reporting period for which a
complete set of financial statements is presented also include the
following:

Fair value hedges
a. For derivative instruments, as well as nonderivative instruments
that may give rise to foreign currency transaction gains or losses
under SFAS 52, that have been designated and have qualified as
fair value hedging instruments and for the related hedged items:
(1)

(2)

The net gain or loss recognized in earnings during the report
ing period representing (a) the amount of the hedges' ineffec
tiveness and (b) the component of the derivative instruments'
gain or loss, if any, excluded from the assessment of hedge
effectiveness, and a description of where the net gain or loss
is reported in the statement of income or other statement of
financial performance?
The amount of net gain or loss recognized in earnings when
a hedged firm commitment no longer qualifies as a fair value
hedge?
[SFAS 133, par. 45a (AC D50)]

____

____

Cash flow hedges

b. For derivative instruments that have been designated and have
qualified as cash flow hedging instruments and for the related
hedged transactions:
(1)

The net gain or loss recognized in earnings during the report
ing period representing (a) the amount of the hedges' ineffec
tiveness and (b) the component of the derivative instruments'
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(2)

(3)

(4)

Yes

No

N/A

gain or loss, if any, excluded from the assessment of hedge
effectiveness, and a description of where the net gain or loss
is reported in the statement of income or other statement of
financial performance?

____

____

____

A description of the transactions or other events that will
result in the reclassification into earnings of gains and losses
that are reported in accumulated other comprehensive in
come, and the estimated net amount of the existing gains or
losses at the reporting date that is expected to be reclassified
into earnings within the next 12 months?

____

____

____

The maximum length of time over which the entity is hedging
its exposure to the variability in future cash flows for fore
casted transactions excluding those forecasted transactions
related to the payment of variable interest on existing finan
cial instruments?

____

____

____

____

____

____

____

____

____

____

____

____

____

____

____

The amount of gains and losses reclassified into earnings as
a result of the discontinuance of cash flow hedges because it
is probable that the original forecasted transactions will not
occur by the end of the originally specified time period (as
documented at the inception of the hedging relationship) or
within an additional two-month period of time thereafter?
[SFAS133, par. 45b, as amended by SFAS138, par. 4r (AC D50)]

Hedges of the net investment in a foreign operation

c. For derivative instruments, as well as nonderivative instruments
that may give rise to foreign currency transaction gains or losses
under SFAS 52, that have been designated and have qualified as
hedging instruments for hedges of the foreign currency exposure
of a net investment in a foreign operation, the net amount of gains
or losses included in the cumulative translation adjustment during
the reporting period?
[SFAS 133, par. 45c (AC D50)]

7.

The quantitative disclosures about derivative instruments may be more
useful, and less likely to be perceived to be out of context or otherwise
misunderstood, if similar information is disclosed about other financial
instruments or nonfinancial assets and liabilities to which the derivative
instruments are related by activity. Accordingly, in such situations, has
the entity presented a more complete picture of its activities by disclosing
that information? (Encouraged, but not required.)
[SFAS 133, par. 45 (AC D50)]

Disclosures About Fair Value of Financial Instruments

8.

9.

Has the entity disclosed, either in the body of the financial statements
or in the accompanying notes13 the fair value of financial instruments
(except for those excluded in paragraphs 8 and 13 of SFAS 107) for
which it is practicable to estimate fair value?
[SFAS 107, par. 10 (AC F25)]
Has the fair value disclosed in the notes been presented together with
the related carrying amount in a form that makes it clear whether the

13 If disclosed in more than a single note, one of the notes shall include a summary table. The summary table shall contain the fair
value and related carrying amounts and cross-references to the location(s) of the remaining disclosures required by this Statement as
amended.
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fair value and carrying amount represent assets or liabilities and how
the carrying amounts relate to what is reported in the statement of
financial position?
[SFAS 107, par. 10 (AC F25)]
10. In disclosing the fair value of a financial instrument, has the entity
taken care not to net that fair value with the fair value of other financial
instruments—even if those financial instruments are of the same class
or are otherwise considered to be related, for example, by a risk
management strategy—except to the extent that the offsetting of
carrying amounts in the statement of financial position is permitted
under the general principle in paragraphs 5 and 6 of FASBI 39,
Offsetting of Amounts Related to Certain Contracts, or the exceptions for
master netting arrangements in paragraph 10 of FASBI 39 and for
amounts related to certain repurchase and reverse repurchase agree
ments in paragraphs 3 and 4 of FASBI 41, Offsetting of Amounts Related
to Certain Repurchase and Reverse Repurchase Agreements?
[SFAS 107, par. 14 (AC F25)]

Yes

No

N/A

____

____

____

____

____

____

____

____

____

____

____

____

11. If it is not practicable to estimate the fair value of a financial instru
ment or a class of financial instruments, are the following disclosed:

a. Information pertinent to estimating the fair value of that financial
instrument or class of financial instruments, such as the carrying
amount, effective interest rate, and maturity?

b. The reasons why it is not practicable to estimate fair value?
[SFAS 107, par. 14 (AC F25)]

Note: SFAS 126, Exemption from Certain Required Disclosures about Financial
Instruments for Certain Nonpublic Entities, as amended, makes the disclo
sures about fair values of financial instruments prescribed in SFAS 107
optional for reporting entities that:
a. Are nonpublic entities.
b. Have total assets of less than $100 million on the date of the financial
statements.
c. Have no instrument that, in whole or in part, is accounted for as a
derivative instrument under SFAS 133, Accounting for Derivative
Instruments and Hedging Activities, other than commitments related
to the origination of mortgage loans to be held for sale† during the
reporting period.
Disclosure About Concentrations of Credit Risk ofAll Financial Instruments

12. Except as indicated in paragraph 15b14 of SFAS 107, has the entity
disclosed all significant concentrations of credit risk arising from all

† For institutions that choose the option of disclosure, or for institutions not meeting the exemption requirements, the AICPA is
developing an illustrative practice aid to assist institutions in complying with various loan commitment derivative disclosure
requirements.
14 SFAS 107 paragraph 15b provides that these disclosure requirements do not apply to the following financial instruments, whether
written or held:
a. Financial instruments of a pension plan, including plan assets, when subject to the accounting and reporting requirements of
SFAS 87 (Financial instruments of a pension plan, other than the obligations for pension benefits, when subject to the accounting
and reporting requirements of SFAS 35, Accounting and Reporting by Defined Benefit Pension Plans, are subject to the reporting of
paragraph 15a).
b. The financial instruments described in paragraphs 8a, 8c, 8e, and 8f of SFAS 107, as amended by SFAS 112, Employers' Accounting
for Postemployment Benefits, SFAS 123, Accounting for Stock-Based Compensation, and SFAS 140, except for reinsurance receivables
and prepaid reinsurance premiums.
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financial instruments, whether from an individual counterparty or
groups of counterparties? (Group concentrations of credit risk exist if a
number of counterparties are engaged in similar economic charac
teristics that would cause their ability to meet contractual obligations
to be similarly affected by changes in economic or other conditions.)
[SFAS 107, par. 15a (AC F25)]

No

N/A

____

13. Has the entity made the following disclosures about each significant
concentration:

a. Information about the (shared) activity, region, or economic char
acteristic that identifies the concentration?

b. The maximum amount of loss due to credit risk that, based on the
gross fair value of the financial instrument, the entity would incur
if parties to the financial instruments that make up the concentra
tion failed completely to perform according to the terms of the
contracts and the collateral or other security, if any, for the amount
due proved to be of no value to the entity?

c. The entity's policy of requiring collateral or other security to
support financial instruments subject to credit risk, information
about the entity's access to that collateral or other security, and the
nature and a brief description of the collateral or other security
supporting those financial instruments?

d. The entity's policy of entering into master netting arrangements
to mitigate the credit risk of financial instruments, information
about the arrangements for which the entity is a party, and a brief
description of the terms of those arrangements, including the
extent to which they would reduce the entity's maximum amount
of loss due to credit risk?
[SFAS 107, par. 15a (AC F25)]
14. Has the entity disclosed quantitative information15 about the market
risks of financial instruments that is consistent with the way it man
ages or adjusts those risks? (Encouraged, but not required.)
[SFAS 107, par. 15c (AC F25)]
15. Are the classification and presentation consensuses reached in EITF
00-19, regarding derivative financial instruments indexed to, and
potentially settled in, a company's own stock complied with?
[EITF 00-19]
16. Are gains and losses (realized and unrealized) on all derivative instru
ments within the scope of SFAS 133 shown net when recognized in
the income statement, whether or not settled physically, if the deriva
tive instruments are held for trading purposes?
[EITF 02-3]
15 Appropriate ways of reporting the quantitative information encouraged will differ for different entities and will likely evolve over
time as management approaches and measurement techniques evolve. Possibilities include disclosing (a) more details about current
positions and perhaps activity during the period, (b) the hypothetical effects on comprehensive income (or net assets), or annual
income, of several possible changes in market prices, (c) a gap analysis of interest rate repricing or maturity dates, (d) the duration of
the financial instruments, or (e) the entity's value at risk from derivatives and from other positions at the end of the reporting period
and the average value at risk during the year. This list is not exhaustive, and an entity is encouraged to develop other ways of reporting
quantitative information.
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17. If derivative transactions are entered into in connection with the
issuance of contingently convertible securities, do disclosures of the
potential impact of the contingently convertible securities include the
terms of those derivative transactions (including the terms of settle
ment), how those transactions relate to the contingently convertible
securities and the number of shares underlying the derivatives?
[FSP 129-1, par. 5 (AC C24.806)]

Yes

No

____

___

N/A

Disclosures About Certain financial Instruments With Characteristics of
Both Liabilities and Equity

Important: Depending upon whether an entity is a nonpublic entity, a
public entity, or an SEC registrant, FSP 150-3 defers the effective date for
applying the provisions of SFAS 150, Accounting for Certain Financial
Instruments with Characteristics of both Liabilities and Equity. Readers should
read FSP 150-3 to understand the various effective dates of SFAS 150. FSP
150-3 is available at the FASB Web site at www.fasb.org.
Early adoption of the provisions of SFAS 150 for instruments within the
scope of the indefinite deferrals established by FSP 150-3 is precluded
during the deferral period.
During the deferral period, all public entities as well as nonpublic entities
that are SEC registrants are required to follow the disclosure requirements
in paragraphs 26 and 27 of SFAS 150 (Questions 20 and 21 below) as well
as disclosures required by other applicable guidance.

18. For items within the scope of SFAS 150, are they presented as liabilities
(or assets in some circumstances), and are those items not presented
between the liabilities section and the equity section of the statement
of financial position?
[SFAS 150, par. 18 (AC F41.116)]

____

19. If the entity has no equity instruments outstanding but has financial
instruments in the form of shares, all of which are mandatorily
redeemable financial instruments:

a. Are they classified as liabilities?

____

b. Are they described in the statement of financial position as "shares
subject to mandatory redemption?"

____

c. Are payments to holders of such instruments and related accruals
presented separately from payments to and interest due to other
creditors in statements of cash flows and income?
[SFAS 150, pars. 19 and 28 (AC F41.117 and .126)]

20. Do the entities referred to in Question 17 above disclose the compo
nents of the liability that would otherwise be related to shareholders'
interest and other comprehensive income, if any, subject to the re
demption feature (for example, par value and other paid-in amounts
of mandatorily redeemable instruments should be disclosed sepa
rately from the amount of retained earnings or accumulated deficit)?
[SFAS 150, par. 28 (AC F41.126)]

____

____

21. For issuers of financial instruments within the scope of SFAS 150:
a. Are the nature and terms of the financial instruments and the
rights and obligations embodied in those instruments disclosed?

____
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b. Does that disclosure include information about settlement alter
natives, if any, in the contract and identify the entity that controls
the settlement alternatives?
[SFAS 150, par. 26 (AC F41.124]

22. For all outstanding financial instruments within the scope of SFAS 150
and for each settlement alternative, do issuers disclose:

a. The amount that would be paid, or the number of shares that
would be issued and their fair value, determined under the con
ditions specified in the contract if the settlement were to occur at
the reporting date?

b. How changes in the fair value of the issuer's equity shares would
affect those settlement amounts (for example, 'the issuer is obli
gated to issue an additional x shares or pay an additional y dollars
in cash for each $1 decrease in the fair value of one share")?
c. The maximum amount that the issuer could be required to pay to
redeem the instrument by physical settlement, if applicable?

d. The maximum number of shares that could be required to be
issued, if applicable?
e. That a contract does not limit the amount that the issuer could be
required to pay or the number of shares that the issuer could be
required to issue, if applicable?

f.

For a forward contract or an option indexed to the issuer's equity
shares, the forward price or option strike price, the number of
issuer's shares to which the contract is indexed, and the settlement
date or dates of the contract, as applicable?
[SFAS 150, par. 27 (AC F41.125)]

23. Are mandatorily redeemable financial instruments classified as li
abilities unless the redemption is required to occur only upon the
liquidation or termination of the reporting entity?
[SFAS 150, par. 9 (AC F41.107)]
24. Are financial instrument, other than an outstanding share, that, at
inception, (a) embodies an obligation to repurchase the issuer's equity
shares, or is indexed to such an obligation, and (b) requires or may
require the issuer to settle the obligation by transferring assets, clas
sified as liabilities (or assets in some circumstances)?
[SFAS 150, par. 11 (AC F41.109)]

25. Are financial instruments that embody an unconditional obligation,
or financial instruments other than an outstanding share that embod
ies a conditional obligation, that the issuer must or may settle by
issuing a variable number of its equity shares, classified as liabilities
(or assets in some circumstances) if, at inception, the monetary value
of the obligation is based solely or predominantly on any one of the
items indicated in paragraph 12 of SFAS 150?
[SFAS 150, par. 12 (AC F41.110)]
Related to the Adoption of SFAS 150

26. Is the cumulative transition adjustment and any subsequent adjust
ment reported as an excess of liabilities over assets (a deficit) and
changes thereto even though the mandatorily redeemable shares are
reported as a liability?
[FSP 150-2]
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27. Is the resulting change in the amount of the mandatorily redeemable
shares, depending on the settlement terms, either measured at the
present value of the amount to be paid at settlement or the amount of
cash that would be paid under the conditions specified in the contract
if settlement occurred at the reporting date recognized as interest cost
(change in redemption amount)?
[FSP 150-2]
28. Although the disclosure requirements of SFAS 150 do not apply for
those mandatorily redeemable instruments of certain nonpublic com
panies while application of the provisions of SFAS 150 to those
instruments is deferred, are the disclosure requirements regarding
"Capital Structure: Disclosures" in paragraph 4 of SFAS 129, in par
ticular, information about the pertinent rights and privileges of the
various securities outstanding, including mandatory redemption re
quirements, still disclosed?
[FSP 150-3]

29. Although the disclosure requirements of SFAS 150 do not apply for
those mandatorily redeemable instruments of certain nonpublic com
panies while application of the provisions of SFAS 150 to those
instruments is deferred, are the disclosure requirements regarding
"Capital Structure: Disclosures" in paragraph 8 of SFAS 129, which
requires disclosure of the amount of redemption requirements for all
issues of stock that are redeemable at fixed or determinable prices on
fixed or determinable dates in each of the next five years, still dis
closed?
[FSP 150-3]

30. During the deferral period, if the entity is a public entity or a nonpub
lic entity that is an SEC registrant, are the disclosure requirements in
paragraphs 26 and 27 of SFAS 150 as well as disclosures required by
other applicable guidance complied with?
[FSP 150-3]

Yes

No

____

___

____

___

____

___

____

___

□

M. Foreign Currency
1.

2.

Is the aggregate transaction gain or loss included in net income for the
period disclosed? (Note: For this disclosure, gains and losses on
derivative instruments shall comply with paragraph 45 of SFAS 133.)
[SFAS 52, par. 30, as amended by SFAS 133 (AC F60.140)]

N/A

____

___

a. Beginning and ending amounts of cumulative translation adjust
ments?

____

___

b. The aggregate adjustment for the period resulting from translation
adjustments and gains and losses from certain hedges and inter
company balances?

____

___

c. The amount of income taxes for the period allocated to translation
adjustments?

____

___

____

___

Is an analysis of changes during the period in the accumulated
amount of translation adjustments reported in equity, included, and
does it disclose:

d. The amounts transferred from cumulative translation adjustments
and included in the determination of net income for the period as
a result of the sale or complete or substantially complete liquida
tion of an investment in a foreign entity?
[SFAS 52, par. 31 (AC F60.141)]
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3.

4.

Are rate changes occurring after the date of the financial statements
and the effects on unsettled balances related to foreign currency
translations disclosed, if significant?
[SFAS 52, par. 32 (AC F60.142)]
Are any foreign earnings reported in addition to amounts received in
the U.S. disclosed, if significant?
[ARB 43, Ch. 12, par. 5 (AC F65.102)]

____

____

N. Impairment of Long-Lived Assets to Be Held and Used

1.

2.

Is an impairment loss recognized for a long-lived asset (asset group)
to be held and used included in income from continuing operations
before income taxes in the income statement of a business enterprise?
[SFAS 144, par. 25 (AC I08.160)]

____

Is the following information disclosed in the notes to the financial
statements that include the period in which an impairment loss is
recognized:

a. A description of the impaired long-lived asset (asset group) and
the facts and circumstances leading to the impairment?

____

b. If not separately presented on the face of the statement, the amount
of the impairment loss and the caption in the income statement
that includes the loss?

____

c. The method or methods for determining fair value (whether based
on a quoted market price, prices for similar assets, or another
valuation technique)?

____

d. If applicable, the segment in which the impaired long-lived asset
(asset group) is reported under SFAS 131, Disclosures about Segments
of an Enterprise and Related Information?
[SFAS 144, par. 26 (AC I08.161)]

____

Note: EITF 03-13 should be applied to a component of an enterprise that
is either disposed of or classified as held for sale in fiscal periods beginning
after December 15,2004. Operating results related to a component that is
disposed of or classified as held for sale within an enterprise's fiscal year
that includes the date that this consensus is ratified may be classified to
reflect the consensus.
3.

4.

If the occurrence of a significant event or circumstance at any time
during the assessment period results in an expectation that the criteria
in paragraph 42 of EITF 03-13 will be met by the end of the assessment
period, is the component's operations presented as discontinued
operations?
[EITF 03-13, par. 13]

____

Is the following information disclosed in the notes to the financial
statements for each discontinued operation that generates continuing
cash flows:

a. The nature of the activities that give rise to continuing cash flows?

____

b. The period of time continuing cash flows are expected to be
generated? and

____

c. The principal factors used to conclude that the expected continuing
cash flows are not direct cash flows of the disposed component?
[EITF 03-13, par. 17]
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5.

6.

Additionally, for each discontinued operation in which the ongoing
entity will engage in a "continuation of activities" with the disposed
component after its disposal and for which the amounts presented in
continuing operations after the disposal transaction include a con
tinuation of revenues and expenses that were intercompany transac
tions (eliminated in consolidated financial statements) before the
disposal transaction, are the intercompany amounts before the dis
posal transaction disclosed for all periods presented?
[EITF 03-13, par. 17]
Are the types of continuing involvement, if any, that the entity will
have after the disposal transaction disclosed? Also, is that information
disclosed in the period in which operations are initially classified as
discontinued?
[EITF 03-13, par. 17]

Yes

No

____

___

____

___

____

___

____

___

____

___

____

___

____

___

____

___

____

___

N/A

O. Long-Lived Assets and Disposal Groups to Be Disposed Of

Reporting Discontinued Operations
1.

Are the results of operations of a component of an entity (as that phrase
is defined in SFAS144) that either has been disposed of or is classified
as held for sale reported in discontinued operations in accordance
with paragraph 43 of SFAS 144 (Questions 2,3,4, and 5 below) if both
of the following conditions are met:

a. The operations and cash flows of the component have been (or will
be) eliminated from the ongoing operations of the entity as a result
of the disposal transaction? and

b. The entity will not have any significant continuing involvement in
the operations of the component after the disposal transaction?
[SFAS 144, par. 42 (AC I14.102)]

2.

3.

4.

5.

6.

In a period in which a component of an entity either has been disposed
of or is classified as held for sale, does the income statement for current
and prior periods report the results of operations of the component,
including any gain or loss recognized in accordance with paragraph
37 of SFAS 144, in discontinued operations?
[SFAS 144, par. 43 (AC I14.103)]
Are the results of operations of a component classified as held for sale
reported in discontinued operations in the period(s) in which they
occur?
[SFAS 144, par. 43 (AC I14.103)]

Are the results of discontinued operations, less applicable income
taxes (benefit), reported as a separate component of income before
extraordinary items and the cumulative effect of accounting changes
(if applicable)?
[SFAS 144, par. 43 (AC I14.103)]
Is the gain or loss recognized on the disposal disclosed either on the
face of the income statement or in the notes to the financial statements?
[SFAS 144, par. 43 (AC I14.103)]

Are adjustments to amounts previously reported in discontinued
operations that are directly related to the disposal of a component of
an entity in a prior period classified separately in the current period
in discontinued operations?
[SFAS 144, par. 44 (AC I14.104)]
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7.

Are the nature and amount of such adjustments (as discussed in
Question 6 above) disclosed?
[SFAS 144, par. 44 (AC I14.104)]

Reporting Disposal Gains or Losses in Continuing Operations

8.

Is a gain or loss, that is recognized on the sale of a long-lived asset
(disposal group) that is not a component of an entity, included in
income from continuing operations before income taxes in the income
statement?
[SFAS 144, par. 45 (AC D60.118)]

9.

If a subtotal such as "income from operations" is presented, does it
include the amounts of those gains or losses considered in Question
8 above?
[SFAS 144, par. 45 (AC D60.118)]

Reporting a Long-Lived Asset or Disposal Group Sold or Classified as
Held for Sale

10. If the criteria of paragraph 30 of SFAS 144 are met (and thus a
long-lived asset is classified as held for sale) after the balance sheet
date but before issuance of the financial statements, does the longlived asset continue to be classified as held and used in those financial
statements when issued and is the information required by paragraph
47(a) of SFAS 144 (Question 15a below) disclosed in the notes to the
financial statements?
[SFAS 144, par. 33 (AC D60.110)]
11. Is a long-lived asset that is classified as held for sale presented
separately in the statement of financial position?
[SFAS 144, par. 46 (AC D60.119)]

12. Are the assets and liabilities of a disposal group that is classified as
held for sale presented separately in the asset and liability sections,
respectively, of the statement of financial position?
[SFAS 144, par. 46 (AC D60.119)]
13. Are those assets and liabilities considered in Question 12 above, not
offset and presented as a single amount?
[SFAS 144, par. 46 (AC D60.119)]
14. Are the major classes of assets and liabilities that are classified as held
for sale separately disclosed either on the face of the statement of
financial position or in the notes to financial statements?
[SFAS 144, par. 46 (AC D60.119)]

15. Is the following information disclosed in the notes to the financial
statements that cover the period in which a long-lived asset (disposal
group) either has been sold or is classified as held for sale:
a. A description of the facts and circumstances leading to the ex
pected disposal, the expected manner and timing of that disposal,
and, if not separately presented on the face of the statement, the
carrying amount(s) of the major classes of assets and liabilities
included as part of a disposal group?
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b. The gain or loss recognized in accordance with paragraph 37 of
SFAS144 and if not separately presented on the face of the income
statement, the caption in the income statement that include that
gain or loss?

c. If applicable, amounts of revenue and pretax profit or loss re
ported in discontinued operations?

d. If applicable, the segment in which the long-lived asset (disposal
group) is reported under SFAS 131?
[SFAS 144, par. 47 (AC D60.120 and I14.105)]
16. If either paragraph 38 or 40 of SFAS 144 applies, is a description of the
facts and circumstances leading to the decision to change the plan to
sell the long-lived asset (disposal group) and its effect on the results
of operations for the period and any prior periods presented disclosed
in the notes to the financial statements that include the period of that
decision?
[SFAS 144, par. 48 (AC D60.121 and I14.106)]
17. If a long-lived asset is to be disposed of other than by sale, does it
continue to be classified as held and used until it is disposed of?
[SFAS 144, par. 27, as amended by SFAS 153 (AC D60.104)]

P.

Transfers and Servicing of Financial Assets and Securitizations

1.

Is the policy for requiring collateral or other security disclosed if the
entity has entered into repurchase agreements or securities lending
transactions?
[SFAS 140, par. 17(a) (AC F39.110a)]

2.

If it is not practicable to estimate the fair value of certain assets
obtained or liabilities incurred in transfers of financial assets during
the period, are those items and the reasons why it is not practicable to
estimate fair value described in the notes to the financial statements?
[SFAS 140, par. 17(d) (AC F39.110b)]

3.

For all servicing assets and servicing liabilities are the following
disclosures made:

a. The amounts of servicing assets or liabilities recognized and am
ortized during the period?
b. The fair value of recognized servicing assets and liabilities for
which it is practicable to estimate that value and the method and
significant assumptions used to estimate the fair value?
c. The risk characteristics of the underlying financial assets used to
stratify recognized servicing assets for purposes of measuring
impairment in accordance with paragraph 63 of SFAS 140?

d. The activity in any valuation allowance for impairment of recog
nized servicing assets—including beginning and ending balances,
aggregate additions charged and reductions credited to opera
tions, and aggregate direct write-downs charged against the al
lowances—for each period for which results of operations are
presented?
[SFAS 140, par. 17(e) (AC F35.102a)]
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If the entity has securitized financial assets during any period pre
sented and accounts for that transfer as a sale, are the following items
disclosed for each major asset type:

a. Its accounting policies for initially measuring the retained inter
ests, if any, including the methodology (whether quoted market
price, prices based on sales of similar assets and liabilities, or prices
based on valuation techniques) used in determining their fair
value?
b. The characteristics of securitizations (a description of the trans
feror's continuing involvement with the transferred assets, includ
ing, but not limited to, servicing, recourse, and restrictions on
retained interests) and the gain or loss from sale of financial assets
in securitizations?

c. The key assumptions‡ used in measuring the fair value of retained
interests at the time of securitization (including, at a minimum,
quantitative information about discount rates, expected prepay
ments including the expected weighted-average life of prepayable
financial assets, and anticipated credit losses, if applicable)?
d. Cash flows between the securitization SPE and the transferor,
unless reported separately elsewhere in the financial statements
or notes (including proceeds from new securitizations, proceeds
from collections reinvested in revolving-period securitizations,
purchases of delinquent or foreclosed loans, servicing fees, and
cash flows received on interests retained)?
[SFAS 140, par. 17(f) (AC F39.110c)]
5.

If the entity has retained interests in securitized financial assets at the
date of the latest statement of financial position presented, are the
following items disclosed for each major asset type:

a. Its accounting policies for subsequently measuring those re
tained interests, including the methodology (whether quoted
market price, prices based on sales of similar assets and liabili
ties, or prices based on valuation techniques) used in determin
ing their fair value?
b. The key assumptions used in subsequently measuring the fair
value of those interests (including, at a minimum, quantitative
information about discount rates, expected prepayments includ
ing the expected weighted-average life of prepayable financial
assets, and anticipated credit losses, including expected static pool
losses, if applicable)?
c. A sensitivity analysis or stress test showing the hypothetical
effect on the fair value of those interests of two or more unfa
vorable variations from the expected levels for each key as
sumption that is reported under b. above independently from
any change in another key assumption, and a description of the
objectives, methodology, and limitations of the sensitivity
analysis or stress test?

d. For the securitized assets and any other financial assets that it
manages together with them:||
‡ If an entity has made multiple securitizations of the same major asset type during a period, it may disclose the range of
assumptions.
|| Excluding securitized assets that an entity continues to service but with which it has no other continuing involvement.
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The total principal amount outstanding, the portion that has
been derecognized, and the portion that continues to be
recognized in each category reported in the statement of
financial position, at the end of the period?

____

____

____

(2)

Delinquencies at the end of the period?

____

____

____

(3)

Credit losses, net of recoveries, during the period?

____

____

____

____

____

____

____

____

____

____

____

____

(1)

Disclosure of average balances during the period is encouraged,
but not required.
[SFAS 140, par. 17(g) (AC F39.110d)]
Collateral
6.

7.

8.

If the entity has pledged any of its assets as collateral that are not
reclassified and separately reported in the statement of financial
position pursuant to paragraph 15(a) of SFAS 140, is the carrying
amount and classification of those assets as of the date of the latest
statement of financial position presented?
[SFAS 140, par. 17(a)(2) (AC F39.110a)]
If the entity has accepted collateral that it is permitted by contract or
custom to sell or repledge, is the fair value, as of the date of each
statement of financial position presented, of that collateral and of the
portion of that collateral that it has sold or repledged disclosed?
[SFAS 140, par. 17(a)(3) (AC F39.110a)]

Is information about the sources and uses of that collateral, as of the
date of each statement of financial position presented, disclosed?
[SFAS 140, par. 17(a)(3) (AC F39.110a)]

Q. Nonmonetary Transactions
1.

2.

□

Do disclosures for nonmonetary transactions during the period include:

a. Nature of the transactions?

____

____

____

b. Basis of accounting for the assets transferred?

____

____

____

c. Gains or losses recognized on the transfers?
[APB 29, par. 28, fn. 7 (AC 01.102 and N35.120); FASBI 30 (AC
N35.114-.119)]

____

____

____

____

____

____

Is the amount of gross operating revenue recognized as a result of
nonmonetary transactions addressed by EITF 00-8, Accounting by a
Grantee for an Equity Instrument to Be Received in Conjunction with
Providing Goods or Services, disclosed in each period's financial statements?
[EITF 00-8]

R. Subsequent Events
1.

Are the financial statements adjusted for any changes in estimates
resulting from subsequent events that provide additional evidence
about conditions that existed at the balance-sheet date?
[SFAS 5, par. 8 (AC C59.105); SAS 1, secs. 560.03, .04, .07, and 561.01.10 (AU 560.03, .04, .07, and 561.01-.10)]

□

____

____

____
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2.

Are subsequent events that provide evidence about conditions that
did not exist at the balance-sheet date, but arose subsequent to that
date, adequately disclosed to keep the financial statements from
being misleading?
[SFAS 5, par. 11 (AC C59.112); SAS1, secs. 560.05-.07, .09, and 561.01.09 (AU 560.05-.07, .09, and 561.01-.09)]

Note: Consider the appropriateness of dual-dating the auditor's report if
a subsequent event is disclosed in the financial statements.
[SAS 1, sec. 530.05 (AU 530.05)]

S.

Costs Associated With Exit or Disposal Activities
Note: SFAS 146, Accounting for Costs Associated With Exit or Disposal
Activities, is effective for exit or disposal activities initiated after December
31, 2002. For the purposes of SFAS 146, an exit or disposal activity is
initiated when management, having the authority to approve the action,
commits to an exit or disposal plan or otherwise disposes of a long-lived
asset (disposal group) and, if the activity involves the termination of
employees, the criteria for a plan of termination in paragraph 8 of SFAS
146 are met. The provisions of EITF 94-3 shall continue to apply for an exit
activity initiated under an exit plan that met the criteria of EITF 94-3 prior to
SFAS 146's initial application. Questions 1 through 3 apply only if the
provisions of SFAS 146 are not effective.

1.

If a material liability is recognized for certain employee termination
benefits in accordance with Section A of EITF 94-3, Liability Recognition
for Certain Employee Termination Benefits and Other Costs to Exit an
Activity (including Certain Costs Incurred in a Restructuring), are the
following disclosures made in all periods until the plan of termination
is completed:

a. The amount of termination benefits accrued and charged to ex
pense and the classification of those costs in the income statement?

____

b. The number of employees to be terminated?

____

c. A description of the employee group(s) to be terminated?

____

d. The amount of actual termination benefits paid and charged
against the liability and the number of employees actually termi
nated as a result of the plan to terminate employees?

____

e. The amount of any adjustment(s) to the liability?
[EITF 94-3, Section A]

2.

____

If management commits to an exit plan that meets the criteria in
Section B of EITF 94-3, are the following reporting requirements
followed:
a. Reporting the statement of income effect of recognizing a liability
at the commitment date in income from continuing operations and
not on the face of the statement of income net of taxes?
b. No disclosure made on the face of the statement of income for
earnings per share effect?
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c. Revenue and related costs and expenses of activities that will not
be continued should not be combined and reported as a separate
component of income?
[EITF 94-3, Section B]

3.

If the activities that will not be continued are significant to the com
pany's revenue or operating results, or if the exit costs recognized at
the commitment date are material, are the following disclosures made
in all periods until the exit plan is completed:

a. A description of the major actions comprising the exit plan, activi
ties that will not be continued, including the method of disposi
tion, and the anticipated date of completion?
b. A description of the type and amount of exit costs recognized as
liabilities and the classification of those costs in the income statement?

c. A description of the type and amount of exit costs paid and
charged against the liability?
d. The amount of any adjustment(s) to the liability?
e. For all periods presented, the revenue and net operating income
or losses from activities that will not be continued if those activities
have separately identifiable operations?
[EITF 94-3, Section B]
Note: Questions 4 through 8 apply only if the provisions of SFAS146 are
effective. The provisions of SFAS 146 are effective for exit or disposal
activities initiated after December 31,2002.

4.

Is the following information disclosed in notes to the financial state
ments that include the period in which an exit or disposal activity is
initiated and any subsequent period until the activity is completed:

a. A description of the exit or disposal activity, including the facts
and circumstances leading to the expected activity and the ex
pected completion date?

b. For each major type of cost associated with the activity (for exam
ple, one-time termination benefits, contract termination costs, and
other associated costs):
(1)

The total amount expected to be incurred in connection with
the activity, the amount incurred in the period, and the cu
mulative amount incurred to date?

(2)

A reconciliation of the beginning and ending liability bal
ances showing separately the changes during the period at
tributable to costs incurred and charged to expense, costs
paid or otherwise settled, and any adjustment to the liability
with an explanation of the reason(s) therefor?

c. The line item(s) in the income statement in which the costs in b
above are aggregated?
d. For each reportable segment:
(1)

The total amount of costs expected to be incurred in connec
tion with the activity?
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(2)

The amount incurred in the period?

(3) The cumulative amount incurred to date, net of any adjust
ments to the liability with an explanation of the reason(s)
therefor?

e. If a liability for a cost associated with the activity is not recognized
because fair value cannot be reasonably estimated, that fact and
the reasons therefor?
[SFAS 146, par. 20 (AC L32.120)]

5.

Are costs associated with an exit or disposal activity that does not
involve a discontinued operation included in income from continuing
operations before income taxes, for example, in a subtotal such as
"income from operations"?
[SFAS 146, par. 18 (AC L32.118)]

6.

Are costs associated with an exit or disposal activity that involves
a discontinued operation included in the results of discontinued
operation?
[SFAS 146, par. 18 (AC L32.118)]

7.

If an event or circumstance occurs that discharges or removes an
entity's responsibility to settle a liability for a cost associated with an
exit or disposal activity recognized in a prior period, is the liability
reversed?
[SFAS 146, par. 19 (AC L32.119)]

8.

Are the related costs reversed through the same line item(s) in the
income statement used when those costs were recognized initially?
[SFAS 146, par. 19 (AC L32.119)]

T. Business Combinations
Note: This section does not apply if the provisions of SFAS 141 are being
applied to the financial statements. The provisions of SFAS 141 apply to
all business combinations initiated after June 30, 2001. SFAS 141 also
applies to all business combinations accounted for using the purchase
method for which the date of acquisition is July 1, 2001, or later. If the
provisions of SFAS 141 are being applied, refer to section T1 below.

Pooling of Interests Method

If a business combination occurred during the period and met the
specified conditions for a pooling-of-interests, are the following
disclosed:
a. The fact that a combination accounted for by the pooling-of-interests
method has occurred during the period disclosed?
[APB 16, pars. 63 and 64b (AC App. E, B50.122 and .123b)]
b. The name and a brief description of the enterprises combined?
[APB 16, par. 64a (AC App. E, B50.123a)]
c. A description and the number of shares of stock issued in the
combination?
[APB 16, par. 64c (AC App. E, B50.123c)]
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d. Details (including revenue, extraordinary items, net income, other
changes in shareholders' equity, and amount of and manner of
accounting for intercompany transactions) of the results of opera
tions of the previously separate enterprises for the period before
the combination is consummated that are included in the current
combined net income?
[APB 16, par. 64d (AC App. E, B50.123d)]
e. Descriptions of the nature of adjustments of net assets of the
combining enterprises to adopt the same accounting practices
and the effects of the changes on net income previously re
ported separately and now presented in comparative financial
statements?
[APB 16, par. 64e (AC App. E, B50.123e)]

f.

Details (including at least revenue, expenses, extraordinary items,
net income, and other changes in shareholders' equity for the
period excluded from the reported results of operations) of in
creases or decreases in retained earnings from changing the fiscal
year of a combining enterprise?
[APB 16, par. 64f (AC App. E, B50.123f)]

g. Reconciliations of amounts of revenue and earnings previously
reporting by the enterprise that issued the stock to effect the
combination with the combined amounts currently presented in
financial statements and summaries? (Or if a new enterprise was
formed to effect the combination, the earnings of the separate
enterprises that comprise combined earnings for prior periods
may be disclosed.)
[APB 16, par. 64g (AC App. E, B50.123g)]
2.

If a business combination that was either incomplete as of the date of
the financial statements or initiated after that date is consummated
before the financial statements are issued, are details (including reve
nue, net income, earnings per share, and the effects of anticipated
changes in accounting methods as if the combination had been con
summated at the date of the financial statements) of the effects of the
combination disclosed?
[APB 16, par. 65 (AC App. E, B50.124)]

Yes

No

N/A

____

____

____

____

____

____

____

____

____

____

____

____

____

____

____

Practice Tip

Information relating to several relatively minor acquisitions may be combined for disclosure.
Purchase Method

3.

If a business combination occurred during the period and is to be
accounted for under the purchase method, are the following disclosed:

a. The name and a brief description of the acquired enterprise?
[APB 16, par. 95a (AC App. E, B50.164a)]

____

b. The method of accounting for the combination—that is, the pur
chase method?
[APB 16, par. 95b (AC App. E, B50.164b)]

____

c. The period for which results of operations of the acquired enterprise
are included in the income statement of the acquiring enterprise?
[APB 16, par. 95c (AC App. E, B50.164c)]

____
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d. The cost of the acquired enterprise and, if applicable, the number
of shares of stock issued or issuable and the amount assigned to
the shares?
[APB 16, par. 95d (AC App. E, B50.164d)]
e. A description of the plan for amortization of acquired goodwill,
the amortization method, and period?
[APB 16, par. 95e (AC App. E, B50.164e)]
f.

Contingent payments, options, or commitments specified in the
acquisition agreement and their proposed accounting treatment
(including consideration that is issued or issuable at the end of a
contingency period or that is held in escrow)?
[APB 16, pars. 78 and 95f (AC App. E, B50.136 and .164f)]

g. For public companies only, the following as supplemental in
formation (including at least revenue, income before extraordi
nary items, net income, and earnings per share) on a pro forma
basis:
(1)

Results of operations for the current period as though the
enterprises had combined at the beginning of the period,
unless the acquisition was at or near the beginning of the
period?
[APB 16, par. 96a (AC App. E, B50.165a); SFAS 79, par. 6 (AC
B50.165)]

(2)

Results of operations for the immediately preceding period
as though the enterprises had combined at the beginning of
that period if comparative statements are presented?
[APB 16, par. 96b (AC App. E, B50.165b); SFAS 79, par. 6 (AC
B50.165)]

4.

If the reporting entity elects not to include a preacquisition contin
gency (other than the effects of tax loss carryforwards) in the purchase
price allocation or, for those that arise after the end of the allocation
period, are not included in net income of the period in which the
adjustment is determined as described in SFAS 38, is there disclosure
of the amount and nature of adjustments, including the effect of the
adjustments on current or expected future cash flows?
[SFAS 38, par. 10 (AC App. E, B50.166)]

5.

If, as part of a business combination accounted for as a purchase, a
material liability is recognized by the combined company for costs
incurred to (a) exit an activity, (b) involuntarily terminate employees
of an acquired company, or (c) relocate employees of an acquired
company:

a. Are the following disclosures made for the period in which a
purchase business combination occurs:
(1)
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(2)

A description of the type and amount of liabilities assumed
in the purchase price allocation for costs to exit an activity or
involuntary terminate (relocate) employees?

(3)

A description of the major actions comprising the plan to exit
an activity or involuntarily terminate (relocate) employees of
an acquired company?

(4)

A description of activities of the acquired company that will
not be continued, including the method of disposition, and
the anticipated date of completion and description of em
ployee group(s) to be terminated (relocated)?

No

N/A

b. Are the following disclosures made for all periods presented
subsequent to the acquisition date in which a purchase business
combination occurred, until a plan to exit an activity or involun
tarily terminate or relocate employees of an acquired company is
fully executed:

6.

(1)

A description of the type and amount of exit costs, involun
tary employee termination costs, and relocation costs paid
and charged against the liability?

(2)

The amount of any adjustment to the liability account and
whether the corresponding entry was an adjustment of the
costs of the acquired company or included in the determina
tion of net income for the period?
[EITF 95-3]

Is any portion of the valuation allowance for deferred tax assets for
which subsequently recognized tax benefits will be allocated to re
duce goodwill and other noncurrent intangible assets of an acquired
entity or directly to contributed capital (paragraphs 30 and 36 of SFAS
109, AC section I27.129 and .135) disclosed?
[SFAS 109, par. 48 (AC I27.147)]

T1. Business Combinations

Notes: This section applies if the provisions of SFAS 141 are being applied
to the financial statements. The provisions of SFAS 141 apply to all
business combinations initiated after June 30,2001. SFAS 141 also applies
to all business combinations accounted for using the purchase method for
which the date of acquisition is July 1, 2001, or later. If the provisions of
SFAS 141 are not being applied, refer to section T above.
For combinations between two or more mutual enterprises, SFAS 141 will
not be effective until interpretive guidance related to application of the
purchase method to those transactions issued. The FASB intends to con
sider issues related to the application of the purchase method to combi
nations between two or more mutual enterprises in a separate project.
1.

Do the notes to the financial statements of a combined entity disclose
the following information in the period in which a material business
combination is completed:
a. The name and a brief description of the acquired entity and the
percentage of voting equity interests acquired?
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b. The primary reasons for the acquisition, including a description of
the factors that contributed to a purchase price that results in
recognition of goodwill?

____

c. The period for which the results of operations of the acquired entity
are included in the income statement of the combined entity?

____

d. The cost of the acquired entity and, if applicable, the number of
shares of equity interests (such as common shares, preferred
shares, or partnership interests) issued or issuable, the value as
signed to those interests, and the basis for determining that value?

____

e. A condensed balance sheet disclosing the amount assigned to each
major asset and liability caption of the acquired entity at the
acquisition date?

____

f.

Contingent payments, options, or commitments specified in the
acquisition agreement and the accounting treatment that will be
followed should any such contingency occur?

____

g. The amount of purchased research and development assets ac
quired and written off in the period (refer to paragraph 42 of SFAS
141) and the line item in the income statement in which the
amounts written off are aggregated?

____

h. For any purchase price allocation that has not been finalized, that
fact and the reasons therefore?

____

i.

2.

In subsequent periods, the nature and amount of any material
adjustment made to the initial allocation of the purchase price?
[SFAS 141, par. 51 (AC B51.164)]

____

Is the following information disclosed in the notes to the financial
statements in the period in which a material business combination is
completed if the amounts assigned to goodwill or to other intangible
assets acquired are significant in relation to the total cost of the
acquired entity:

a. For intangible assets subject to amortization:

(1)

The total amount assigned and the amount assigned to a
major intangible asset class?

____

The amount of any significant residual value, in total and by
major intangible asset class?

____

The weighted-average amortization period, in total and by
major intangible asset class?

____

b. For intangible assets not subject to amortization the total amount
assigned and the amount assigned to any major intangible asset
class?

____

(2)
(3)

c. For goodwill:
(1)
(2)
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3.

a. The number of entities acquired and a brief description of those
entities?

____

___

b. The aggregate cost of the acquired entities, the number of equity
interests, (such as common shares, preferred shares, or partner
ship interests) issued or issuable, and the value assigned to those
interests?

____

___

c. The aggregate amount of any contingent payments, options, or
commitments and the accounting treatment that will be followed
should any contingency occur (if potentially significant in relation
to the aggregate cost of the acquired entities)?

____

___

____

___

____

___

____

___

____

___

If the combined entity is a public business enterprises, is the following
supplemental information on a pro forma basis for the period in
which a material business combinations occurs (or for the period in
which a series of individually immaterial business combinations oc
cur that are material in the aggregate) disclosed:
a. Results of operations for the current period as though the business
combination or combinations had been completed at the begin
ning of the period unless the acquisition was at or near the begin
ning of the period?

b. Results of operations for the comparable period as though the
business combination or combinations had been completed at the
beginning of that period if comparative financial statements are
presented?
[SFAS 141, par. 54 (AC B51.167)]

5.

N/A

If a series of individually immaterial business combinations completed
during the period are material in the aggregate, is the following dis
closed:

d. The information described in Question 2 above, if the aggregate
amount assigned to goodwill or to other intangible assets acquired
is significant in relation to the aggregate cost of the acquired entities?
[SFAS 141, par. 53 (AC B51.166)]
4.

No

Does the supplemental pro forma information display revenue, in
come before extraordinary items and the cumulative effect of account
ing changes, net income, and earnings per share at a minimum?
[SFAS 141, par. 55 (AC B51.168)]

Note: In determining the pro forma amounts, income taxes, interest
expense, preferred share dividends, and depreciation and amortization of
assets shall be adjusted to the accounting base recognized for each in
recording the combination. Pro forma information related to results of
operations of periods prior to the combination shall be limited to the
results of operations for the immediately preceding period.
[SFAS 141, par. 55]
6.

Does the supplemental pro forma information disclose the nature and
amount of material, nonrecurring items included in the reported pro
forma results of operations, if any?
[SFAS 141, par. 55 (AC B51.168)]

7.

In the period in which an extraordinary gain is recognized related to
a business combination, do the notes to the financial statements
disclose the information required by paragraph 11 of APB 30?
[SFAS 141, par. 56 (AC B51.169)]
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8.

If a material business combination is completed after the balance sheet
date but before the financial statements are issued, is the information
required by Questions 1 and 2 above disclosed if practicable?
[SFAS 141, par. 57 (AC B51.170)]

____

Interim Financial Information

9.

For summarized interim financial information of a public business
enterprise is the following information disclosed if a material business
combination is completed during the current year up to the date of
the most recent interim statement of financial position presented:

a. The name and a brief description of the acquired entity and the
percentage of voting equity interests acquired?

____

b. The primary reasons for the acquisition, including a brief descrip
tion of the factors that contributed to a purchase price that results
in recognition of goodwill?

____

c. The period for which the results of operations of the acquired entity
are included in the income statement of the combined entity?

____

d. The cost of the acquired entity and, if applicable, the number of
shares of equity interests (such as common shares, preferred
shares, or partnership interests) issued or issuable, the value as
signed to those interests, and the basis for determining that value?

____

e. Supplemental pro forma information that discloses the results of
operations for the current interim period and the current year up
to the date of the most recent interim statement of financial posi
tion presented (and for the corresponding periods in the preceding
year) as though the business combination had been completed as
of the beginning of the period reported on?

____

f.

The nature and amount of any material, nonrecurring items in
cluded in the reported pro forma results of operations?

g. Do the pro forma information disclosures in e above display at a
minimum, revenue, income before extraordinary items and the
cumulative effect of accounting changes (including those on an
interim basis), net income and earnings per share?
[SFAS 141, par. 58 (AC B51.171)]

____

____

Other Disclosures and Presentation Items

10. Is any portion of the valuation allowance for deferred tax assets for
which subsequently recognized tax benefits will be allocated to re
duce goodwill and other noncurrent intangible assets of an acquired
entity or directly to contributed capital (paragraphs 30 and 36 of SFAS
109, AC section I27.129 and.135) disclosed?
[SFAS 109, par. 48 (AC I27.147)]
11. If a material liability is recognized by the combined institution for
costs incurred to (1) exit and activity, (2) involuntarily terminate
employees of an acquired institution, or (3) relocate employees of an
acquired entity, are disclosures made in accordance with EITF 95-3,
Recognition of Liabilities In Connection with a Purchase Business Combination?
[EITF 95-3]
Note: EITF 04-1 should be applied to business combinations consum
mated and goodwill impairment tests performed in reporting periods
beginning after October 13,2004.
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12. Are the following disclosures made for business combinations be
tween parties with a preexisting relationship:

a. The nature of the preexisting relationship?

____

___

b. The measurement of the settlement amount of the preexisting
relationship, if any, and the valuation method used to determine
the settlement amount?

____

___

____

___

____

___

c. The amount of any settlement gain or loss recognized and its
classification in the statement of operations?
[EITF 04-1]

13. Amounts previously recognized as goodwill should not be reclassi
fied as an identifiable intangible asset, however, previously recog
nized goodwill should be tested for impairment by applying the
consensuses in Step 2 of a goodwill impairment test. As a result of the
application of EITF 04-1, is any effect on a goodwill impairment
charge reported in operating income?
[EITF 04-1]

U. Segment Information

Note: Public business enterprises are required to provide the disclosures
described in SFAS131 and nonpublic business enterprises are encouraged
to do so.
1.

Are the factors used to identify the reporting entity's reportable
segments, including the basis of organization (for example, whether
management has chosen to organize the reporting entity around
differences in products and services, geographic areas, regulatory
environments, or a combination of factors and whether operating
segments have been aggregated) disclosed?
[SFAS 131, par. 26 (AC F30.125)]

2.

Are the types of products and services from which each reportable
segment derives its revenues disclosed?
[SFAS 131, par. 26 (AC F30.125)]

3.

Has a measure of profit or loss and total assets been reported for each
reportable segment?
[SFAS 131, par. 27 (AC F30.126)]

4.

If the following specified amounts (a) are included in the measure of
segment profit or loss reviewed by the chief operating decision maker
or (b) are otherwise regularly provided to the chief operating decision
maker, even if not included in that measure of segment profit or loss,
are they disclosed for each reportable segment:
a. Revenues from external customers?
b. Revenues from transactions with other operating segments of the
reporting entity?

c. Interest revenue?
d. Interest expense?
e. Depreciation, depletion, and amortization expense?
f.

Unusual items as described in paragraph 26 of APB 30?

g. Equity in the net income of investees accounted for by the equity
method?
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h. Income tax expense or benefit?
i. Extraordinary items?
j.

5.

Significant noncash items other than depreciation, depletion, and
amortization expense?
[SFAS 131, par. 27 (AC F30.126)]

If the following specified amounts are (a) included in the determina
tion of segment assets reviewed by the chief operating decision maker
or (b) are otherwise regularly provided to the chief operating decision
maker, even if not included in that measure of segment assets, are they
disclosed for each reportable segment:
a. The amount of investment in equity method investees?

b. Total expenditures for additions to long-lived assets other than
financial instruments and deferred tax assets?
[SFAS 131, par. 28 (AC F30.127)]

6.

9.

____
____

____

b. The nature of any differences between the reporting entity's con
solidated income before taxes, extraordinary items, discontinued
operations, and the cumulative effect of changes in accounting
principle?

____

e. The nature and effect of any asymmetrical allocations to segments?
[SFAS 131, par. 31 (AC F30.130)]

8.

____

Is an explanation of the measurements of segment profit or loss and
segment assets that discloses the following for each reportable seg
ment provided:
a. The basis of accounting for any transactions between reportable
segments?

c. The nature of any differences between the measurements of the
reportable segments' assets and the reporting entity's consoli
dated assets?
d. The nature of any changes from prior periods in the measurement
methods used to determine reported segment profit or loss and
the effect, if any, of those changes on the measure of segment profit
or loss?

7.

____
____

Are reconciliations of the totals of the reportable segments' revenues,
measures of profit or loss, assets, and every other significant item of
information disclosed to corresponding consolidated amounts pre
sented with all significant reconciling items separately identified and
described?
[SFAS 131, par. 32 (AC F30.131)]
If the reporting entity changes the structure of its internal organization
in a manner that changes the composition of its reportable segments,
is the corresponding information for prior periods restated and is the
fact that the corresponding items of segment information for earlier
periods have been restated disclosed?
[SFAS 131, par. 34 (AC F30.133)]

If the reporting entity changes the structure of its internal organization
in a manner that changes the composition of its reportable segments
and the corresponding information for prior periods is not restated,
does disclosure in the year in which the change occurs include seg
ment information for the current period under both the old basis and
the new basis?
[SFAS 131, par. 35 (AC F30.134)]
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10. For all reporting entities subject to SFAS131, including those that have
a single reportable segment, are the following enterprise-wide items
disclosed:

a. Revenues from external customers for each product and service or
each group of similar products and services unless it is impracti
cable to do so?
[SFAS 131, par. 37 (AC F30.136)]

____

___

Revenues from external customers (a) attributed to the re
porting entity's country of domicile and (b) attributed to all
foreign countries in total from which the reporting entity
derives revenue?

____

___

Revenues from external customers attributed to an individ
ual foreign country, if material?

____

___

The basis for attributing revenues from external customers to
individual countries?

____

___

(4)

Long-lived assets other than financial instruments and de
ferred tax assets (a) located in the reporting entity's country
of domicile and (b) located in all foreign countries in total in
which the reporting entity holds assets?

____

___

(5)

Long-lived assets as described above in an individual foreign
country, if material?
[SFAS 131, par. 38 (AC F30.137)]

____

___

____

___

____

___

____

____

b. The following geographic information unless it is impracticable to
do so:

(1)

(2)
(3)

c. Information about the extent of the reporting entity's reliance on
its major customers, including the following:

(1)

If revenues from transactions with any single customer
amount to 10 percent or more of the reporting entity's reve
nues, that fact, the total amount of revenues from each such
customer, and the identity of the segment or segments report
ing the revenue?
[SFAS 131, par. 39 (AC F30.138)]

11. If the information described in Questions 10a and b above has not been
disclosed because it is impracticable, is that fact disclosed?
[SFAS 131, pars. 37 and 38 (AC F30.136 and .137)1
V. Postemployment Benefits
1.

If an obligation for postemployment benefits (for example, salary
continuation, supplemental unemployment benefits, severance bene
fits, disability related benefits, job training and counseling, and con
tinuation of health and insurance coverage) has not been accrued
because the amount cannot be reasonably estimated, is that fact
disclosed in the financial statements?
[SFAS 112, par. 7 (AC P32.105)]

W. Stock Compensation Plans
Note: If the provisions of SFAS 123(R) are effective, refer to Questions
12-17 and ignore Questions 1-11 below.

1.

Has the entity disclosed the following information in the "Summary
of Significant Accounting Policies" or its equivalent:
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a. The method used—either the intrinsic value method or the fair
value based method—to account for stock-based employee com
pensation in each period presented?

b. For an entity the adopts the fair value recognition provisions of
SFAS 123, for all financial statements in which the period of
adoption is presented, is there a description of the method of
reporting the change in accounting principle?

c. If awards of stock-based employee compensation were outstand
ing and accounted for under the intrinsic value method of APB 25
for any period for which an income statement is presented, is there
a tabular presentation of the following information for all periods
presented:
(1)

Net income and basic and diluted earnings per share as
reported?

(2)

The stock-based employee compensation cost, net of related
tax effects, included in the determination of net income, as
reported?

(3)

The stock-based employee compensation cost, net of related
tax effects, that would have been included in the determina
tion of net income if the fair value based method had been
applied to all awards?

(4)

Pro forma net income as if the fair value based method had
been applied to all awards?

(5)

Pro forma basic and diluted earnings per share as if the fair
value based method had been applied to all awards?
[SFAS 148, par. 2(e) (AC C36.144)]

2.

Does the required pro forma amounts reflect the difference in stockbased employee compensation cost, if any, included in the net income
and the total cost measured by the fair value based method, as well
as additional tax effects, if any, that would have been recognized in
the income statement if the fair value based method had been applied
to all awards?
[SFAS 148, par. 2(e) (AC C36.144)]

3.

Does the required pro forma per share amounts reflect the change in
the denominator of the diluted earnings per share calculation as if the
assumed proceeds under the treasury stock method, including meas
ured but unrecognized compensation cost and the excess tax benefits
credited to additional paid-in capital, were determined under the fair
value based method?
[SFAS 148, par. 2(e) (AC C36.144)]

4.

Is a description of the plan(s), including the general terms of awards
under the plan(s) disclosed?
[SFAS 123, par. 46 (AC C36.145)]

5.

Are the following disclosed for each year for which an income state
ment is presented:

a. The number and weighted-average exercise prices of options for
each of the following groups of options:

(1)

Those outstanding at the beginning of the year?

(2)

Those outstanding at the end of the year?
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(3)
(4)

Those exercisable at the end of the year?
Those granted during the year?

____
____

___
___

(5)

Those exercised during the year?

____

___

(6)

Those forfeited during the year?

____

___

(7)

Those expired during the year?

____

___

b. The weighted-average grant-date fair value of options granted
during the year? (Note: That is, if the exercise prices of some
options differ from the market price of the stock on the grant date,
weighted-average fair values of options shall be disclosed sepa
rately for options whose exercise price (1) equals, (2) exceeds, or
(3) is less than the market price of the stock on the grant date.)

____

___

c. The number and weighted-average grant date-fair value of equity
instruments other than options granted during the year?

____

___

d. A description of the method and significant assumptions used
during the year to estimate the fair values of options, including the
following weighted-average information: (1) risk-free interest rate,
(2) expected life, (3) expected volatility, and (4) expected dividends?

____

___

e. Total compensation cost recognized in income for stock-based
employee compensation awards?

____

___

____

___

____

___

a. The range of exercise prices?

____

___

b. The weighted-average exercise price?

____

___

c. The weighted-average remaining contractual life?
[SFAS 123, par. 48 (AC C36.147)]

____

___

____

___

____

___

____

___

f.

6.

7.

8.

The terms of significant modifications of outstanding awards?
[SFAS123, par. 47a-f (AC C36.146)]

If the reporting entity grants options under multiple stock-based
employee compensation plans, are the items in Question 3 above
disclosed separately for different types of awards to the extent that
the differences in the characteristics of the awards make separate
disclosure important to an understanding of the reporting entity's use
of stock-based compensation?
[SFAS 123, par. 47 (AC C36.146)]

N/A

For options outstanding at the date of the latest balance sheet pre
sented, are the following disclosed:

If the range of exercise prices is wide (the highest exercise price
exceeds approximately 150 percent of the lowest exercise price), are
the exercise prices segregated into ranges that are meaningful for
assessing the number and timing of additional shares that may be
issued and the cash that may be received as a result of option exercises
and are the following disclosed for each range:
a. The number, weighted-average exercise price, and weightedaverage remaining contractual life of options outstanding?
b. The number and weighted-average exercise price of options cur
rently exercisable?
[SFAS 123, par. 48 (AC C36.147)]

9.

No

For bonus arrangements issued in connection with the grant of stock
compensation awards, is any amount recognized as a bonus liability
during the service period that exceeds the ultimate bonus paid to the
employee reclassified to equity?
[EITF 00-23]
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10. Is the accounting policy for recognizing compensation cost related to
fixed stock awards with pro rata vesting disclosed?
[EITF 00-23]
11. Are changes in fair value of an option award granted to employees,
in unrestricted, publicly traded shares of an unrelated entity prior to
vesting characterized as compensation expense in the employer's
income statement?
[EITF 02-8]

Notes: The provisions of SFAS 123(R) are effective (a) for public entities
that do not file as small business issuers—as of the beginning of the first
interim or annual reporting period that begins after June 15,2005; (b) for
public entities that file as small business issuers—as of the beginning of
the first interim or annual reporting period that begins after December 15,
2005; and (c) for nonpublic entities—as of the beginning of the first annual
reporting period that begins after December 15,2005.
These questions apply only if the provisions of SFAS 123(R) are effective.
12. If the entity has one or more share-based payment arrangements, does
it disclose information that enables users of the financial statements
to understand:

a. The nature and terms of such arrangements that existed during
the period and the potential effects of those arrangements on
shareholders?

b. The effect of compensation cost arising from share-based payment
arrangements on the income statement?

c. The method of estimating the fair value of the goods or services
received, or the fair value of the equity instruments granted (or
offered to grant), during the period?

d. The cash flow effects resulting from share-based payment ar
rangements?
[SFAS 123(R), par. 64]

Note: Paragraphs A240 and A241 of SFAS 123(R) indicate the minimum
information needed to achieve those objectives and illustrate how the
disclosure requirements might be satisfied. In some circumstances, an
entity may need to disclose information beyond that listed in paragraph
A240 to achieve the disclosure objectives.
13. If the entity acquires goods or services other than employee services
in share-based payment transactions, does it provide disclosures
similar to those in Question 11 above required by paragraph 64 of
SFAS 123(R) to the extent that those disclosures are important to an
understanding of the effects of those transactions on the financial
statements?
[SFAS 123(R), par. 65]
14. If the entity has multiple share-based payment arrangements with
employees, does it disclose information separately for different types
of awards under those arrangements to the extent that differences in
the characteristics of the awards make separate disclosure important
to an understanding of the entity's use of share-based compensation?
(See paragraph A240 of SFAS 123(R).)
[SFAS 123(R), par. 65]

FSP §20,300.03

____

____

No

N/A

103

Financial Statements and Notes Checklist
Yes

No

N/A

Required Disclosures in the Period SFAS 123(R) Is Adopted

15. In the period that SFAS 123(R) is adopted, does an entity disclose the
effect of the change from applying the original provisions of SFAS 123
on income from continuing operations, income before income taxes,
net income, cash flow from operations, cash flow from financing
activities, and basic and diluted earnings per share?
[SFAS 123(R), par. 84]

____

___

a. Net income and basic and diluted earnings per share as reported?

____

___

b. The share-based employee compensation cost, net of related tax
effects, included in net income as reported?

____

___

c. The share-based employee compensation cost, net of related tax
effects, that would have been included in net income if the fairvalue-based method had been applied to all awards?

____

___

d. Pro forma net income as if the fair-value-based method had been
applied to all awards?

____

___

____

___

____

___

a. A general description of the asset retirement obligations and the
associated long-lived assets?

____

___

b. The fair value of assets that are legally restricted for purposes of
settling asset retirement obligations?

____

___

____

___

____

___

16. If awards under share-based payment arrangements with employees
are accounted for under the intrinsic value method of APB 25 for any
reporting period for which an income statement is presented, and if
the entity is a public entity, does it continue to provide the tabular
presentation of the following information that was required by para
graph 45 of SFAS 123 for all those periods:

e. Pro forma basic and diluted earnings per share as if the fair-valuebased method had been applied to all awards?
[SFAS 123(R), par. 84]
17. Are changes in fair value of an option award granted to employees,
in unrestricted, publicly traded shares of an unrelated entity prior to
vesting characterized as compensation expense in the employer's
income statement?
[EITF 02-8]

X. Asset Retirement Obligations
1.

Is the following information about its asset retirement obligations
disclosed:

c. A reconciliation of the beginning and ending aggregate carrying
amount of asset retirement obligations showing separately the
changes attributable to (1) liabilities incurred in the current period,
(2) liabilities settled in the current period, (3) accretion expense,
and (4) revisions in estimated cash flows, whenever there is a
significant change in one or more of those four components during
the reporting period?
[SFAS 143, par. 22 (AC A50.122)]

2.

If the fair value of an asset retirement obligation cannot be reasonably
estimated is that fact and the reasons therefore disclosed?
[SFAS 143, par. 22 (AC A50.122)]
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3.

Y.

In addition to the disclosures required by paragraphs 19 (c), 19 (d),
and 21 of APB 20, is the liability for the asset retirement obligation
computed on a pro forma basis disclosed in the footnotes for the
beginning of the earliest year presented and at the end of all years
presented as if SFAS 143 had been applied during all periods
affected?
[SFAS 143, par. 27]

____

Demutualizations and Formations of Mutual Insurance Holding
Companies

1.

2.

3.

Are the nature and terms of a demutualization or formation of and
MIHC and the basis of presentation and terms of operation of the
closed block disclosed?
[SOP 00-3, par. 24]
Is a general description of the method of emergence of earnings from
the closed block, presentation of assets and liabilities of the closed
block, and policyholder dividend obligation provided?
[SOP 00-3, par. 24]

____

____

If a closed block has formed, is the following disclosed (Note: Refer
to SOP 00-3, Appendix A, "Illustrative Guidance—Footnote Disclo
sure for the Closed Block," for an illustrative example):

a. A general description of the closed block, including the purpose
of the closed block, the types of insurance policies included, and
the nature of the cash flows that increase and decrease the amount
of closed block liabilities?
[SOP 00-3, par. 25a]

____

b. An indication the continuing responsibility of the insurance enter
prise to support the payment of contractual benefits and the nature
of expenses charged to the closed block operations?
[SOP 00-3, par. 25a]
4.

____

Is summarized financial data of the closed block as of, or for periods
ending on the date of, the financial statements presented, including
at a minimum:

a. The carrying amounts for the major types of invested assets of the
closed block?

____

b. Future policy benefits and policyholders' account balances?

____

c. Policyholder dividend obligation?

____

d. Premiums?

____

e. Net investment income?

____

f.

Realized investment gains and losses?

____

g. Policyholder benefits?

____

h. Policyholder dividends?

____

i. The amount of maximum future earnings remaining to inure to
the benefit of stockholders from the assets and liabilities of the
closed block as well as an analysis of the changes in the policy
holder dividend obligation?
[SOP 00-3, par. 25b]
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Note: GAAP disclosures that typically would be required for the various
specific elements included in the closed block need not be made separately
for the closed block if the nature of the information for the closed block
would not differ significantly from that already included for the reporting
entity as a whole. For example, it is not necessary to show a separate
schedule of contractual maturities of closed block fixed maturity securities
if the relative composition of contractual maturities is similar to those of
the reporting entity taken as a whole. However, if the relative maturities
of the closed block fixed maturities securities differ from those of the
reporting entity taken as a whole, separate disclosures should be made.
[SOP 00-3, par. 25c]
Z. Guarantees
1.

Is the following information disclosed by a guarantor about each
guarantee, or each group of similar guarantees, even if the likelihood
of the guarantor's having to make any payments under the guarantee
is remote:

a. The nature of the guarantee, including the approximate term, how
the guarantee arose, and the events or circumstances that would
require the guarantor to perform under the guarantee?

____

b. The maximum potential amount of future payments (undis
counted) the guarantor could be required to make under the
guarantee?

____

c. If the terms of the guarantee provide for no limitation to the
maximum potential future payments under the guarantee, is that
fact disclosed?

____

d. If the guarantor is unable to develop an estimate of the maximum
potential amount of future payments under its guarantee, are the
reasons why the maximum potential amount cannot be estimated
disclosed?

____

e. The current carrying amount of the liability, if any, for the guar
antor's obligations under the guarantee, including the amount, if
any, recognized under SFAS 5, paragraph 8, regardless of whether
the guarantee is freestanding or embedded in another contract?

____

f.

The nature of—
(1)

Any recourse provisions that would enable the guarantor to
recover from third parties any of the amounts paid under the
guarantee? and

(2)

Any assets held either as collateral or by third parties that,
upon the occurrence of any triggering event or condition
under the guarantee, the guarantor can obtain and liquidate
to recover all or a portion of the amounts paid under the
guarantee?
[FASBI45, par. 13 (AC G80.112)]

g. If estimable, the approximate extent to which the proceeds from
liquidation of those assets would be expected to cover the maxi
mum potential amount of future payments under the guarantee?
[FASBI 45, par. 13 (AC G80.112)]

2.

____

____

____

For product warranties and other guarantee contracts that are excluded
from the initial recognition and initial measurement requirements of
FASBI 45 pursuant to paragraph 7(b) of FASBI 45 (collectively referred
to as product warranties), is the following information disclosed:
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a. The guarantor's accounting policy and methodology used in de
termining its liability for product warranties (including any liabil
ity associated with extended warranties)?

b. A tabular reconciliation of the changes in the guarantor's aggre
gate product warranty liability for the reporting period?

c. Does the tabular reconciliation present—
(1)

The beginning balance of the aggregate product warranty
liability?

(2)

The aggregate reductions in that liability for payments made
(in cash or in kind) under the warranty?

(3)

The aggregate changes in the liability for accruals to product
warranties issued during the reporting period, and the aggre
gate changes in the liability for accruals related to preexisting
warranties, including adjustments related to changes in esti
mates?

(4)

The ending balance of the aggregate product warranty liabil
ity?
[FASBI45, par. 14 (AC G80.113)]

3. Are the disclosure requirements in paragraphs 13 and 14 of FASBI 45
complied with for intellectual property infringement indemnifica
tions as described in FSP 45-1?
[FSP 45-1]
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Auditors’ Reports Checklist
.01 This checklist has been developed by the staff of the Accounting and Auditing Publications Team of
the AICPA as a nonauthoritative practice aid.

.02 Explanation of References:
SAS =

AICPA Statement on Auditing Standards

SOP =

AICPA Statement of Position

AU =

Reference to section number in AICPA Professional Standards (vol. 1)

SSARS =

AICPA Statement on Standards for Accounting and Review Services

AR =

Reference to section number in AICPA Professional Standards (vol. 2)

.03 Checklist Questionnaire:
Yes

1.

Is every financial statement audited specifically identified in the
introductory paragraph of the auditor's report?
[SAS 58, par. 6 (AU 508.06)]

2.

Do the titles of the financial statements referred to in the introductory
paragraph of the auditor's report match the titles of the financial
statements presented?
[Generally Accepted]

3.

Do the dates of the financial statements referred to in the introductory
paragraph of the auditor's report match the dates of the financial
statements presented?
[Generally Accepted]

4.

Is the report appropriately addressed?
[SAS 58, par. 9 (AU 508.09)]

No

N/A

Note: The Public Company Accounting Oversight Board (PCAOB) estab
lishes standards for audits of Issuers," as that term is defined by the
Sarbanes-Oxley Act of 2002 (the Act) or whose audit is prescribed by the
rules of the SEC. Other entities are referred to as "nonissuers." Interpre
tation 17, 'Clarification in the Audit Report of the Extent of Testing of
Internal Control Over Financial Reporting in Accordance With Generally
Accepted Auditing Standards,"of SAS No. 58, Reports on Audited Financial
Statements, as amended (AU 9508.85-.88), provides language that may be
added to the auditor's standard report on the financial statements of a
nonissuer to clarify differences between a GAAS audit and an audit
conducted in accordance with the standards of the PCAOB. Interpretation
18, "References to PCAOB Standards in an Audit Report on a Nonissuer,"
of SAS No. 58, as amended (AU 9508.89-92), explains how the auditor
should report if engaged to also follow PCAOB auditing standards in the
audit of a nonissuer.
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5.

Yes

No

N/A

____

____

____

____

____

____

____

____

____

____

____

____

____

____

____

____

____

____

____

____

____

____

____

____

____

____

____

____

____

____

____

____

____

Does the auditor's report include appropriate:

a. A title that includes the word "independent"?
[SAS 58, par. 8a (AU 508.08a)]
b. A statement that the financial statements identified in the report
were audited?
[SAS 58, par. 8b (AU 508.08b)]
c. A statement that the financial statements are the responsibility of
management and that the auditor's responsibility is to express an
opinion on the financial statements based on his or her audit?
[SAS 58, par. 8c (AU 508.08c)]

d. (Audits of Non-Public Companies Only) A statement that the
audit was conducted in accordance with generally accepted audit
ing standards and an identification of the country of origin of those
standards (for example, auditing standards generally accepted in
the United States of America or U.S. generally accepted auditing
standards)?
[SAS 58, par. 8d, as amended by SAS 93 (AU sec. 508.08d)]

e.

f.

(Audits of Public Companies Only) A statement that the audit
was conducted in accordance with the standards of the Public
Company Accounting Oversight Board (United States)?
[PCAOB Auditing Standard No. 1, Appendix, par. 3]

A statement that these standards require that the auditor plan and
perform the audit to obtain reasonable assurance about whether
the financial statements are free of material misstatement?
[SAS 58, par. 8e (AU 508.08e)]

g. A statement that an audit includes examining, on a test basis,
evidence supporting the amounts and disclosures in the financial
statements; assessing the accounting principles used and signifi
cant estimates made by management; and evaluating the overall
financial statement presentation?
[SAS 58, par. 8f (AU 508.08f)]

h. A statement that the auditor believes that his audit provides a
reasonable basis for his opinion?
[SAS 58, par. 8g (AU 508.08g)]

i.

j.

An opinion as to whether the financial statements present fairly,
in all material aspects, the financial position of the reporting entity
as of the balance sheet date and the results of operations and its
cash flows for the period then ended in conformity with generally
accepted accounting principles and an identification of the coun
try of origin of those accounting principles (for example, account
ing principles generally accepted in the United States of America
or U.S. generally accepted accounting principles?
[SAS 58, par. 8h, as amended by SAS 93 (AU sec. 508.08h)]

The manual or printed signature of the auditor's firm?
[SAS 58, par. 8i (AU 508.08i)]

k. The date of the audit report?
[SAS 58, par. 8j (AU 508.08j)]
Practice Tip

Paragraph 8 of SAS 58 illustrates the form of the auditor's standard report on financial statements covering
a single year and on comparative financial statements.
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6.

If a subsequent event disclosed in the financial statements occurs after
completion of field work but before the issuance of the related finan
cial statements, has the need for dual-dating of the report been con
sidered?
[SAS 1, sec. 530, as amended by SAS 98, pars. 3-5 (AU 530.03-.05)]

7.

If the accountant is not independent, is a compilation report indicating
the lack of independence issued (non-public companies only)?
[SAS 26, par. 10 (AU 504.10); SSARS1, pars. 22 and 38 (AR 100.22 and
.38)]

8.

If the opinion is based in part on the report of another auditor:

No

N/A

a. Does the introductory paragraph of the standard report disclose
the fact that the opinion is based, in part, on the report of other
auditors?
b. Does the opinion paragraph include a reference to the report of
the other auditor?
[SAS 58, pars. 11a, 12, and 13 (AU 508.11a, .12, and .13)]

9.

If, to prevent the financial statements from being misleading because
of unusual circumstances, the financial statements contain a depar
ture from an accounting principle promulgated by a body designated
by the AICPA Council to establish such principles, does the report
include, in a separate paragraph or paragraphs, the information re
quired by the rule?
[SAS 58, pars. 11b and 15 (AU 508.11b and .15)]

10. If there is substantial doubt about the entity's ability to continue as a
going concern:

a. Does the report include an explanatory paragraph, following the
opinion paragraph, to reflect that conclusion?
b. Is that conclusion expressed through the use of the phrase "sub
stantial doubt about its (the entity's) ability to continue as a going
concern" or similar wording that includes the terms substantial
doubt and going concern?
[SAS 58, par. 11c (AU 508.11c); SAS 59, as amended by SAS 64, par.
12 (AU 341.12)]

Practice Tip
In a going concern paragraph, the auditor should not use conditional language in expressing a conclusion
concerning the existence of substantial doubt about the entity's ability to continue as a going concern. See
SAS 77 (AU sec. 341.13) for an example.
11. If there has been a material change between periods in accounting
principles or in the method of their application that has a material effect
on the comparability of the reporting entity's financial statements:

a. Does the report include an explanatory paragraph, following the
opinion paragraph, that refers to the change?

b. Does the explanatory paragraph identify the nature of the change
and refer the reader to the note to the financial statements that
discusses the change in detail?
[SAS 58, as amended by SAS 79, pars. 11d and 16 (AU 508.11d and .16)]
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c. If the change in the accounting principle is a change in reporting
entity that did not result from a transaction or an event, is an
explanatory paragraph included in the auditor's report? (Note: A
change in the reporting entity resulting from a transaction or
event, such as a pooling of interest, or the creation, cessation or
complete or partial purchase or disposition of a subsidiary or other
business unit does not require that an explanatory paragraph
about consistency be included in the auditor's report.)
[SAS 88, par. 8 (AU 420.08)]
12. In an updated report, the opinion is different from the opinion pre
viously expressed on the financial statements of a prior period:

a. Does the report include an explanatory paragraph, preceding the
opinion paragraph, that discloses all of the substantive reasons for
the different opinion?
b. Does the explanatory paragraph disclose:
(1)

The date of the auditor's previous report?

(2)

The type of opinion previously expressed?

(3)

The circumstances or events that caused the auditor to ex
press a different opinion?

(4)

That the auditor's updated opinion on the financial state
ments of the prior period is different from his or her previous
opinion on those statements?
[SAS 58, as amended by SAS 79, pars. 11e and 69 (AU 508.11e
and .69)]

13. If financial statements of a prior period (presented for comparative
purposes) have been audited by a predecessor auditor whose report
is not presented:

a. Does the introductory paragraph of the report indicate:
(1)

That the financial statements of the prior period were audited
by another auditor?

(2)

The date of the predecessor auditor's report?

(3)

The type of report issued by the predecessor auditor?

(4)

If the report was other than a standard report, the substantive
reasons therefor including a description of the nature of and
reasons for the explanatory paragraph added to the predeces
sor's report or his or her opinion qualification?

b. If the financial statements have been restated, does the introduc
tory paragraph indicate that the predecessor auditor reported on
the financial statements of the prior period before restatement?
[SAS 58, as amended by SAS 79, pars, lie and 74 (AU 508.11e and .74)]
14. Is an explanatory paragraph (or other explanatory language) added
to the standard auditor's report if the prior period's financial state
ments are audited by a predecessor auditor who had ceased opera
tions?
[Interpretation 15 of SAS 58 (AU 9508.60-.75)]
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15. If selected quarterly financial data required by SEC Regulation S-K
has been omitted or has not been reviewed, does the report include
an additional paragraph stating that fact?
[SAS 58, par. 11f (AU 508.11f); SAS 100, par. 50 (AU 722.50)]
16. If supplementary information required by GAAP has been omitted,
the presentation of such information departs materially from pre
scribed guidelines, the auditor is unable to complete prescribed pro
cedures with respect to such information, or the auditor is unable to
remove substantial doubt about whether the supplementary informa
tion conforms to prescribed guidelines, does the report include an
additional paragraph stating that fact?
[SAS 58, par. 11g (AU 508.11g); SAS 52, par. 8, as amended by SAS 98
(AU 558.08)]
17. Is an explanatory paragraph (or other explanatory language) added
to the standard auditor's report if there is a material change between
periods in accounting principles or in the method of their application?
[SAS 58, pars. 16-18, as amended by SAS 79 (AU 508.16-.18)]
18. If the audit also was conducted in accordance with International
Standards on Auditing, in their entirety, does the auditor's report
indicate that the audit was also conducted in accordance with another
set of auditing standards?
[Interpretation 14 of SAS 58 (AU 9508.56-.59)]
19. If other information in a document containing audited financial state
ments is materially inconsistent with information appearing in the
financial statements, has it been determined whether the financial
statements, the auditor's report, or both require revision?
[SAS 58, par. 11h (AU 508.11h); SAS 8, par. 4 (AU 550.04)]

20. If certain other information has been subjected to auditing procedures
applied in the audit of the basic financial statements, does the auditor
express an opinion on whether the information is fairly stated in all
material respects in relation to those financial statements taken as a
whole in the auditor's report describing clearly the character of the
auditor's work and the degree of responsibility the auditor is taking?
[SAS 8, par. 7, as amended by SAS 98 (AU 550.07); SAS 52, par. 9, as
amended by SAS 98 (AU 558.09)]

21. If the auditor decides to emphasize a matter regarding the financial
statements in the report, is the explanatory information presented in
a separate paragraph that avoids use of phrases such as "with the
foregoing (following) explanation"?
[SAS 58, pars. 11 and .19, as amended by SAS 79 (AU 508.11 and .19);
Interpretation 3 of SAS 1, sec. 410 (AU 9410.18); Interpretation 1 of
SAS 57 (AU 9342.03)]
22. If it has not been possible to conduct the audit in accordance with
GAAS or to apply all of the procedures considered necessary in the
circumstances, has consideration been given to the need to issue a
qualified opinion or to disclaim an opinion?
[SAS 58, as amended by SAS 79, par. 22 (AU 508.22)]

No

____

___

____

___

____

___

____

___

____

___

____

___

____

___

____

___

____

___

N/A

23. If a qualified opinion is to be expressed because of a scope limitation:

a. Are all of the substantive reasons for the qualification disclosed in one
or more explanatory paragraphs preceding the opinion paragraph?
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No

N/A

b. Does the qualified opinion include the word except or exception in
a phrase such as except for or with the exception of?

____

____

____

c. Is the situation described and referred to in both the scope and
opinion paragraphs?

____

____

____

____

____

____

d. Does the wording in the opinion paragraph indicate that the
qualification pertains to the possible effects on the financial state
ments and not the scope limitation itself?
[SAS 58, as amended by SAS 79, pars. 22-27 (AU 508.22-.27)]
Practice Tip

Scope limitations include situations in which the auditor is unable to obtain sufficient evidential matter to
support management's assertions about the nature of a matter involving an uncertainty and its presentation
or disclosure in the financial statements.
[SAS 58, as amended by SAS 79, par. 31 (AU 508.31)]

Note: Consult the AU Topical Index to the AICPA Professional Standards
under "Scope of Audit—Limitations" for additional references to specific
types of scope limitations that could result in either a qualified or dis
claimer of opinion.

24. If an opinion is disclaimed because of a scope limitation:
a. Are all of the substantive reasons for the disclaimer stated in a
separate paragraph or paragraphs?

____

b. Does the report state that the scope of the audit was not sufficient
to warrant the expression of an opinion?

____

c. Does the report avoid identifying procedures that were performed?

____

d. Is the scope paragraph omitted?

____

e. If there are reservations about fair presentation of the financial
statements in conformity with GAAP, are they described in the
report?
[SAS 58, as amended by SAS 79, par. 63 (AU 508.63)]
25. If the financial statements are materially affected by a departure from
GAAP (including inadequate disclosure, inappropriate accounting
principles, and unreasonable accounting estimates), has considera
tion been given to the need to issue a qualified opinion or an adverse
opinion?
[SAS 58, as amended by SAS 79, par. 35 (AU 508.35)]

____

____

26. If a qualified opinion is to be expressed because of a GAAP departure:

a. Are all of the substantive reasons that have led to the conclusion
that there is a departure from GAAP disclosed in one or more
separate explanatory paragraphs preceding the opinion paragraph?

____

b. Does the qualified opinion include the word except or exception in
a phrase such as except for or with the exception of and a reference to
the explanatory paragraph?

____
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N/A

c. Does the explanatory paragraph disclose the principle effects of
the departure on financial position, results of operations, and cash
flows, if practicable, or state that the effects are not reasonably
determinable, if not practicable to do so?
[SAS 58, as amended by SAS 79, pars. 37 and 38 (AU 508.37 and .38)]
27. If an adverse opinion is to be expressed because of a GAAP departure:
a. Are all of the substantive reasons for the adverse opinion disclosed
in one or more separate explanatory paragraphs preceding the opin
ion paragraph?

b. Does the explanatory paragraph disclose the principle effects of
the departure on financial position, results of operations, and cash
flows, if practicable, or state that the effects are not reasonably
determinable, if not practicable to do so?
c. State that the financial statements do not present fairly the financial
position, or results of operations or cash flows in conformity with
GAAP?
[SAS 58, as amended by SAS 79, pars. 58 and 59 (AU 508.58 and .59)]
Note: Consult the AU Topical Index to the AICPA Professional Standards
under "Departures From Established Principles," "Adverse Opinions,"
and "Qualified Opinions" for additional references to specific types of
GAAP departures that could result in either a qualified or adverse opinion.

28. If information accompanies the basic financial statements and audi
tor's report in an auditor-submitted document, is it accompanied by
a report that:
a. States that the audit was performed for the purpose of forming an
opinion on the basic financial statements taken as a whole?

b. Specifically identifies the accompanying information?
c. States that the accompanying information is presented for pur
poses of additional analysis and is not a required part of the basic
financial statements?

d. Includes either an opinion on whether the accompanying informa
tion is fairly stated in all material respects in relation to the basic
financial statements taken as a whole or a disclaimer of opinion
(depending on whether the information was subjected to the
auditing procedures applied in the audit of the basic financial
statements)?
[SAS 29, par. 6 (AU 551.06)]
Practice Tip
SAS 87, Restricting the Use of an Auditor's Report, provides guidance to auditors in determining whether an
engagement requires a restricted-use report and, if so, what elements to include in that report.
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Supplemental Information for Life
Insurance Companies That Are
Securities and Exchange
Commission Registrants
.01 Footnote 3 to SAS 69 states, in part, that for Securities and Exchange Commission (SEC) registrants,
rules and releases of the SEC have an authority similar to other officially established accounting principles.
Regulation S-X is the primary source of requirements for financial statements and related footnotes required
to be included in documents filed with the SEC. In addition to Regulation S-X, preparers and auditors of
financial statements should be familiar with the SEC's Financial Reporting Releases (FRR) and Staff Account
ing Bulletins (SAB). FRRs communicate the SEC's position on accounting and auditing principles and
practices. SABs represent interpretations and practices followed by the Division of Corporation Finance and
the Office of the Chief Accountant of the SEC. Insurance companies are subject to the requirements of Articles
1-4, 7,10, and 12 of Regulation S-X.

When determining compliance with SEC requirements, preparers and auditors should refer to the appropri
ate SEC pronouncements to ensure compliance with SEC disclosure rules. In particular, the following
documents should be consulted:
•

Regulation S-X, Article 1, Application of Regulation S-X

•

Regulation S-X, Article 2, Qualifications and Reports of Accountants

•

Regulation S-X, Article 3, General Instructions as to Financial Statements

•

Regulation S-X, Article 4, Rules of General Application

•

Regulation S-X, Article 7, Insurance Companies

•

Regulation S-X, Article 10, Interim Financial Statements

•

Regulation S-X, Article 12, Form and Content of Schedules

•

Staff Accounting Bulletins—SABs reflect the SEC staff's views regarding accounting-related disclo
sure practices. They represent interpretations and policies followed by the Division of Corporation
Finance and the Office of the Chief Accountant in administering the disclosure requirements of the
federal securities laws.

•

Financial Reporting Releases (FRR)—FRRs adopt, change, or interpret requirements relating to
accounting, auditing, and disclosure issues.
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Illustrative Financial Statements
.01 This section contains illustrative financial statements prepared in conformity with generally accepted
accounting principles (GAAP). The financial statements are for illustrative purposes only, are not intended
to be comprehensive and are not intended to establish preference among alternative principles acceptable
under GAAP. Decisions about the application of the GAAP discussed in the accounting and financial
reporting sections of the AICPA Audit and Accounting Guide Life and Health Insurance Entities, should not
be made by reference to the illustrative financial statements but by a careful reading to the specified
authoritative literature. The illustrative financial statements reflect many of the minimum disclosure
requirements for a life and health insurance entity but do not include all of the amounts or transactions
discussed in other chapters of the Guide or that might be found in practice. For example, the illustrative
notes indicate the subject matter generally required to be disclosed, but they should be expanded, reduced,
or otherwise modified to suit individual circumstances based on a careful reading of the specified
authoritative literature.

.02 The illustrative financial statements do not include other transactions not unique to life and health
insurance entities, such as disclosures about segments, employee benefit plans, certain risks and uncertain
ties, or postemployment benefits other than pensions. Preparers and auditors should consult authoritative
pronouncements for guidance on presenting such other information.
.03 The illustrative financial statements do not reflect rules and releases of the Securities and Exchange
Commission (SEC) that, for SEC registrants, have an authority similar to other officially established account
ing principles. SEC Regulation S-X, Article 7, Insurance Companies, should be referred to.

.04 The illustrative financial statements also do not reflect the impact of laws and regulations of the
insurance entity's state of domicile. The impact on the financial statements of such laws and regulations vary
by state. Many states require conformity with the codification of statutory accounting practices in the NAIC
Accounting Practices and Procedures Manual to the extent it does not conflict with its own state laws and
regulations. Refer to the NAIC Accounting Practices and Procedures Manual, NAIC Annual Statement
Instructions, and specific state laws and regulations to determine the impact of codification and individual
state laws and regulations.

.05 These illustrative financial statements are not intended to include items that should be accounted for
under the requirements of SFAS 133, Accounting for Derivative Instruments and Hedging Activities, and,
therefore, do not reflect the requirements of SFAS 133 or its amendments. Practitioners should refer to SFAS
133 and related amendments for guidance on reporting derivative instruments and hedging activities. Items
in the balance sheet and income statement have been cross-referenced to the applicable chapters of this Guide,
for ease of locating information.
.06 Life and health insurance entities generally present unclassified balance sheets.

.07 Also, preparers and auditors of SEC-registrant financial statements are reminded that as discussed
in SAB Topic 11M (SAB No. 74), and AU section 9410, Interpretation No. 3, The Impact on an Auditor's
Report of an FASB Statement Prior to the Statement's Effective Date," filings with the SEC that include
financial statements for a period ending after the issuance of an accounting standard but before the required
date of adoption of that accounting standard should include disclosure of the impact that the recently issued
accounting standard will have on the financial position and results of operations of the registrant when such
standard is adopted in a future period. The following disclosures should be considered by registrants:
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•

A brief description of the new standard, the date that adoption is required and the date that the
registrant plans to adopt, if earlier;

•

A discussion of the methods of adoption allowed by the standard and the method expected to be
utilized by the registrant, if determined;

•

A discussion of the impact that adoption of the standard is expected to have on the financial
statements of the registrant, unless unknown or not reasonably estimable. In that case, a statement
to that effect may be made;

•

Disclosure of the potential impact of other significant matters that the registrant believes might result
from the adoption of the new standard (such as technical violations of debt covenant agreements,
planned or intended changes in business practices, etc.).
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ABC LIFE INSURANCE COMPANY
Balance Sheet

December 31, 20X2 and 20X1
(Amounts in Thousands)
Assets
Investments:
Debt and equity securities:
Fixed maturities, held to maturity, at amortized cost
(estimated fair value: $47,830 in 20X2 and $45,255 in 20X1)
Fixed maturities, available for sale, at estimated fair value
(amortized cost: $247,525 in 20X2 and $219,565 in 20X1)
Trading account securities, at estimated fair value
(cost: $4,220 in 20X2 and $4,419 in 20X1)
Mortgage loans
Real estate
Policy loans
Short-term investments
Total investments
Cash and cash equivalents
Accrued investment income
Premiums due and other receivables,1 net of allowance
of $4,500 and $2,100 for doubtful accounts
Reinsurance receivable on paid and unpaid losses
Reinsurance receivable related to contract holder liabilities
Deferred policy acquisition costs
Property and equipment, net of accumulated depreciation
Other assets
Separate account assets
Total assets
Liabilities
Future policy benefits
Guaranteed interest contracts
Policyholders funds on deposit
Unpaid claims
Policyholders dividends
Amounts held in escrow and accrued expenses
Deferred federal income taxes
Other liabilities
Separate account liabilities
Total liabilities
Commitments and contingencies (Note 12)1

20X2

20X1

$ 44,864

$ 46,310

255,893

214,563

3,950
79,258
6,410
43,549
7,515
441,439
5,285
6,660

4,190
106,692
6,147
51,013
6,321
435,236
3,343
8,026

1,647
596
5,714
38,936
501
152
732
$501,662

1,092
407
3,048
36,429
420
158
525
$488,684

$345,887
21,342
49,408
5,418
2,335
4,977
1,412
253
732
431,764

$341,207
23,555
46,202
4,737
3,450
4,562
1,027
4,465
525
429,730
(continued)

1 SOP 01-6, Accounting by Certain Entities (Including Entities With Trade Receivables) That Lend to or Finance the Activities of Others,
requires, among other things, that the summary of significant accounting policies include the basis for accounting for trade receivables,
and the classification and method of accounting for other receivables. SOP 01-6 requires that a description of the accounting policies
and methodology the entity used to estimate its allowance for doubtful accounts be included in the notes to the financial statements.
Such a description should identify the factors that influenced management's judgment and may also include discussion of risk
elements relevant to particular categories of financial instruments. In addition, SOP 01-6 requires that the summary of significant
accounting policies include the policy for charging off uncollectible trade receivables.
SOP 01-6 contains other presentation and disclosure requirements that may apply to the financial statements of insurance entities.
Readers should refer to the full text of SOP 01-6.
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20X2

20X1

Shareholders' Equity

Capital stock: authorized—5,000,000 shares of $2 par value;
3,341,624 shares issued and outstanding
Retained earnings
Accumulated other comprehensive income

Total shareholders' equity
Total liabilities and shareholders' equity
See accompanying notes to financial statements.
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69,898

58,954
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ABC LIFE INSURANCE COMPANY
Statements of Income

Years Ended December 31,20X2 and 20X1

(Amounts in Thousands)
20X2

20X1

Premiums and Other Revenues
Premiums:
Life and annuity premiums
Accident and health premiums
Other premiums
Contract holder fees
Net investment income
Net realized gains (losses) on investments and other

$24,833
10,141
20
1,961
32,998
4,222

$24,783
9,153
43
1,844
35,141
(2,670)

74,175

68,294

Policyholder benefits
Interest credited to policyholder accounts
General expenses
Amortization of deferred policy acquisition costs
Underwriting, acquisition, and insurance expenses
Policyholders' dividends

39,158
4,363
4,288
1,276
18,029
4,665

30,815
4,156
4,984
1,305
17,266
6,898

Total benefits and expenses
Income before income taxes

71,779
2,396

65,424
2,870

Income taxes:
Current
Deferred

1,547
(1,405)

Total premiums and other revenues
Benefits and Other Expenses

Total income taxes
Net income

142

1,141

2,254

1,729

Net income per common share

Dividends per common share

601
540

.67
—

.52
.98

See accompanying notes to financial statements.
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.10

ABC LIFE INSURANCE COMPANY
Statements of Comprehensive Income (Loss)

Years Ended December 31,20X2 and 20X1
(Amounts in Thousands)
20X2

20X1

Net Income
Other comprehensive income (loss)

$ 2,254
8,690

$ 1,729
(1,730)

Total comprehensive income (loss)

$10,944

$____ (1)

See Note 5 to the financial statements for information about other comprehensive income (loss).
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ABC LIFE INSURANCE COMPANY
Statement of Changes in Shareholders' Equity

Years Ended December 31,20X2 and 20X1
(Amounts in Thousands)
Accumulated
Other
Comprehensive
Income (Loss)

Total
Shareholders'
Equity

Capital
Stock

Retained
Earnings

$6,683
—
—
—

$57,068
1,729
(3,275)
—

$(1,521)
—
—
(1,730)

$62,230
1,729
(3,275)
(1,730)

Balance at December 31,20X1
Net income for 20X2
Other comprehensive income

6,683
—
—

55,522
2,254
—

(3,251)
—
8,690

58,954
2,254
8,690

Balance at December 31,20X2

$6,683

$57,776

Balance at January 1,20X1
Net income for 20X1
Shareholders' dividends
Other comprehensive income (loss)

$ 5,439

$69,898

See accompanying notes to financial statements.
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.12

ABC LIFE INSURANCE COMPANY
Statements of Cash Flows
Years Ended December 31,20X2 and 20X1

(Amounts in Thousands)
20X1

20X2

Cash flows from operating activities:
Net income
Adjustments to reconcile net income to net
cash provided by operating activities:
Interest credited to universal life policies
Accrual of discount on investments, net
Net realized (gains) losses on investments
Depreciation and amortization
Amortization of deferred policy acquisition costs

$

Deferred federal income taxes
Change in operating assets and liabilities:
Accrued investment income
Capitalization of deferred policy acquisition costs
Policy liabilities
Other items, net

Net cash provided by operating activities
Cash flows from investing activities:
Cost of investments purchased:
Fixed maturities and equity securities
Mortgage loans and real estate
Proceeds from investments sold, redeemed, or matured:
Fixed maturities and equity securities
Mortgage loans and real estate
Policy loans, net
Short-term investments, net

2,254

$

1,729

7,927
(976)
(4,222)
3,041
1,276
(2,538)

10,445
(1,328)
2,670
3,534
1,305

1,366
(3,783)
(3,440)
(644)

880
(6,645)
(16,234)
3,269

540

261

165

(228,053)
(921)

(122,495)
—

206,051
27,970
2,320
409
7,776

95,177
18,621
6,468
15,446
13,217

—

(3,275)

Net cash provided by investing activities

Cash flows from financing activities:
Dividends to shareholders
Receipts from universal life policies credited to
contract holder account balances
Return of contract holder account balances on
universal life policies
Withdrawals from interest-sensitive contracts
Cash used in financing activities

Net increase in cash and cash equivalents
Cash and cash equivalents, beginning of year
Cash and cash equivalents, end of year

7,918

8,365

(4,165)
(9,848)

(3,718)
(13,046)
(11,674)

(6,095)
1,942
3,343
$ 5,285

$

1,708
1,635
3,343

$

$

785

Supplemental cash flow information:
Income taxes paid
See accompanying notes to financial statements.
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.13

ABC LIFE INSURANCE COMPANY

Notes to Financial Statements
Years Ended December 31,20X2 and 20X1
Note 1: Organization and Significant Accounting Policies

Organization. ABC Life Insurance Company (ABC or the Company) is a stock life insurance
company incorporated in the state of ABC that offers individual life, disability income, long-term
care, annuity, and investment products. ABC does business in the continental United States, with
a concentration in New York, New Jersey, and Connecticut.
Basis of presentation. The significant accounting policies followed by ABC that materially affect
financial reporting are summarized below. The accompanying financial statements have been
prepared in accordance with generally accepted accounting principles (GAAP) that differ from
statutory accounting practices (SAP) used for regulatory authorities. The preparation of the
financial statements in conformity with GAAP requires management to make estimates and
assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent
assets and liabilities at the date of the financial statements and the reported amounts of revenues
and expenses during the reporting period. Actual results could differ from those estimates.

Investments. Fixed maturity securities available for sale consist of bonds, notes, and redeemable
and nonredeemable preferred stock not classified as either trading or held to maturity, and are
reported at estimated fair value. Unrealized holding gains and losses, net of tax, on available-forsale securities are reported as a net amount in other comprehensive income. Deferred policy
acquisition cost offsets for universal life type contracts and amounts attributable to certain
participating contracts are recorded as a separate component of accumulated other comprehen
sive income. Fixed maturity securities held to maturity consist of bonds, notes, redeemable and
nonredeemable preferred stock which the insurance company has the intent and ability to hold
to maturity, and are reported at amortized cost and adjusted for amortization of premium or
discount. Declines in fair value of individual held-to-maturity and available-for-sale securities
below their cost that are other then temporary have resulted in write-downs of the individual
securities to their fair value. The related write-downs have been included in earnings as realized
losses. Trading account securities consist of bonds, notes, and redeemable and nonredeemable
preferred stock, and common stock held principally for resale in the near term, and are recorded
at their estimated fair values. Realized and unrealized gains and losses on trading account
securities are included in other income.
Mortgage loans on real estate are carried at unpaid balances and are adjusted for amortization of
premium or discount, less allowance for losses. Real estate held for sale is carried at the lower of
depreciated cost or fair value less estimated selling costs. Real estate classified as held-for-sale is
no longer depreciated. Real estate, including real estate acquired in satisfaction of debt, is carried
at depreciated cost. Impaired real estate is written down to fair value with the impairment loss
being included in net realized gains (losses) on investments and other. Upon foreclosure (includ
ing in-substance foreclosure), the carrying value of the property is recorded at the lower of cost
or fair value (less selling costs if to be sold), which becomes its new cost basis. The estimated fair
value for real estate is determined based upon independent appraisals and other available
information about the property, which may take into consideration a number of factors, including:
(i) discounted cash flows (ii) sales of comparable properties (iii) geographic location of property
and related market conditions (iv) disposition costs.

Foreclosed properties are actively managed by the company in order to maximize their value.
Subsequent to foreclosure, the carrying value of the property is periodically evaluated and a
valuation allowance is established, if necessary, to reflect any additional amounts considered
unrecoverable upon sale. At the time of the sale, the difference between the sales price and the
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carrying value is recorded as a realized gain or loss. Policy loans are carried at unpaid balances.
Short-term investments are stated at amortized cost, which approximates fair value.

Provisions for impairments of securities classified as held to maturity are included in net realized
gains (losses) on investments and other. Realized gains and losses are determined by specific
identification.
Cash and cash equivalents. Cash equivalents are carried at cost, which approximates fair value. Cash
equivalents are highly liquid financial instruments with an original maturity of three months or less.

Deferred policy acquisition costs. Commissions and other costs of acquiring traditional life insur
ance, universal life insurance and investment products, and accident and health insurance, that
vary with and are primarily related to the production of new and renewal business, have been
deferred. Traditional life insurance and accident and health insurance acquisition costs are being
amortized over the premium-paying period of the related policies using assumptions consistent
with those used in computing future policy benefit liabilities. For universal life-type contracts and
investment contracts that include significant surrender charges or that yield significant revenues
from sources other than the investment of contract holders' funds, the deferred contract acquisi
tion cost amortization is matched to the recognition of gross profit.
Otherwise, deferred contract acquisition costs on investment contracts are amortized using an
accounting method that recognizes acquisition costs as expenses at a constant rate applied to net
policy liabilities. The effect on the deferred acquisition costs (DAC) asset that would result from
realization of unrealized gains (losses) is recognized with an offset to accumulated other compre
hensive income in consolidated shareholders' equity as of the balance sheet date.

Deferred sales inducements. Costs related to sales inducements offered on sales to new customers,
principally on investment contracts and primarily in the form of additional credits to the
customer's account value or enhancements to interest credited for a specified period, which are
beyond amounts currently being credited to existing contracts, are deferred and recorded as other
assets. All other sales inducements are expensed as incurred and included in interest credited to
contract holders' funds. Deferred sales inducements are amortized to income using the same
methodology and assumptions as deferred acquisition costs, and are included in interest credited
to contract holders' funds. Deferred sales inducements are periodically reviewed for recoverabil
ity and written down when necessary.
Property and equipment. Property and equipment are reported at cost, net of accumulated depre
ciation of $1,915,000 and $1,721,000 in 20X2 and 20X1, respectively. Property and equipment are
depreciated using the straight-line method over their estimated useful lives.

Future policy benefits and expenses. The liabilities for traditional life insurance and accident and
health insurance contract benefits and expenses are computed using a net level premium method
including assumptions as to investment yields, mortality, withdrawals, and other assumptions
based on ABC's experience modified as necessary to reflect anticipated trends and to include
provisions for possible unfavorable deviations. Liability interest assumptions are graded and
range from 3 percent to 10 percent. Benefit liabilities for traditional life insurance contracts include
certain deferred profits on limited-payment policies that are being recognized in income over the
contract term. Contract benefit claims are charged to expense in the period that the claims are incurred.

The accrued account balance for nontraditional life insurance and investment contracts is com
puted as deposits net of withdrawals made by the contract holder, plus amounts credited based
on contract specifications, less contract fees and charges assessed, plus any additional interest.
Interest crediting rates for universal life and investment products range from 5.50 percent to 9.25
percent.
Included in contract holders' account balances is a provision for contract holder dividends. Benefit
liabilities for contract holders' account balances are computed under a retrospective deposit
method and represent contract account balances before applicable surrender charges. Contract
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benefits and claims that are charged to expense include benefit claims incurred in the period in
excess of related contract account balances. Interest crediting rates for universal life and invest
ment products range from 5.50 percent to 9.25 percent. Benefits and expenses are charged against
the account balance to recognize costs as incurred over the estimated lives of the contracts.
Expenses include interest credited to contract account balances and benefits paid in excess of
contract account balances.

Minimum Guarantees. The company issues variable annuity contracts through separate accounts
where the company contractually guarantees to the contract holder total deposits made to the
contract less any partial withdrawals plus a minimum return. This guarantee includes benefits
that are payable in the event of death, annuitization, or at specified dates during the accumulation
period.

Accounting policy for health liabilities. Unpaid claims on accident and health policies represent the
estimated liability for benefit expenses both reported but not paid and incurred but not reported
to ABC through December 31. ABC does not discount its liabilities for unpaid claims. Liabilities
for unpaid claims are estimated using individual case-basis valuations and statistical analyses.
Those estimates are subject to the effects of trends in claim severity and frequency. Although
considerable variability is inherent in such estimates, management believes that the liabilities for
unpaid claims are adequate. The estimates are continually reviewed and adjusted as necessary as
experience develops or new information becomes known; such adjustments are included in
current operations.
Income taxes. Federal income taxes are charged or credited to operations based upon amounts
estimated to be payable or recoverable as a result of taxable operations for the current year.
Deferred income taxes have been provided for temporary differences between the tax basis of
assets and liabilities and their reported amounts in the financial statements using enacted income
tax rates and laws.

Reinsurance. In the normal course of business, the Company seeks to limit its exposure to loss on
any single insured and to recover a portion of benefits paid by ceding reinsurance to other
insurance entities or reinsurers under excess coverage and coinsurance contracts. The Company
retains a maximum of $400,000 of coverage per individual life. Amounts paid or deemed to have
been paid for reinsurance contracts are recorded as reinsurance receivable.
Insurance premium revenues. Traditional life premiums, which include those products with fixed
and guaranteed premiums and benefits and consist principally of whole life insurance contracts,
limited-payment life insurance contracts, and certain annuities with life contingencies, are gener
ally recognized as revenue when due. Revenues on universal life and investment-type contracts
consist of contract charges against contract holders' funds for the cost of insurance, administra
tion, surrender charges, actuarial margin, and other fees. Accident and health insurance premi
ums are recognized as revenue pro rata over the terms of the contracts.

Separate accounts. Separate account assets and liabilities generally represent funds maintained in
accounts to meet specific investment objectives of contract holders who bear the investment risk.
Investment income and investment gains and losses accrue directly to such contract holders. The
assets supporting the variable portion of both traditional variable annuities and variable contracts
with guarantees are carried at fair value and reported as summary total separate account assets with
an equivalent summary total reported for liabilities. Amounts assessed against the contract holders
for mortality, administrative, and other services are included in revenue and changes in liabilities for
minimum guarantees are included in policyholder benefits in the Statement of Operations. Separate
account net investment income, net investment gains and losses, and the related liability changes are
offset within the same line item in the Statement of Operations.
Business risks and uncertainties. The development of liabilities for future policy benefits for the
Company's products requires management to make estimates and assumptions regarding mor
tality, morbidity, lapse, expense, and investment experience. Such estimates are primarily based
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on historical experience and future expectations of mortality, morbidity, expense, persistency,
and investment assumptions. Actual results could differ materially from those estimates. Man
agement monitors actual experience and, if circumstances warrant, revises its assumptions and
the related future policy benefit estimates.
The Company's investments are primarily comprised of fixed maturity securities, equity securi
ties, real estate, and mortgage loans. Significant changes in prevailing interest rates and geo
graphic conditions may adversely affect the timing and amount of cash flows on such investments
and their related values. In addition, the value of these investments is often derived from an
appraisal, an estimate or opinion of value. A significant decline in the fair value of these
investments could have an adverse effect on the Company's balance sheet.
The Company regularly invests in mortgaged backed securities (MBS) and other securities
subject to prepayment and call risk. Significant changes in prevailing interest rates may ad
versely affect the timing and amount of cash flows on such securities. In addition, the amortiza
tion of market premium and accretion of market discount for MBS is based on historical
experience and estimates of future payment speeds on the underlying mortgage loans. Actual
prepayment speeds will differ from original estimates and may result in material adjustments
to amortization or accretion recorded in future periods.

Codification. The National Association of Insurance Commissioners revised the Accounting Prac
tices and Procedures Manual in a process referred to as Codification. Codification became effective
on January 1, 2001. The Company's state of domicile has adopted the provisions of the revised
manual effective January 1, 2001. The revised manual has changed to some extent, prescribed
statutory accounting practices, and has resulted in changes to the Company's statutory-based
financial statements. The cumulative effect of changes in accounting principles adopted to
conform to the revised Accounting Practices and Procedures Manual of $____ has been reported as
an adjustment to increase (decrease) surplus in the Company's statutory-based financial state
ments as of January 1,2001.
Guaranty Funds. Guaranty fund (and other) assessments are accrued at the time the events occur
on which assessments are expected to be based.

Note 2: Earnings Per Common Share
Basic and diluted earnings per common share (EPS) are as follows.
(Thousands, except per
common share data)
20X2
Net income
Income applicable to common ownership

20X1
Net income
Income applicable to common ownership

Income
(Numerator)

Shares
(Denominator)

Per Common
Share Amount

2,254
2,254

3,342

.67

1,729
1,729

3,342

.52

Note 3: Investments

In reporting disclosures about investments in securities, entities should comply primarily with
the requirements of paragraphs 6,17,19,20,21, and 22 of SFAS 115 (as amended); paragraphs 47
and 48 of SFAS 60 (as amended); paragraphs 22, 23, and 28 of SFAS 91 (as amended); and
Appendix C of this Audit and Accounting Guide. Other disclosure requirements may also be
applicable.
Note 4: Fair Value of Financial Instruments

The following methods and assumptions were used to estimate the fair value of each class of
financial instruments for which it is practicable to estimate that value.
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Short-term investments. For those short-term instruments amortized cost is a reasonable estimate
of fair value.
Investment securities and trading account assets. For securities held for trading purposes and
marketable equity securities held for investment purposes, fair values are based on quoted market
prices or dealer quotes. For other securities held as investments, fair value equals quoted market
price, if available. If a quoted market price is not available, fair value is estimated using quoted
market prices for similar securities.

Mortgage loans on real estate and policy loans. The fair value of mortgage loans on real estate is
estimated using discounted cash flows. The fair value of policy loans is estimated by discounting
the future cash flows using reasonable assumptions for mortality and repayments and using the
current rates at which similar loans would be made to contract holders with similar credit ratings
and the same remaining maturities.

The estimated fair values of ABC's mortgage loans on real estate and policy loans are as follows.
20X1
20X2
(Amounts in thousands)
Carrying
Fair
Carrying
Fair
Amount
Value
Amount
Value

Mortgage loans on real estate
Policy loans

$79,258
43,549

$106,692
51,013

$83,506
60,000

$112,027
59,000

Note 5: Accumulated Other Comprehensive Income
Accumulated other comprehensive income (loss) represents cumulative gains and losses on items
that are not reflected in earnings. The balances and activity for the years 20X2 and 20X1 are as follows.

20X2
20X1
(Amounts in thousands)

Changes in net unrealized gains (losses) on investment securities:
Net unrealized gains (losses) arising during the period
Reclassification adjustment for gains (losses) included
in net earnings
Changes in net unrealized gains (losses) on investment securities
Adjustments for:
Policyholder liabilities, deferred acquisition costs and deferred
federal income taxes
Changes in net unrealized gains (losses) net of adjustments
Total other comprehensive income (loss)

$13,324

$(1,873)

46
13,370

(300)
(2,173)

(4,680)
8,690
$ 8,690

443
(1,730)
$(1,730)

Note 6: Income Taxes
Significant components for income tax expense attributable to continuing operations are as
follows.

20X2

20X1

(Amounts in thousands)

Current income tax expense
Deferred income tax (benefit) expense
Total income tax expense

$ 1,547
(1,405)

$

142

$ 601
540
$1,141

Deferred income taxes reflect the net tax effects of temporary differences between the carrying
amounts of assets and liabilities for financial reporting purposes and the amounts used for income
tax purposes. Significant components of the company's deferred tax liabilities and assets are as
follows.
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December 31,
20X2

December 31,
20X1

(Amounts in thousands)
Deferred tax liabilities:
Deferred policy acquisition costs
Future policy benefits
Accrual of discount on bonds
Other
Total deferred tax liabilities

$13,131
—
924
3,641
17,696

$12,297
512
1,982
1,024
15,815

Deferred tax assets:
Policyholder dividends
Future policy benefits
Deferred policy acquisition costs
Investment valuation allowance
Retirement plan accruals
Tax credits and loss carryforwards
Investment income differences
Other
Total deferred tax assets
Valuation allowance for deferred tax assets
Net deferred tax assets
Net deferred tax liabilities

8,067
851
2,078
1,087
1,917
1,820
574
406
16,800
(516)
16,284
$ 1,412

8,224
—
1,561
1,651
497
1,945
556
354
14,788
—
14,788
$ 1,027

A Valuation allowance has been established due to the uncertainty of realized certain tax credits
and loss carryforwards, and a portion of other deferred tax assets.
A reconciliation of federal income tax expense as presented in the financial statements and income
taxes calculated using the statutory corporate tax rate follows.
20X2
20X1
(Amounts in thousands)
Income from operations
$2,396
$2,870
Application of income tax rate
838
1,005
Small company deduction for life insurance companies
(556)
(496)
Policyholders' share of income (loss) in excess of (less than)
dividends paid
(264)
752
Dividend received deduction
(50)
(3)
Other
127
(70)
Total tax expense
$ 142
$1,141
Note 7: Concentration of Credit Risk
At December 31,20X2, ABC held unrated or less-than-investment grade corporate debt securities
of $8,000,000, net of allowance for losses, with an aggregate market value of $7,500,000. Those
holdings amounted to 4 percent of ABC's corporate debt securities investments and less than 2
percent of total assets. The holdings of less-than-investment grade securities are widely diversi
fied and of satisfactory quality based on ABC's investment policies and credit standards. ABC
also invests in mortgage loans principally involving commercial real estate. At December 31,20X2,
3 percent of such mortgages ($2,000,000) involved properties located in California and Arizona.
Such investments consist of first mortgage liens on completed income-producing properties, and
mortgages on individual properties do not exceed $300,000.

Note 8: Liability for Unpaid Claims and Claim Adjustment Expenses
The liability for unpaid claims and claim adjustment expenses is based on the estimated amount
payable on claims reported prior to the balance sheet date that have hot yet been settled, claims
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reported subsequent to the balance sheet date that have been incurred during the period then
ended, and an estimate (based on prior experience) of incurred but unreported claims relating to
such period.

Activity in the liability for unpaid claims and claim adjustment expenses for the Company's health
and disability coverages is summarized as follows.
20X2

20X1

(Amounts in thousands)
Balance, beginning of year
Less: reinsurance recoverables

$ 4,737
296

$ 7,669
1,018

Net balance, beginning of year

4,441

6,651

Amount incurred, related to
Prior years
Current year

$

Total

Amount paid, related to
Prior years
Current year

Total
Net balance, end of year
Plus: reinsurance recoverables
Balance, end of year

(297)
26,197

$ 313
25,671

25,900

25,984

6,923
18,303

8,937
19,257

25,226

28,194

5,115
303

4,441
296

$ 5,418

$ 4,737

As a result of changes in estimates of insured events in prior years, the claims and claim
adjustment expenses (net of reinsurance recoveries of $(7,000) and $722,000 in 20X2 and 20X1,
respectively) decreased by $297,000 in 20X2 reflecting lower-than-anticipated losses on____
___________ , and increased by $313,000 in 20X1 reflecting higher-than-anticipated losses and
related expenses for claims for_________________ .

Note 9: Minimum Guarantees
The following summarizes the liabilities for guarantees on variable contracts reflected in the
general account:

Balance at January 1
Incurred guarantee
benefits2
Paid guarantee
benefits

Balance at
December 31,20XX3

Minimum
Guaranteed Death
Benefit (MGDB)

Guaranteed
Minimum
Accumulation
Benefit (GMAB)

Guaranteed
Minimum Income
Benefit (GMIB)

Totals

$X,XXX,XXX

$X,XXX,XXX

$X,XXX,XXX

$X,XXX,XXX

X,XXX,XXX

X,XXX,XXX

X,XXX,XXX

$X,XXX,XXX

X,XXX,XXX

X,XXX,XXX

X,XXX,XXX

$X,XXX,XXX

$X,XXX,XXX

$X,XXX,XXX

$X,XXX,XXX

$X,XXX,XXX

2 For guaranteed minimum accumulation benefits, incurred guarantee benefits incorporates all changes in fair value other than
amounts resulting from paid guarantee benefits.
3 Included in the total reserve balance are reserves for variable annuity death benefits of $_____ , variable annuity income benefits of
$_______and other guarantees of $______ .
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The minimum guaranteed death benefit (MGDB) liability is established equal to a benefit ratio
multiplied by the cumulative contract charges earned, plus accrued interest less contract benefit
payments. The benefit ratio is calculated as the estimated present value of all expected contract
benefits divided by the present value of all expected contract charges. The Company regularly
evaluates estimates used and adjusts the additional liability balance, with a related charge or
credit to benefit expense, if actual experience or other evidence suggests that earlier assumptions
should be revised.
The following assumptions and methodology were used to determine the MGDB liability at
December 31,20XX:
•

Data used was 1,000 stochastically generated investment performance scenarios.

•

Mean investment performance assumption was XX.

•

Volatility assumption was XX.

•

Mortality was assumed to be 90 percent of the Annuity 2000 table.

•

Lapse rates vary by contract type and duration and range from 1 percent to 20 percent,
with an average of 3 percent.

•

Discount rate was XX%.

Guaranteed minimum accumulation benefits are considered to be derivatives under SFAS 133,
Accounting for Derivative Instruments and Hedging Activities, and are recognized at fair value
through earnings.
The guaranteed minimum income benefit (GMIB) liability is established equal to a benefit
ratio multiplied by the cumulative contract charges earned, plus accrued interest less contract
benefit payments. The benefit ratio is calculated as the estimated present value of all expected
contract benefits divided by the present value of all expected contract charges. The Company
regularly evaluates estimates used and adjusts the additional liability balance, with a related
charge or credit to benefit expense, if actual experience or other evidence suggests that earlier
assumptions should be revised. The assumptions used for calculating the GMIB liability at
December 31, 20XX, are consistent with those used for calculating the MGDB liability.
[Underlying assumptions for the liability related to income benefits include assumed future
annuitization elections based on factors such as the extent of benefit to the potential annuitant,
eligibility conditions and the annuitant's attained age.] In addition, the calculation of the
GMIB liability assumes X percent of the potential annuitizations that would be beneficial to
the contract holder will be elected.
Note 10: Reinsurance

The Company utilizes indemnity reinsurance agreements to reduce its exposure to large losses
in all aspects of its insurance business. Such reinsurance permits recovery of a portion of losses
from reinsurers, although it does not discharge the primary liability of the Company as direct
insurer of the risks reinsured. The Company evaluates the financial strength of potential reinsur
ers and continually monitors the financial condition of reinsurers. The following tables include
premium amounts ceded/assumed to/from other companies.
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Direct
Amount

Ceded to
Other Companies

Assumed from
Other Companies

Net
Amount

(Amounts in thousands)

20X2

Premiums:
Life insurance
Accident and health
Annuities

Total earned premiums

$2,090
1,440
3,130

$ 560
1,290
—

$3,330
—
70

$4,860
150
3,200

$6,660

$1,850

$3,400

$8,210

$2,080
1,510
1,840

$ 520
1,370
—

$3,680
—
30

$5,240
140
1,870

$5,430

$1,890

$3,710

$7,250

20X1

Premiums:
Life insurance
Accident and health
Annuities

Total earned premiums

Note 11: Separate Accounts

At December 31,20X1 and 20X2, the company had the following variable contracts with guaran
tees. The Company's variable annuity contracts may offer more than one type of guarantee in
each contract; therefore, the sum of amounts listed exceeds the total account balances of variable
annuity contracts' separate accounts with guarantees.
Return of net deposits plus a minimum return:
In the event of death

Account value

$XXX

$XXX

Net amount at risk4

$XXX

$XXX

Average attained age of contract holders

XX

XX

Range of guaranteed minimum return rates

X-X%

X-X%

At annuitization

Account value

$XXX

$XXX

Net amount at risk5

$XXX

$XXX

Weighted average period remaining until expected annuitization

XX

XX

Range of guaranteed minimum return rates

X-X%

X-X%

Accumulation at specified date
Account value

$XXX

$XXX

Net amount at risk6

$XXX

$XXX

Range of guaranteed minimum return rates

X-X%

X-X%

4 Defined as the current guaranteed minimum death benefit in excess of the current account balance at the balance sheet date.
5 Defined as the present value of the minimum guaranteed annuity payments determined in accordance with the terms of the
contract in excess of the current account balance.

6 Defined as the present value of the guaranteed minimum accumulation balance in excess of the current account balance.
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Account balances of contracts with guarantees were invested in variable separate accounts as
follows:

Asset Type
U.S. Treasury securities and obligations of
U.S. government corporations and agencies
Obligations of states of the United States and
political subdivisions of the states

December 31,20X1

December 31,20X2

$

$

$X,XXX,XXX

$X,XXX,XXX

Corporate debt securities:
—Investment grade
—Noninvestment grade
Foreign debt securities
Mortgage-backed securities
Equity securities (including mutual funds)7
Real estate
Mortgage loans
Derivative financial instruments
Cash and cash equivalents
Total

Assets transferred from the general account to the separate accounts are recognized at fair value
to the extent of third-party contract holders' proportionate interest in separate accounts when the
arrangement meets applicable criteria (paragraph 11 of SOP 03-1). The gains recognized assets
transferred to the separate accounts during 20X2 and 20X1 were XX,XXX and XX,XXX, respec
tively.
Note 12: Guaranty Fund Assessments

At December 31,20X2 and 20X1, ABC has recorded $45,000 and $67,000, respectively, in liabilities
related to guaranty fund (and other) assessments which are included in other liabilities in the
balance sheet. At December 31,20X2 and 20X1, the carried liability Was reduced by recoverables
for related premium tax offsets and policy surcharges in the amount of $25,000 and $35,000,
respectively. The period over which the assessments are expected to be paid and the recorded
premium tax offsets and policy surcharges are expected to be realized is up to five and four years,
respectively.

Note 13: Statutory Financial Information
Under the law of ABC State, the state of incorporation, the maximum dividend that may be paid
(without prior approval of the (ABC State) Insurance Department), in any twelve-month period
is the greater of (a) net investment income for the preceding calendar year or (b) 10 percent of
contract holders' surplus at the end of the preceding calendar year. In general, net investment
income for dividend purposes is interpreted by the Insurance Department to be the statutory
pretax net investment income including net realized capital losses but excluding net realized
capital gains. The maximum permissible amount of dividends for 20X3, based on statutory net
investment income for 20X2, is $20,000.
The Company, which is domiciled in ABC State, prepares its statutory financial statements in
accordance with accounting principles and practices prescribed or permitted by the ABC state
insurance department, which (state of domicile) recognizes for determining solvency under the
7 The insurance enterprise may want to consider disclosing mutual funds by investment objective or other meaningful groupings
that are useful in understanding the nature of the guarantee risk.
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(state of domicile) Insurance Law. The commissioner of the state of domicile Insurance Depart
ment has the right to permit other practices that may deviate from prescribed practices. Prescribed
SAP are those practices that are incorporated directly or by reference in state laws, regulations,
and general administrative rules applicable to all insurance enterprises domiciled in (state of
domicile). Permitted SAP encompass all accounting practices that are not prescribed; such
practices differ from state to state, may differ from company to company within a state, and may
change in the future.
Note: Although the following reconciliation to statutory financial information is not required to
be disclosed in financial statements prepared in conformity with GAAP, insurance entities
sometimes include such disclosures to facilitate use of those financial statements for purposes of
filing with state regulatory authorities. The second disclosure on variances from NAIC SAP (as
defined below) and permitted accounting practices is required under SOP 94-5, as amemded by
SOP 01-5.

The following reconciles ABC's statutory net income and statutory surplus and capital stock
determined in accordance with accounting practices prescribed or permitted by the Insurance
Department of Connecticut with net earnings (loss) and equity on a GAAP basis.
20X2

20X1

(Amounts in thousands)
Statutory net income
Adjustments:
Future policy benefits and policyholders' account balances
Deferred policy acquisition costs
Deferred federal income tax (expense) benefit
Valuation of investments
Postretirement benefits
Other, net

$ 3,572

GAAP net income

$ 2,254

$ 1,729

Statutory surplus and capital stock
Asset valuation reserves
Statutory surplus, capital stock and asset valuation reserves

$65,388
(1,054)
(875)

$54,505
(1,972)
(967)

Adjustments:
Fixed income securities
Future policy benefits and policyholders' account balances
Deferred federal income taxes
Valuation of investments
Deferred policy acquisition costs
Postretirement benefits
Other, net

(29,472)
115
(1,412)
772
38,936
(2,272)
(1,228)

(27,905)
270
(1,027)
891
36,429
(2,354)
(1,084)

GAAP equity

$69,898

$58,954

572
60
(1,405)
115
272
(932)

$ 2,719
894
40
540
270
354
(3,088)

The Company's statutory financial statements are presented on the basis of accounting practices
prescribed or permitted by the [state of domicile] Insurance Department. [State of domicile] has
adopted the National Association of Insurance Commissioners' statutory accounting practices
(NAIC SAP) as the basis of its statutory accounting practices, except that it has retained the
prescribed practice of writing off goodwill immediately to statutory surplus in the year of
acquisition.
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In addition, the commissioner of [state of domicile] Insurance Department has the right to permit
other specific practices that may deviate from prescribed practices. The commissioner has
permitted the Company to record its home office property at estimated fair value instead of at
depreciated cost, as required by NAIC SAP. This accounting practice increased statutory capital
and surplus by $X million and $X million at December 31,20X2 and 20X1, respectively, over what
it would have been had the permitted practice not been allowed. The Company's statutory capital
and surplus, including the effects of the permitted practice, was $X million and $X million at
December 31,20X2 and 20X1, respectively.

Had the Company amortized its goodwill over ten years and recorded its home office property
at depreciated cost, in accordance with NAIC SAP, the Company's capital and surplus would
have been $X million and $X million at December 31,20X2 and 20X1, respectively.
Note 14: Commitments and Contingencies
Future minimum rental payments, principally for administrative offices, under noncancellable
operating leases at December 31, 20X2, are: 20X3, $1,113,000; 20X4, $1,064,000; 20X5, $1,011,000;
20X6, $976,000; 20X7, $976,000; and $3,906,000 thereafter. Rental expense was $1,164,000 in 20X2
and $1,184,000 in 20X1.

ABC is named as defendant in a number of legal actions arising primarily from claims made under
insurance contracts or in connection with previous reinsurance agreements. These actions have
been considered in establishing its contract benefit liability. Management and its legal counsel are
of the opinion that the settlement of these actions will not have a material effect on ABC's financial
position or results of operations.
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